| Symbol | NVO |
|---|---|
| Name | NOVO NORDISK A S |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Pharmaceutical Preparations |
| Address | NOVO ALLE DK 2880, BAGSVAERD DENMARK, G7 00000 |
| Telephone | 4544448888 |
| Fax | — |
| — | |
| Website | https://www.novonordisk.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000353278 |
| Description | Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Additional info from NASDAQ: |
2026-08-10 12:00
Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI
Read more
2026-08-05 13:48
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
Read more
2026-08-04 16:40
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
Read more
2026-08-04 16:37
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
Read more
2026-07-31 11:26
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
Read more
2026-07-21 11:35
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT04921956 | Compassionate Use of Concizumab if You Have Haemophilia | — | Congenital Haemophilia | Available | — | — | ClinicalTrials.gov |
| NCT00663624 | Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcuta… | Phase4 | Diabetes | Withdrawn | — | — | ClinicalTrials.gov |
| NCT07731256 | Semaglutide for Low Back Pain | Phase2 | Lower Back Pain | Not_Yet_Recruiting | 2027-02-01 | 2031-09-01 | ClinicalTrials.gov |
| NCT07668401 | AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Help… | Phase3 | Obesity | Not_Yet_Recruiting | 2027-01-07 | 2029-01-11 | ClinicalTrials.gov |
| NCT06977438 | GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward | Phase4 | Obesity, Childhood | Not_Yet_Recruiting | 2026-10-01 | 2032-01-31 | ClinicalTrials.gov |
| NCT07668414 | A Research Study Investigating How Well the Medicine Zenagamtide Helps People W… | Phase3 | Overweight | Not_Yet_Recruiting | 2026-09-22 | 2028-10-10 | ClinicalTrials.gov |
| NCT07720271 | AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help Peopl… | Phase3 | Overweight | Not_Yet_Recruiting | 2026-09-01 | 2028-08-22 | ClinicalTrials.gov |
| NCT07357740 | A Research Study to Compare Two Different Versions of Injectable CagriSema in P… | Phase2 | Diabetes Mellitus, Type 2 | Withdrawn | 2026-08-27 | 2027-10-13 | ClinicalTrials.gov |
| NCT07663123 | Health Assessment of Low Glycaemic Index - High Protein Rice to Enhance Glycemi… | Na | Prediabetes / Type 2 Diabetes | Not_Yet_Recruiting | 2026-08-10 | 2029-04-30 | ClinicalTrials.gov |
| NCT07282613 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight C… | Phase3 | Diabetes Mellitus, Type 2 | Not_Yet_Recruiting | 2026-08-04 | 2030-03-30 | ClinicalTrials.gov |
| NCT07745504 | A Research Study to Compare Two Different Versions of Injectable Cagrilintide a… | Phase3 | Overweight | Not_Yet_Recruiting | 2026-08-04 | 2027-07-06 | ClinicalTrials.gov |
| NCT07757087 | A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a … | Phase1 | Overweight | Recruiting | 2026-08-03 | 2028-09-18 | ClinicalTrials.gov |
| NCT07710729 | A Research Study Looking Into How UBT251 Works With Birth Control Tablets and E… | Phase1 | Overweight | Not_Yet_Recruiting | 2026-07-17 | 2027-04-27 | ClinicalTrials.gov |
| NCT07710768 | A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfar… | Phase1 | Obesity | Not_Yet_Recruiting | 2026-07-15 | 2027-04-07 | ClinicalTrials.gov |
| NCT07739901 | Korean Real-world Study on MASLD/MASH Outcomes. | — | MASLD/MASH | Active_Not_Recruiting | 2026-07-13 | 2026-09-30 | ClinicalTrials.gov |
| NCT07653139 | Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: … | — | Haemophilia A | Not_Yet_Recruiting | 2026-07-10 | 2026-10-26 | ClinicalTrials.gov |
| NCT07607600 | Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X… | — | X-linked Hypophosphatemia (XLH) | Not_Yet_Recruiting | 2026-07-07 | 2030-07-07 | ClinicalTrials.gov |
| NCT07693868 | A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and … | Phase1 | Obesity | Not_Yet_Recruiting | 2026-07-06 | 2027-08-01 | ClinicalTrials.gov |
| NCT07357766 | A Research Study to Compare Different Versions of Injectable CagriSema and Plac… | Phase3 | Overweight | Withdrawn | 2026-06-22 | 2028-01-17 | ClinicalTrials.gov |
| NCT07668388 | A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lowe… | Phase2 | Diabetes Mellitus, Type 2 | Recruiting | 2026-06-22 | 2027-11-15 | ClinicalTrials.gov |
| NCT07656454 | A Study Understanding How Much CDR132L Enters the Bloodstream After Injection U… | Phase1 | Healthy Volunteers | Recruiting | 2026-06-17 | 2026-12-31 | ClinicalTrials.gov |
| NCT07658417 | Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adher… | — | Diabetes Mellitus, Type 2 | Not_Yet_Recruiting | 2026-06-15 | 2027-12-01 | ClinicalTrials.gov |
| NCT07639021 | A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-041… | Phase2 | Obesity | Recruiting | 2026-06-09 | 2027-07-12 | ClinicalTrials.gov |
| NCT07673822 | Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Kor… | — | Diabetes Mellitus, Type 2 | Enrolling_By_Invitation | 2026-06-08 | 2026-08-03 | ClinicalTrials.gov |
| NCT07632404 | A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adh… | — | Diabetes Mellitus, Type 2 | Not_Yet_Recruiting | 2026-06-05 | 2027-12-01 | ClinicalTrials.gov |
| NCT07682363 | Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease… | — | Liver Disease | Recruiting | 2026-06-03 | 2027-02-23 | ClinicalTrials.gov |
| NCT07423481 | Weight Trajectories and Predictive Factors After Semaglutide in Patients With G… | — | Obesity & Overweight | Not_Yet_Recruiting | 2026-06-01 | 2027-03-01 | ClinicalTrials.gov |
| NCT07607587 | Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating G… | Phase1 | Obesity | Recruiting | 2026-05-29 | 2027-11-19 | ClinicalTrials.gov |
| NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose o… | Phase3 | Obesity | Recruiting | 2026-05-21 | 2028-04-19 | ClinicalTrials.gov |
| NCT07605052 | A Research Study to Compare Blood Levels of Two Different Versions of Cagrilint… | Phase1 | Overweight | Active_Not_Recruiting | 2026-05-20 | 2026-09-03 | ClinicalTrials.gov |
| NCT07400107 | AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Comp… | Phase3 | Obesity | Not_Yet_Recruiting | 2026-05-20 | 2029-01-26 | ClinicalTrials.gov |
| NCT07597018 | A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses o… | Phase1 | Obesity | Recruiting | 2026-05-18 | 2027-06-01 | ClinicalTrials.gov |
| NCT07587710 | A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the … | Phase1 | Overweight | Not_Yet_Recruiting | 2026-05-13 | 2027-12-01 | ClinicalTrials.gov |
| NCT07627074 | Weight Loss in Adults Using Semaglutide (Real-world Study) | — | Overweight | Recruiting | 2026-05-12 | 2026-06-01 | ClinicalTrials.gov |
| NCT07567001 | A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in … | Phase3 | Obesity | Recruiting | 2026-05-11 | 2029-08-15 | ClinicalTrials.gov |
| NCT07578584 | A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participan… | Phase1 | Type 1 Diabetes (T1D) | Recruiting | 2026-05-07 | 2028-02-18 | ClinicalTrials.gov |
| NCT07571109 | AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Help… | Phase3 | Obesity | Recruiting | 2026-05-05 | 2028-08-21 | ClinicalTrials.gov |
| NCT07571005 | AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Help… | Phase3 | Obesity | Recruiting | 2026-05-05 | 2028-10-04 | ClinicalTrials.gov |
| NCT07570992 | A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy P… | Phase1 | Healthy Volunteers | Recruiting | 2026-05-04 | 2028-06-25 | ClinicalTrials.gov |
| NCT07566390 | A Research Study Investigating How a New Medicine NNC0113-5840 Works in People … | Phase1 | Obesity | Recruiting | 2026-05-01 | 2026-12-26 | ClinicalTrials.gov |
| NCT07557953 | A Research Study Looking Into How Cagrilintide Influences Food Intake and Appet… | Phase1 | Overweight | Recruiting | 2026-04-30 | 2027-04-13 | ClinicalTrials.gov |
| NCT07503210 | AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Hel… | Phase3 | Obesity | Recruiting | 2026-04-21 | 2028-07-04 | ClinicalTrials.gov |
| NCT07509307 | AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Help… | Phase3 | Obesity | Recruiting | 2026-04-20 | 2028-08-14 | ClinicalTrials.gov |
| NCT07415954 | A Research Study Comparing How Well Different Doses of the Medicine NNC0662-041… | Phase2 | Diabetes Mellitus, Type 2 | Recruiting | 2026-04-17 | 2027-10-01 | ClinicalTrials.gov |
| NCT07481630 | A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People … | Phase3 | Obesity | Recruiting | 2026-04-13 | 2028-08-14 | ClinicalTrials.gov |
| NCT07533175 | AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Help… | Phase3 | Diabetes Mellitus | Recruiting | 2026-04-13 | 2028-08-07 | ClinicalTrials.gov |
| NCT07535307 | Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes | Phase1 | Diabetes Mellitus | Recruiting | 2026-04-10 | 2027-12-06 | ClinicalTrials.gov |
| NCT07527195 | Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle … | Phase1 | Obesity | Recruiting | 2026-04-10 | 2028-06-09 | ClinicalTrials.gov |
| NCT07525791 | A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills a… | Phase1 | Overweight | Recruiting | 2026-04-07 | 2027-05-04 | ClinicalTrials.gov |
| NCT07508020 | A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and … | Phase1 | Obesity | Recruiting | 2026-03-30 | 2028-01-22 | ClinicalTrials.gov |
| NCT07532863 | A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagn… | — | Diabetes Mellitus, Type 2 | Recruiting | 2026-03-13 | 2027-03-27 | ClinicalTrials.gov |
| NCT07448623 | A Research Study to Look at the Distribution and Effects of Coramitug on Amyloi… | Phase1 | Transthyretin Amyloid Cardiomyopathy | Recruiting | 2026-03-02 | 2028-07-25 | ClinicalTrials.gov |
| NCT07437079 | A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Livi… | Phase1 | Overweight | Recruiting | 2026-02-24 | 2027-01-21 | ClinicalTrials.gov |
| NCT07339423 | AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Help… | Phase3 | Obesity | Recruiting | 2026-02-24 | 2029-08-21 | ClinicalTrials.gov |
| NCT07456774 | A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adhere… | — | Type 2 Diabetes | Enrolling_By_Invitation | 2026-02-13 | 2026-08-31 | ClinicalTrials.gov |
| NCT07411560 | A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Aff… | Phase1 | Overweight | Recruiting | 2026-02-09 | 2027-01-26 | ClinicalTrials.gov |
| NCT05689372 | Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to… | — | Diabetes Mellitus, Type 2 | Enrolling_By_Invitation | 2026-02-02 | 2027-05-31 | ClinicalTrials.gov |
| NCT07395687 | A Research Study on How Well Different Doses of the Medicine UBT251 Help People… | Phase2 | Overweight | Recruiting | 2026-02-02 | 2027-02-18 | ClinicalTrials.gov |
| NCT07246421 | Glucagon Resistance in Patients With MASLD and T2DM | Na | Metabolic Associated Fatty Liver Disease | Recruiting | 2026-01-29 | 2028-07-31 | ClinicalTrials.gov |
| NCT07404150 | Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in W… | — | Obesity and Cardiovascular Risk | Enrolling_By_Invitation | 2026-01-12 | 2027-09-15 | ClinicalTrials.gov |
| NCT07253285 | A Research Study on How Well Cagrilintide and CagriSema Work in Children and Ad… | Phase3 | Overweight | Recruiting | 2026-01-08 | 2033-09-20 | ClinicalTrials.gov |
| NCT07713901 | Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma | — | Medullary Thyroid Carcinoma | Enrolling_By_Invitation | 2025-12-31 | 2026-12-31 | ClinicalTrials.gov |
| NCT05714683 | Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semagluti… | — | Diabetes Mellitus, Type 2 | Not_Yet_Recruiting | 2025-12-31 | 2026-10-30 | ClinicalTrials.gov |
| NCT07276282 | Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acu… | Phase3 | Coronary Artery Disease | Recruiting | 2025-12-19 | 2028-12-01 | ClinicalTrials.gov |
| NCT07301034 | A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood V… | Phase3 | Myocardial Infarction | Recruiting | 2025-12-18 | 2029-02-24 | ClinicalTrials.gov |
| NCT07305805 | A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Dia… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2025-12-16 | 2026-05-08 | ClinicalTrials.gov |
| NCT07358052 | Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Popula… | — | Obesity | Completed | 2025-12-08 | 2025-12-12 | ClinicalTrials.gov |
| NCT07271251 | A Research Study to See if Two Different Formulations of Oral Semaglutide Are E… | Phase3 | Type 2 Diabetes | Completed | 2025-12-01 | 2026-08-04 | ClinicalTrials.gov |
| NCT07255807 | Defining the Human Insulin Resistance Molecular Network; SIGNATURE | Na | Metabolic Health | Not_Yet_Recruiting | 2025-12-01 | 2038-06-30 | ClinicalTrials.gov |
| NCT07302802 | Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adole… | — | Monogenic Obesity | Recruiting | 2025-12-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07270731 | A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and P… | Phase1 | Healthy Volunteer | Recruiting | 2025-11-25 | 2028-03-15 | ClinicalTrials.gov |
| NCT07238816 | A Research Study Looking at How Food Intake Affects Inno8 in the Body of Health… | Phase1 | Haemophilia A | Completed | 2025-11-18 | 2026-05-08 | ClinicalTrials.gov |
| NCT06185296 | The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patient… | Na | Type 2 Diabetes Treated With Insulin | Recruiting | 2025-11-15 | 2026-09-01 | ClinicalTrials.gov |
| NCT07444203 | Transformative Research in Diabetic Nephropathy 2.0 | — | Diabetic Nephropathies | Recruiting | 2025-11-12 | 2028-11-12 | ClinicalTrials.gov |
| NCT07280221 | WEgovy Real World Assessment of Weight Loss in Korea | — | Obesity | Enrolling_By_Invitation | 2025-11-10 | 2027-10-31 | ClinicalTrials.gov |
| NCT07225816 | Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medi… | Phase1 | Obesity | Recruiting | 2025-11-07 | 2027-01-06 | ClinicalTrials.gov |
| NCT07220642 | Weight Loss in People Living With Overweight or Obesity Following Treatment Wit… | Phase3 | Obesity | Active_Not_Recruiting | 2025-11-05 | 2027-06-29 | ClinicalTrials.gov |
| NCT07220759 | Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Fol… | Phase3 | Overweight | Active_Not_Recruiting | 2025-11-05 | 2027-06-30 | ClinicalTrials.gov |
| NCT07220564 | A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work … | Phase1 | Haemophilia A | Recruiting | 2025-10-23 | 2027-02-05 | ClinicalTrials.gov |
| NCT07218627 | A Research Study on the Effects of NNC0537-1482 in Participants With Heart Fail… | Phase1 | Heart Failure | Recruiting | 2025-10-23 | 2027-01-15 | ClinicalTrials.gov |
| NCT07191925 | An Evaluation of "Growing Healthy Places: Mississauga" | Na | Quality of Life (QOL) | Active_Not_Recruiting | 2025-10-16 | 2027-11-01 | ClinicalTrials.gov |
| NCT07214870 | A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease i… | Phase1 | Fatty Liver Disease | Recruiting | 2025-10-08 | 2027-05-14 | ClinicalTrials.gov |
| NCT07207811 | CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicin… | Phase3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | Recruiting | 2025-10-02 | 2029-06-29 | ClinicalTrials.gov |
| NCT07201831 | A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Unders… | — | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Completed | 2025-10-02 | 2026-01-17 | ClinicalTrials.gov |
| NCT07184632 | A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help … | Phase2 | Overweight | Active_Not_Recruiting | 2025-10-01 | 2026-12-14 | ClinicalTrials.gov |
| NCT07184086 | A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention … | Phase1 | Obesity | Recruiting | 2025-09-26 | 2027-10-12 | ClinicalTrials.gov |
| NCT07154238 | Characteristics and Treatment Experiences of Individuals Using Injectable Semag… | — | Obesity | Enrolling_By_Invitation | 2025-09-26 | 2026-09-30 | ClinicalTrials.gov |
| NCT07500610 | Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact … | — | Peripheral Vascular Disease | Recruiting | 2025-09-25 | 2026-07-01 | ClinicalTrials.gov |
| NCT07160829 | Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Sys… | — | Atherosclerotic Cardiovascular Disease | Completed | 2025-09-18 | 2025-10-30 | ClinicalTrials.gov |
| NCT07141914 | A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related… | — | Overweight | Completed | 2025-08-29 | 2025-12-19 | ClinicalTrials.gov |
| NCT07160816 | A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Co… | — | Diabetes Mellitus, Type 1 | Active_Not_Recruiting | 2025-08-28 | 2027-01-20 | ClinicalTrials.gov |
| NCT07157423 | A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleedi… | Phase4 | Severe Postpartum Haemorrhage | Recruiting | 2025-08-26 | 2027-08-26 | ClinicalTrials.gov |
| NCT07112339 | A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Le… | Phase4 | Diabetes Mellitus, Type 2 | Recruiting | 2025-08-15 | 2028-03-23 | ClinicalTrials.gov |
| NCT07076199 | A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing… | Phase3 | Diabetes Mellitus, Type 1 | Recruiting | 2025-08-11 | 2027-03-01 | ClinicalTrials.gov |
| NCT07121153 | A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Particip… | Phase1 | Overweight | Completed | 2025-08-11 | 2025-12-20 | ClinicalTrials.gov |
| NCT07081178 | A Non-interventional Study Investigating Semaglutide in Combination With Lifest… | — | Obesity | Terminated | 2025-08-08 | 2025-12-18 | ClinicalTrials.gov |
| NCT07153172 | Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108 | Phase1 | Obesity | Recruiting | 2025-08-06 | 2027-09-15 | ClinicalTrials.gov |
| NCT07101783 | A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and N… | Phase1 | Overweight | Completed | 2025-08-01 | 2025-10-31 | ClinicalTrials.gov |
| NCT07068295 | A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants Wi… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2025-07-11 | 2026-03-10 | ClinicalTrials.gov |
| NCT07087795 | A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglut… | Phase1 | Diabetes Mellitus, Type 1 | Active_Not_Recruiting | 2025-07-01 | 2026-09-25 | ClinicalTrials.gov |
| NCT07061665 | Cities for Better Health Childhood Obesity Prevention Initiative in JAPAN | Na | Quality of Life (QOL) | Not_Yet_Recruiting | 2025-07-01 | 2027-09-01 | ClinicalTrials.gov |
| NCT07052292 | User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes | — | Diabetes Mellitus, Type 1 | Completed | 2025-07-01 | 2026-01-09 | ClinicalTrials.gov |
| NCT06979375 | A Research Study Comparing CDR132L With Placebo on the Structure and Function o… | Phase2 | Heart Failure | Recruiting | 2025-06-30 | 2028-01-23 | ClinicalTrials.gov |
| NCT06979362 | A Research Study Comparing Different Doses of CDR132L With Placebo on the Struc… | Phase2 | Heart Failure | Recruiting | 2025-06-27 | 2028-07-25 | ClinicalTrials.gov |
| NCT07029568 | A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People | Phase1 | Healthy Volunteers | Completed | 2025-06-13 | 2025-12-10 | ClinicalTrials.gov |
| NCT07010432 | The Role of the Amylin Analogue Cagrilintide in Bone Metabolism | Phase1 | Obesity | Recruiting | 2025-06-12 | 2028-05-03 | ClinicalTrials.gov |
| NCT07023029 | A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2025-06-09 | 2025-09-22 | ClinicalTrials.gov |
| NCT07237685 | Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellit… | — | Type 2 Diabetes | Recruiting | 2025-06-06 | 2036-10-01 | ClinicalTrials.gov |
| NCT07011667 | A Research Study to Look at How Well CagriSema Helps People Living With Obesity… | Phase3 | Obesity | Active_Not_Recruiting | 2025-06-03 | 2028-10-17 | ClinicalTrials.gov |
| NCT07004322 | A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2025-05-26 | 2026-01-28 | ClinicalTrials.gov |
| NCT07227246 | Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 | Phase3 | Intracerebral Hemorrhage | Recruiting | 2025-05-06 | 2029-06-01 | ClinicalTrials.gov |
| NCT06831734 | Post-marketing Surveillance (Special Use-results Surveillance) on Treatment Wit… | — | Haemophilia A, Haemophilia B | Enrolling_By_Invitation | 2025-05-02 | 2031-01-31 | ClinicalTrials.gov |
| NCT07055607 | A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Pr… | — | Obesity | Enrolling_By_Invitation | 2025-05-01 | 2028-08-15 | ClinicalTrials.gov |
| NCT06855563 | Cities for Better Health Childhood Obesity Prevention Initiative | Na | Obesity | Enrolling_By_Invitation | 2025-04-30 | 2027-12-31 | ClinicalTrials.gov |
| NCT06807190 | General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus | — | Diabetes Mellitus, Type 1 | Recruiting | 2025-04-15 | 2028-01-31 | ClinicalTrials.gov |
| NCT06805539 | A Study Collecting Remote Data in People With an Overweight Condition or Obesit… | — | Overweight, Obesity | Completed | 2025-04-14 | 2026-04-20 | ClinicalTrials.gov |
| NCT07121114 | CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (C… | — | Type 2 Diabetes Mellitus | Completed | 2025-04-09 | 2025-07-09 | ClinicalTrials.gov |
| NCT06843473 | Prevalence of Weight Related Complications Across Diverse Weight Classification… | — | Obesity | Completed | 2025-03-18 | 2025-10-11 | ClinicalTrials.gov |
| NCT06891365 | Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases | Phase1 | Healthy Volunteers | Recruiting | 2025-03-12 | 2027-11-15 | ClinicalTrials.gov |
| NCT05829460 | Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity… | Phase2 | Endometrial Hyperplasia | Withdrawn | 2025-03-12 | 2032-04-30 | ClinicalTrials.gov |
| NCT06856902 | BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-… | Na | Cardiovascular Diseases | Recruiting | 2025-03-01 | 2026-09-30 | ClinicalTrials.gov |
| NCT06612268 | A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | Phase3 | Sickle Cell Disease | Recruiting | 2025-02-17 | 2029-08-12 | ClinicalTrials.gov |
| NCT06780449 | A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema … | Phase3 | Obesity | Active_Not_Recruiting | 2025-02-10 | 2028-10-31 | ClinicalTrials.gov |
| NCT06820476 | A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Particip… | Phase1 | Overweight | Completed | 2025-02-09 | 2025-05-14 | ClinicalTrials.gov |
| NCT06813924 | A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Particip… | Phase1 | Healthy Volunteers Sickle Cell Disease, Thalassemia | Completed | 2025-02-06 | 2025-05-27 | ClinicalTrials.gov |
| NCT07163260 | Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia | — | Haemophilia | Enrolling_By_Invitation | 2025-01-31 | 2025-12-19 | ClinicalTrials.gov |
| NCT06797869 | A Research Study to Investigate the Effects of CagriSema Compared to Placebo in… | Phase2 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2025-01-29 | 2026-08-21 | ClinicalTrials.gov |
| NCT06809621 | A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants Wi… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2025-01-29 | 2025-07-28 | ClinicalTrials.gov |
| NCT06741111 | A Real-world Assessment in Implementation of the MASH Patient Care Pathway in C… | — | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH) | Completed | 2025-01-21 | 2025-05-27 | ClinicalTrials.gov |
| NCT06609226 | A Research Study Looking at Long-term Treatment With Etavopivat in People With … | Phase3 | Sickle Cell Disease | Recruiting | 2025-01-10 | 2030-12-30 | ClinicalTrials.gov |
| NCT05314140 | Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes… | — | Diabetes Mellitus | Withdrawn | 2025-01-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT06737536 | A First-in-human Research Study on How NNC0662-0419 Works in People Living With… | Phase1 | Overweight | Completed | 2024-12-18 | 2025-07-26 | ClinicalTrials.gov |
| NCT06709040 | A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treate… | — | Growth Hormone Deficiency | Enrolling_By_Invitation | 2024-12-13 | 2034-04-14 | ClinicalTrials.gov |
| NCT06752967 | Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) | Na | Obesity | Recruiting | 2024-12-12 | 2026-06-29 | ClinicalTrials.gov |
| NCT06874751 | Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obe… | — | Overweight | Completed | 2024-12-06 | 2025-03-28 | ClinicalTrials.gov |
| NCT06719011 | A Study on How NNC0174-1213 Works in People With Overweight or Obesity. | Phase1 | Obesity | Recruiting | 2024-12-03 | 2026-05-17 | ClinicalTrials.gov |
| NCT06716307 | A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After … | Phase1 | Obesity | Completed | 2024-12-02 | 2025-05-22 | ClinicalTrials.gov |
| NCT06769646 | SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Fou… | — | Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD) | Completed | 2024-12-02 | 2025-01-06 | ClinicalTrials.gov |
| NCT06717698 | A Research Study Comparing How Well Different Doses of the Medicine NNC0519-013… | Phase2 | Chronic Kidney Disease | Recruiting | 2024-12-02 | 2026-09-17 | ClinicalTrials.gov |
| NCT06655493 | Levels of Inflammation in Middle East People With Cardiovascular Disease With/W… | — | Systemic Inflammation (hsCRP) | Completed | 2024-11-22 | 2025-08-28 | ClinicalTrials.gov |
| NCT06718998 | A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-013… | Phase1 | Obesity | Completed | 2024-11-20 | 2026-01-12 | ClinicalTrials.gov |
| NCT07018544 | A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-mark… | — | Obesity and Overweight | Enrolling_By_Invitation | 2024-11-19 | 2027-02-28 | ClinicalTrials.gov |
| NCT06859073 | A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participa… | Phase1 | Healthy Volunteers | Recruiting | 2024-11-13 | 2026-06-01 | ClinicalTrials.gov |
| NCT06685185 | A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Par… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2024-11-12 | 2026-03-18 | ClinicalTrials.gov |
| NCT06574984 | Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients | — | Congenital Bleeding Disorder | Completed | 2024-11-10 | 2025-11-04 | ClinicalTrials.gov |
| NCT06113341 | A Research Study in Italy to Understand How the Dose Check App Used With Xultop… | — | Diabetes Mellitus, Type 2 | Withdrawn | 2024-11-07 | 2026-03-02 | ClinicalTrials.gov |
| NCT06534411 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight C… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2024-11-05 | 2026-07-09 | ClinicalTrials.gov |
| NCT06642571 | A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blo… | Phase1 | Obesity | Completed | 2024-10-15 | 2025-05-31 | ClinicalTrials.gov |
| NCT06642584 | A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral For… | Phase1 | Healthy Volunteers Type 2 Diabetes | Completed | 2024-10-15 | 2025-08-13 | ClinicalTrials.gov |
| NCT06789900 | Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women | Phase2 | Postmenopausal Women | Active_Not_Recruiting | 2024-10-14 | 2026-10-01 | ClinicalTrials.gov |
| NCT06625307 | A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Inj… | Phase1 | Healthy Volunteers | Completed | 2024-10-03 | 2025-05-04 | ClinicalTrials.gov |
| NCT06269120 | SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Sem… | — | Type 2 Diabetes | Completed | 2024-09-30 | 2026-05-05 | ClinicalTrials.gov |
| NCT06649630 | A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the B… | Phase1 | Haemophilia A | Completed | 2024-09-23 | 2026-03-26 | ClinicalTrials.gov |
| NCT06571383 | STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps T… | Phase4 | Obesity | Active_Not_Recruiting | 2024-09-17 | 2031-11-15 | ClinicalTrials.gov |
| NCT06588504 | Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2024-09-10 | 2025-07-20 | ClinicalTrials.gov |
| NCT06589791 | A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation … | — | Atherosclerotic Cardiovascular Disease (ASCVD) | Completed | 2024-09-09 | 2024-12-05 | ClinicalTrials.gov |
| NCT06507475 | Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type… | — | Diabetes Mellitus, Type 2 | Completed | 2024-09-07 | 2024-12-20 | ClinicalTrials.gov |
| NCT06577766 | A Research Study on How NNC0638-0355, a New Medicine, Works in People Living Wi… | Phase1 | Obesity | Active_Not_Recruiting | 2024-09-03 | 2026-09-24 | ClinicalTrials.gov |
| NCT06442644 | Live Music in the Intensive Care Unit | Na | Stress | Not_Yet_Recruiting | 2024-09-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06581627 | A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Part… | Phase1 | Healthy Volunteers | Completed | 2024-08-26 | 2024-10-31 | ClinicalTrials.gov |
| NCT06559527 | A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-08-20 | 2025-03-05 | ClinicalTrials.gov |
| NCT06449625 | Semaglutide in Auto-HSCT | Phase2 | Intestinal Mucositis | Not_Yet_Recruiting | 2024-08-12 | 2027-02-01 | ClinicalTrials.gov |
| NCT06542536 | A Research Study Investigating Safety and Concentration in the Blood After One … | Phase1 | Obesity | Completed | 2024-08-09 | 2024-10-25 | ClinicalTrials.gov |
| NCT06285071 | Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® i… | — | Haemophilia A | Enrolling_By_Invitation | 2024-08-08 | 2030-04-30 | ClinicalTrials.gov |
| NCT06567041 | A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-08-07 | 2025-12-10 | ClinicalTrials.gov |
| NCT06542874 | A Research Study Comparing How Well Different Doses of the Medicine NNC0487-011… | Phase2 | Type 2 Diabetes (T2D) | Completed | 2024-08-07 | 2025-10-24 | ClinicalTrials.gov |
| NCT06513104 | A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a B… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-07-18 | 2025-09-30 | ClinicalTrials.gov |
| NCT06411210 | Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment | Phase2 | Diabetes type1 | Recruiting | 2024-07-16 | 2028-06-30 | ClinicalTrials.gov |
| NCT06517784 | Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian… | — | Type 2 Diabetes | Completed | 2024-07-05 | 2024-08-16 | ClinicalTrials.gov |
| NCT06421467 | Insulin Injection Practices in Spain | — | Diabetes | Not_Yet_Recruiting | 2024-07-01 | 2024-10-01 | ClinicalTrials.gov |
| NCT06478563 | A Research Study Looking at Different Oral Formulations and the Effect of Food … | Phase1 | Obesity | Completed | 2024-06-27 | 2025-07-01 | ClinicalTrials.gov |
| NCT06478550 | A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® an… | — | Diabetes Mellitus, Type 2 | Completed | 2024-06-26 | 2025-04-23 | ClinicalTrials.gov |
| NCT06118281 | ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placeb… | Phase3 | Cardiovascular Risk | Recruiting | 2024-06-25 | 2026-12-14 | ClinicalTrials.gov |
| NCT06388187 | A Research Study to See How Well Different Doses of CagriSema Help People With … | Phase3 | Obesity | Completed | 2024-06-24 | 2026-04-22 | ClinicalTrials.gov |
| NCT06461039 | A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Cont… | Phase1 | Obesity | Completed | 2024-06-14 | 2025-04-04 | ClinicalTrials.gov |
| NCT06283667 | Special Use - Results Surveillance on Long-term Use With Wegovy® | — | Obesity | Active_Not_Recruiting | 2024-06-11 | 2028-01-31 | ClinicalTrials.gov |
| NCT06433661 | A Research Study of the Effect of Food on Etavopivat in Healthy Participants | Phase1 | Healthy Volunteers Sickle Cell Disease, Thalassemia | Completed | 2024-05-28 | 2024-07-08 | ClinicalTrials.gov |
| NCT06336018 | A Research Study on Etavopivat in Participants With and Without Liver Disease | Phase1 | Liver Diseases | Completed | 2024-05-20 | 2025-08-01 | ClinicalTrials.gov |
| NCT06409130 | Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations… | Phase2 | Alcohol-related Liver Disease | Completed | 2024-05-20 | 2026-01-12 | ClinicalTrials.gov |
| NCT06745011 | Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System | — | Polyneuropathy | Enrolling_By_Invitation | 2024-05-13 | 2031-05-01 | ClinicalTrials.gov |
| NCT06403761 | Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-05-06 | 2026-02-02 | ClinicalTrials.gov |
| NCT04809311 | Remote Study Collecting Blood Glucose Values and Activity Data in Patients With… | — | Diabetes Mellitus, Type 2 | Completed | 2024-04-30 | 2025-01-07 | ClinicalTrials.gov |
| NCT05894876 | A Study of the Genetic Basis of Response to Growth Hormone Treatment in Childre… | — | Idiopathic Short Stature | Terminated | 2024-04-29 | 2025-03-21 | ClinicalTrials.gov |
| NCT06222151 | Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervise… | Na | Postoperative Pain, Acute | Recruiting | 2024-04-22 | 2027-12-26 | ClinicalTrials.gov |
| NCT06340854 | A Research Study to See How Switching From a Daily Basal Insulin to a New Weekl… | Phase3 | Diabetes, Type 2 | Completed | 2024-04-19 | 2025-06-13 | ClinicalTrials.gov |
| NCT06370819 | A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-04-15 | 2024-11-27 | ClinicalTrials.gov |
| NCT06283641 | Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Managemen… | — | Obesity | Completed | 2024-04-08 | 2025-01-13 | ClinicalTrials.gov |
| NCT06131372 | A Research Study to See if Kidney Damage in People With Chronic Kidney Disease … | Phase2 | Chronic Kidney Disease | Completed | 2024-04-01 | 2025-11-06 | ClinicalTrials.gov |
| NCT06200207 | A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Par… | Phase3 | Heart Failure | Active_Not_Recruiting | 2024-04-01 | 2027-01-08 | ClinicalTrials.gov |
| NCT06336005 | A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People | Phase1 | Healthy Volunteers | Completed | 2024-03-28 | 2025-02-17 | ClinicalTrials.gov |
| NCT06322641 | A Study to Understand the Real-world Awareness and Perceptions of Systemic inFL… | — | Atherosclerotic Cardiovascular Disease (ASCVD) | Completed | 2024-03-26 | 2024-05-10 | ClinicalTrials.gov |
| NCT06323161 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight C… | Phase3 | Type 2 Diabetes | Completed | 2024-03-26 | 2025-10-23 | ClinicalTrials.gov |
| NCT06323174 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight C… | Phase3 | Type 2 Diabetes | Completed | 2024-03-19 | 2025-12-22 | ClinicalTrials.gov |
| NCT06326047 | A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2024-03-18 | 2025-10-13 | ClinicalTrials.gov |
| NCT06312410 | The VIA Family 2.0 - a Family Based Intervention for Families with Parental Men… | Na | Child | Recruiting | 2024-03-18 | 2028-12-31 | ClinicalTrials.gov |
| NCT06326060 | A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130… | Phase2 | Obesity | Completed | 2024-03-18 | 2025-05-01 | ClinicalTrials.gov |
| NCT05725902 | Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children … | Phase2 | Sickle Cell Disease | Completed | 2024-03-09 | 2026-03-09 | ClinicalTrials.gov |
| NCT06240208 | Physical Inactivity and Appetite Regulation | Na | Overweight | Recruiting | 2024-03-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06289504 | A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blo… | Phase1 | Obesity | Completed | 2024-02-27 | 2024-11-15 | ClinicalTrials.gov |
| NCT06291285 | A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetr… | Phase1 | Healthy Volunteers | Completed | 2024-02-27 | 2024-06-10 | ClinicalTrials.gov |
| NCT06288412 | A Study to Test How a New Long-acting Insulin Works in the Body of Patients Wit… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2024-02-26 | 2025-04-14 | ClinicalTrials.gov |
| NCT06137261 | Screening Adults With Obesity to Reduce Heart Failure Events | Na | Obesity | Active_Not_Recruiting | 2024-02-26 | 2026-07-08 | ClinicalTrials.gov |
| NCT06207877 | A Research Study to Look at How CagriSema Influences Food Intake, Appetite and … | Phase1 | Obesity | Completed | 2024-02-23 | 2024-11-22 | ClinicalTrials.gov |
| NCT05424003 | Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Ga… | Phase2 | NAFLD | Recruiting | 2024-02-22 | 2026-08-01 | ClinicalTrials.gov |
| NCT06291805 | Phenotyping and Characterization of wtATTR-CM (TRACE 1) | — | Transthyretin Amyloidosis | Recruiting | 2024-02-20 | 2025-12-01 | ClinicalTrials.gov |
| NCT06260709 | A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-… | Phase2 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | Active_Not_Recruiting | 2024-02-20 | 2028-08-15 | ClinicalTrials.gov |
| NCT06267092 | A Study of How CagriSema Works on Appetite in People With Excess Body Weight | Phase1 | Overweight | Completed | 2024-02-15 | 2025-12-08 | ClinicalTrials.gov |
| NCT06269107 | A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combin… | Phase3 | Type 2 Diabetes | Completed | 2024-02-15 | 2025-07-08 | ClinicalTrials.gov |
| NCT06284798 | A Research Study of a New Medicine (NNC0650-0013) in Healthy Men | Phase1 | Healthy Participants | Completed | 2024-01-29 | 2024-07-25 | ClinicalTrials.gov |
| NCT06083675 | Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin T… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2024-01-26 | 2027-05-28 | ClinicalTrials.gov |
| NCT06221969 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight C… | Phase3 | Type 2 Diabetes | Completed | 2024-01-16 | 2026-04-06 | ClinicalTrials.gov |
| NCT06122441 | RE-inventing Strategies for Healthy Ageing; Recommendations and Tools | Na | Lifestyle, Healthy | Active_Not_Recruiting | 2024-01-15 | 2027-06-30 | ClinicalTrials.gov |
| NCT05780905 | Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeabilit… | Phase4 | Diabetes Mellitus, Type 2 | Recruiting | 2024-01-11 | 2026-12-31 | ClinicalTrials.gov |
| NCT06351748 | Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Dia… | — | Diabetes Mellitus, Type 2 | Completed | 2024-01-02 | 2024-03-29 | ClinicalTrials.gov |
| NCT06288399 | Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Reg… | — | Obesity | Completed | 2023-12-21 | 2024-09-30 | ClinicalTrials.gov |
| NCT06188026 | A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Cont… | Phase1 | Healthy Volunteers (Non-alcoholic Steatohepatitis) | Completed | 2023-12-18 | 2024-12-30 | ClinicalTrials.gov |
| NCT06111508 | The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insuli… | Na | Type 2 Diabetes | Completed | 2023-11-29 | 2024-09-16 | ClinicalTrials.gov |
| NCT06153537 | A Research Study in Saudi Arabia to Understand How the Dose Check App Used With… | — | Diabetes Mellitus, Type 2 | Completed | 2023-11-29 | 2025-03-24 | ClinicalTrials.gov |
| NCT06131437 | A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People… | Phase3 | Obesity | Completed | 2023-11-27 | 2026-01-09 | ClinicalTrials.gov |
| NCT06122961 | Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) | — | Cardiovascular Risk | Completed | 2023-11-23 | 2025-04-30 | ClinicalTrials.gov |
| NCT06133270 | A First Human Dose Study Investigating Safety and Concentration of Study Medici… | Phase1 | Healthy Volunteers - Liver Diseases | Completed | 2023-11-13 | 2024-07-04 | ClinicalTrials.gov |
| NCT06592950 | Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experimen… | — | Type-2 Diabetes Mellitus (T2DM) | Completed | 2023-11-02 | 2024-04-29 | ClinicalTrials.gov |
| NCT06109935 | Special Use-results Surveillance on Long Term Use of Sogroya® in Children With … | — | Growth Hormone Deficiency in Children | Enrolling_By_Invitation | 2023-10-04 | 2026-12-31 | ClinicalTrials.gov |
| NCT06069895 | Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of… | Phase1 | Healthy Participants | Completed | 2023-10-04 | 2025-04-23 | ClinicalTrials.gov |
| NCT06097390 | A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral For… | Phase1 | Healthy Participants | Completed | 2023-09-28 | 2024-03-27 | ClinicalTrials.gov |
| NCT06065540 | A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintid… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2023-09-27 | 2026-01-06 | ClinicalTrials.gov |
| NCT05813912 | A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Alo… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2023-09-22 | 2025-05-16 | ClinicalTrials.gov |
| NCT06064006 | A Research Study to See How a New Medicine (NNC0487-0111) Works in People With … | Phase2 | Obesity | Completed | 2023-09-15 | 2024-11-27 | ClinicalTrials.gov |
| NCT06041217 | A Research Study to See How Well Semaglutide Helps People Who Have a Body Weigh… | Phase3 | Overweight | Completed | 2023-09-15 | 2025-05-07 | ClinicalTrials.gov |
| NCT06049329 | A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Work… | Phase1 | Obesity | Completed | 2023-09-14 | 2023-12-15 | ClinicalTrials.gov |
| NCT05917873 | Metabolic Effects of Four-week Lactate-ketone Ester Supplementation | Na | Obesity | Completed | 2023-09-07 | 2024-12-11 | ClinicalTrials.gov |
| NCT04972721 | SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in Pe… | — | Overweight | Completed | 2023-09-01 | 2025-08-25 | ClinicalTrials.gov |
| NCT05948969 | Transform CV Risk in Diabetes | Na | Type 2 Diabetes | Unknown | 2023-09-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT05996848 | A Research Study to See How Well CagriSema Helps People in China With Excess Bo… | Phase3 | Obesity or Overweight | Completed | 2023-08-15 | 2025-02-22 | ClinicalTrials.gov |
| NCT05996874 | A Research Study Comparing the Effect of Different Dosing Conditions on Blood L… | Phase1 | Healthy Participants | Completed | 2023-08-12 | 2024-04-18 | ClinicalTrials.gov |
| NCT06260696 | Assessing Health-Related Quality of Life and Willingness to Pay for Weight Mana… | — | Overweight | Completed | 2023-08-10 | 2023-10-05 | ClinicalTrials.gov |
| NCT05979428 | A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People … | Phase1 | Healthy Volunteers | Completed | 2023-08-07 | 2025-03-14 | ClinicalTrials.gov |
| NCT06152887 | Noninvasive Cortical Neurostimulation For Diabetic Neuropathic Pain | Na | Diabetic Neuropathy, Painful | Unknown | 2023-08-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT05857319 | Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patient… | — | Overweight and Obesity | Not_Yet_Recruiting | 2023-07-15 | 2030-07-15 | ClinicalTrials.gov |
| NCT05726227 | A Research Study on How Well Semaglutide Helps Children and Teenagers With Exce… | Phase3 | Obesity | Active_Not_Recruiting | 2023-07-07 | 2026-12-07 | ClinicalTrials.gov |
| NCT05872022 | A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy | — | Pregnancy | Enrolling_By_Invitation | 2023-07-05 | 2032-12-30 | ClinicalTrials.gov |
| NCT05917938 | A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-049… | Phase1 | Hepatic Impairment | Completed | 2023-07-04 | 2024-12-16 | ClinicalTrials.gov |
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | — | MASH | Recruiting | 2023-06-30 | 2031-03-31 | ClinicalTrials.gov |
| NCT05878938 | A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in… | Phase3 | Haemophilia A | Completed | 2023-06-26 | 2024-07-19 | ClinicalTrials.gov |
| NCT05891496 | A Research Study Looking at the Effect of Semaglutide on the Immune System and … | Phase3 | Alzheimers Disease | Completed | 2023-06-20 | 2025-09-08 | ClinicalTrials.gov |
| NCT05873660 | A Study to Characterize the Prevalence of Overweight and Obesity Among Patients… | — | Obesity | Completed | 2023-06-12 | 2024-06-24 | ClinicalTrials.gov |
| NCT05890976 | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in… | Phase3 | Overweight | Completed | 2023-05-30 | 2025-01-16 | ClinicalTrials.gov |
| NCT05870670 | A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2023-05-15 | 2023-10-16 | ClinicalTrials.gov |
| NCT05378672 | A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Th… | Phase3 | Hypoglycemia | Completed | 2023-05-09 | 2024-12-03 | ClinicalTrials.gov |
| NCT05636176 | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in Peopl… | Phase3 | Heart Failure | Active_Not_Recruiting | 2023-05-08 | 2027-07-02 | ClinicalTrials.gov |
| NCT05795166 | A Study to Understand the Distribution of Obesity Classes and Obesity Related D… | — | Obesity | Completed | 2023-04-27 | 2023-11-30 | ClinicalTrials.gov |
| NCT05790681 | A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2023-04-25 | 2024-02-08 | ClinicalTrials.gov |
| NCT05804162 | A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healt… | Phase1 | Obesity | Completed | 2023-04-12 | 2023-09-18 | ClinicalTrials.gov |
| NCT05823948 | A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2023-04-11 | 2024-04-11 | ClinicalTrials.gov |
| NCT05779475 | An Observational Study of Patients With Moderate Parkinson's Disease | — | Parkinson Disease | Enrolling_By_Invitation | 2023-04-05 | 2030-03-11 | ClinicalTrials.gov |
| NCT05564104 | A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Work… | Phase1 | Hepatic Impairment | Completed | 2023-04-05 | 2024-12-19 | ClinicalTrials.gov |
| NCT05813925 | A Research Study to See How Well CagriSema Helps People in East Asia With Exces… | Phase3 | Obesity or Overweight | Completed | 2023-04-03 | 2025-03-07 | ClinicalTrials.gov |
| NCT05569980 | The Nordic Rectal Prolapse Study | — | Rectal Prolapse | Enrolling_By_Invitation | 2023-04-01 | 2027-05-31 | ClinicalTrials.gov |
| NCT05737810 | Attitudes and Unmet Needs Among Type 2 Diabetes Patients | — | Type 2 Diabetes | Completed | 2023-03-27 | 2023-04-17 | ClinicalTrials.gov |
| NCT05755373 | A Multinational Survey-based Study to Understand the Real-world Awareness and P… | — | Atherosclerotic Cardiovascular Disease (ASCVD) | Completed | 2023-03-24 | 2023-05-15 | ClinicalTrials.gov |
| NCT05765890 | Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-s… | — | Non-alcoholic Steatohepatitis (MASH) | Completed | 2023-03-24 | 2023-09-12 | ClinicalTrials.gov |
| NCT05768958 | Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the … | Na | Overweight and Obesity | Active_Not_Recruiting | 2023-03-22 | 2026-07-31 | ClinicalTrials.gov |
| NCT05784402 | A Research Study to Compare How Much Semaglutide is Found in the Blood With Dif… | Phase1 | Healthy Participants | Completed | 2023-03-16 | 2024-03-29 | ClinicalTrials.gov |
| NCT05441267 | A Study of Cardiovascular Events iN Diabetes Plus | Phase4 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2023-03-13 | 2048-08-17 | ClinicalTrials.gov |
| NCT05443568 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2023-03-09 | 2024-11-16 | ClinicalTrials.gov |
| NCT05284955 | Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… | Phase4 | Advanced Heart Failure | Unknown | 2023-03-02 | 2025-12-31 | ClinicalTrials.gov |
| NCT05766709 | A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semagluti… | Phase1 | Non-alcoholic Steatohepatitis | Completed | 2023-03-02 | 2024-02-09 | ClinicalTrials.gov |
| NCT05669755 | REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living W… | Phase3 | Cardiovascular Disease | Active_Not_Recruiting | 2023-03-01 | 2027-10-13 | ClinicalTrials.gov |
| NCT05502562 | A Research Study to Understand How Oral Semaglutide Works in People With Type 2… | — | Diabetes Mellitus, Type 2 | Completed | 2023-02-24 | 2024-06-03 | ClinicalTrials.gov |
| NCT05755360 | DOORS: A Research Study to Understand How Oral Semaglutide Works in People With… | — | Diabetes Mellitus, Type 2 | Completed | 2023-02-21 | 2024-10-21 | ClinicalTrials.gov |
| NCT05736120 | Persons With Obesity (PwO) Exploratory Research | — | Obesity | Completed | 2023-02-19 | 2023-04-19 | ClinicalTrials.gov |
| NCT05742919 | A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Beha… | Phase1 | Non-alcoholic Fatty Liver Disease | Completed | 2023-02-16 | 2023-06-13 | ClinicalTrials.gov |
| NCT05727644 | A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-04… | Phase1 | Non-alcoholic Steatohepatitis (NASH) | Completed | 2023-02-15 | 2023-11-10 | ClinicalTrials.gov |
| NCT05685238 | A Research Study Looking at Long-term Treatment With Mim8 in People With Haemop… | Phase3 | Haemophilia A | Recruiting | 2023-02-13 | 2028-06-30 | ClinicalTrials.gov |
| NCT05718570 | A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated … | — | Adult Growth Hormone Deficiency | Enrolling_By_Invitation | 2023-02-03 | 2032-12-15 | ClinicalTrials.gov |
| NCT05721989 | A Research Study Looking Into Blood Levels of Three Different Formulations of t… | Phase1 | Healthy Participants | Completed | 2023-02-03 | 2024-01-08 | ClinicalTrials.gov |
| NCT05723835 | A Research Study Looking at How Safe Somapacitan is and How Well it Works in Ch… | Phase3 | SGA | Active_Not_Recruiting | 2023-02-01 | 2027-10-29 | ClinicalTrials.gov |
| NCT05394519 | A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes an… | Phase3 | Overweight | Completed | 2023-02-01 | 2025-02-03 | ClinicalTrials.gov |
| NCT05716724 | O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in Peopl… | — | Diabetes Mellitus, Type 2 | Completed | 2023-01-25 | 2023-07-09 | ClinicalTrials.gov |
| NCT05579249 | A Research Study Comparing Wegovy to Other Weight Management Drugs in People Li… | Phase4 | Obesity | Completed | 2023-01-19 | 2024-11-27 | ClinicalTrials.gov |
| NCT05689099 | A Research Trial Looking at the Comparability of 2 Different Concentrations of … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2023-01-17 | 2023-05-30 | ClinicalTrials.gov |
| NCT06198712 | A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric … | Phase2 | Sickle Cell Disease | Recruiting | 2023-01-12 | 2029-08-08 | ClinicalTrials.gov |
| NCT05646706 | A Research Study to See How Semaglutide Helps People With Excess Weight, Lose W… | Phase3 | Obesity | Completed | 2023-01-04 | 2024-11-26 | ClinicalTrials.gov |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Typ… | Phase3 | Obesity | Completed | 2023-01-04 | 2024-12-13 | ClinicalTrials.gov |
| NCT05681845 | A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered Wi… | Phase1 | Haemophilia A | Completed | 2023-01-02 | 2023-10-13 | ClinicalTrials.gov |
| NCT05642533 | Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia | — | Obesity and Cardiovascular Risk | Completed | 2022-12-31 | 2023-09-14 | ClinicalTrials.gov |
| NCT05732909 | The Metabolic Effects of β-hydroxybutyrate on Working Skeletal Muscle | Na | Aging | Completed | 2022-12-22 | 2024-01-10 | ClinicalTrials.gov |
| NCT05631119 | Biorepository of Biospecimen Samples in Matched Healthy Control Participants an… | — | Diabetic Kidney Disease | Completed | 2022-12-15 | 2023-08-23 | ClinicalTrials.gov |
| NCT05087342 | Latino Semaglutide Study | Phase3 | Obesity | Completed | 2022-12-13 | 2024-05-29 | ClinicalTrials.gov |
| NCT06180772 | FIT FIRST FOR ALL - The Dose-Response Study | Na | Primary Prevention | Unknown | 2022-12-10 | 2024-12-24 | ClinicalTrials.gov |
| NCT05621746 | An Observational Research Study of the Health of Joints in People With Haemophi… | — | Haemophilia A | Recruiting | 2022-11-23 | 2026-06-30 | ClinicalTrials.gov |
| NCT05599945 | First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases | Phase1 | Healthy Volunteers | Completed | 2022-11-23 | 2025-08-29 | ClinicalTrials.gov |
| NCT05624580 | A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transport… | Phase1 | Healthy Volunteers | Completed | 2022-11-15 | 2025-10-16 | ClinicalTrials.gov |
| NCT05638516 | Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digita… | Na | Mental Health Disorder | Completed | 2022-11-07 | 2023-05-06 | ClinicalTrials.gov |
| NCT05567796 | A Research Study to See How Well CagriSema Helps People With Excess Body Weight… | Phase3 | Obesity | Active_Not_Recruiting | 2022-11-01 | 2026-10-19 | ClinicalTrials.gov |
| NCT05195944 | Semaglutide vs Sitagliptin | Phase4 | Liver Transplant; Complications | Enrolling_By_Invitation | 2022-10-26 | 2026-12-01 | ClinicalTrials.gov |
| NCT05299879 | Screening for Advanced Heart Failure IN Stable ouTpatientS - The SAINTS Study | — | Heart Failure With Reduced Ejection Fraction | Unknown | 2022-10-24 | 2025-12-01 | ClinicalTrials.gov |
| NCT05443191 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2022-10-20 | 2023-04-27 | ClinicalTrials.gov |
| NCT05542420 | A Research Study, Looking at the Characterization of Treatment Intensified (Add… | — | Diabetes Mellitus, Type 2 | Completed | 2022-10-19 | 2023-04-20 | ClinicalTrials.gov |
| NCT05564117 | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in… | Phase3 | Overweight | Completed | 2022-10-11 | 2024-05-07 | ClinicalTrials.gov |
| NCT05570396 | Long-term Follow-up on Childhood Adiposity - The FitKids Study | — | Child Obesity | Unknown | 2022-10-10 | 2024-03-01 | ClinicalTrials.gov |
| NCT05444153 | Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken … | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2022-10-06 | 2025-08-29 | ClinicalTrials.gov |
| NCT05483803 | Digital Health Intervention for Caregivers Emotional and Self-management Suppor… | Na | Diabetes Mellitus, Type 1 | Completed | 2022-10-01 | 2023-12-14 | ClinicalTrials.gov |
| NCT05473286 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Withdrawn | 2022-09-30 | 2024-05-16 | ClinicalTrials.gov |
| NCT05690789 | Awareness, Care & Treatment In Obesity Management | — | Obesity | Completed | 2022-09-27 | 2023-03-31 | ClinicalTrials.gov |
| NCT05438186 | INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated … | — | Obesity | Withdrawn | 2022-09-01 | 2022-10-31 | ClinicalTrials.gov |
| NCT05514535 | A Research Study to Look Into How Semaglutide, Together With a Lower Dose of In… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2022-08-29 | 2025-04-09 | ClinicalTrials.gov |
| NCT05521256 | A Research Study of a New Medicine NNC0113-6856 in Healthy Males | Phase1 | Healthy Volunteers | Completed | 2022-08-26 | 2023-03-27 | ClinicalTrials.gov |
| NCT05480085 | Screen Free Time With Friends Feasibility Trial | Na | Screen Media Use | Completed | 2022-08-19 | 2024-01-19 | ClinicalTrials.gov |
| NCT05428501 | Awareness, Care & Treatment In Obesity Management - An Observation in Mainland … | — | Obesity | Completed | 2022-08-18 | 2022-11-30 | ClinicalTrials.gov |
| NCT04998136 | Research Study Investigating How Well Semaglutide Works in People From Thailand… | Phase3 | Obesity | Completed | 2022-08-15 | 2023-11-20 | ClinicalTrials.gov |
| NCT05498610 | A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-08-11 | 2022-10-12 | ClinicalTrials.gov |
| NCT05330325 | A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Da… | Phase3 | SGA, Turner Syndrome, Noonan Syndrome, ISS | Active_Not_Recruiting | 2022-08-10 | 2027-10-29 | ClinicalTrials.gov |
| NCT05486065 | A Research Study to Look Into How Well Semaglutide Medicine Works at Different … | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2022-08-08 | 2023-12-13 | ClinicalTrials.gov |
| NCT05478252 | A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Dia… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2022-08-03 | 2023-09-18 | ClinicalTrials.gov |
| NCT05442047 | A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and Ho… | Phase2 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | Completed | 2022-08-02 | 2025-05-13 | ClinicalTrials.gov |
| NCT05479591 | A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes … | — | Diabetes Mellitus, Type 2 | Withdrawn | 2022-07-30 | 2023-04-30 | ClinicalTrials.gov |
| NCT05443334 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2022-07-28 | 2024-07-04 | ClinicalTrials.gov |
| NCT05548647 | Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects | Phase4 | Obesity | Completed | 2022-07-26 | 2025-05-12 | ClinicalTrials.gov |
| NCT05405114 | Research Study Investigating How Well NDec Works in People With Sickle Cell Dis… | Phase2 | Sickle Cell Disease | Completed | 2022-07-07 | 2025-07-24 | ClinicalTrials.gov |
| NCT05468632 | A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Pe… | — | Diabetes Mellitus, Type 2 | Completed | 2022-07-05 | 2022-07-31 | ClinicalTrials.gov |
| NCT05435677 | A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-06-22 | 2023-04-25 | ClinicalTrials.gov |
| NCT05429593 | A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Bo… | Phase1 | Healthy Volunteers | Completed | 2022-06-22 | 2023-04-13 | ClinicalTrials.gov |
| NCT05352815 | A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Co… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2022-06-01 | 2024-04-23 | ClinicalTrials.gov |
| NCT05379829 | A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese … | Phase1 | Chronic Kidney Disease and Systemic Inflammation | Completed | 2022-05-30 | 2024-09-02 | ClinicalTrials.gov |
| NCT05365217 | A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Pre… | Phase3 | Haemophilia B | Completed | 2022-05-18 | 2024-05-11 | ClinicalTrials.gov |
| NCT05369390 | A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity | Phase1 | Obesity | Completed | 2022-05-11 | 2024-01-09 | ClinicalTrials.gov |
| NCT05250427 | Awareness, Care & Treatment In Obesity Management - An Observation in Asia Paci… | — | Obesity | Completed | 2022-04-26 | 2022-05-23 | ClinicalTrials.gov |
| NCT05533632 | Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2022-04-25 | 2024-01-18 | ClinicalTrials.gov |
| NCT05230589 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2022-04-25 | 2023-03-13 | ClinicalTrials.gov |
| NCT05317845 | An International Chart Review and Survey for the Prevalence and Clinical Manage… | — | Diabetes Mellitus, Type 2 | Completed | 2022-04-21 | 2022-08-31 | ClinicalTrials.gov |
| NCT05363774 | A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With … | Phase1 | Healthy Volunteers (Diabetes Mellitus, Type 2) | Completed | 2022-04-20 | 2024-04-02 | ClinicalTrials.gov |
| NCT05283512 | Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney… | Na | Contrast-induced Nephropathy | Recruiting | 2022-04-20 | 2027-12-31 | ClinicalTrials.gov |
| NCT05333107 | A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral For… | Phase1 | Healthy Volunteers; High Cholesterol | Completed | 2022-04-12 | 2022-09-23 | ClinicalTrials.gov |
| NCT05259033 | A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Co… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2022-04-11 | 2024-01-16 | ClinicalTrials.gov |
| NCT05316662 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2022-04-06 | 2024-04-06 | ClinicalTrials.gov |
| NCT05306418 | A Research Study Looking at Mim8 in Children With Haemophilia A With or Without… | Phase3 | Haemophilia A With or Without Inhibitors | Completed | 2022-04-04 | 2024-11-13 | ClinicalTrials.gov |
| NCT05230615 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2022-04-01 | 2023-10-31 | ClinicalTrials.gov |
| NCT05314283 | A Study Investigating the Safety and Performance of DV3395, a New Concept Devic… | Phase1 | Healthy Volunteers, Medical Device | Completed | 2022-03-28 | 2022-11-08 | ClinicalTrials.gov |
| NCT05135559 | A Research Study on How Well Concizumab Works for You if You Have Haemophilia A… | Phase3 | Haemophilia A and B With and Without Inhibitors | Active_Not_Recruiting | 2022-03-24 | 2029-11-02 | ClinicalTrials.gov |
| NCT04763564 | Efficacy of Liraglutide Therapy in Patients With IPAA | Phase2 | Pouchitis | Terminated | 2022-03-22 | 2023-10-16 | ClinicalTrials.gov |
| NCT05324462 | Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patien… | — | Diabetes Mellitus, Type 2 | Completed | 2022-03-22 | 2022-07-15 | ClinicalTrials.gov |
| NCT05221580 | China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE) | — | Diabetes Mellitus, Type 2 | Completed | 2022-03-18 | 2023-03-31 | ClinicalTrials.gov |
| NCT05223491 | En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer | Na | Non-muscle Invasive Bladder Cancer | Completed | 2022-03-17 | 2025-12-19 | ClinicalTrials.gov |
| NCT05308927 | French Registry of Children Treated With Norditropin® for Short Stature Associa… | — | Noonan Syndrome | Enrolling_By_Invitation | 2022-03-16 | 2028-03-17 | ClinicalTrials.gov |
| NCT04889183 | SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabet… | Phase3 | Obesity | Completed | 2022-03-14 | 2024-05-28 | ClinicalTrials.gov |
| NCT05350592 | Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction … | Phase2 | Acute Myocardial Infarction | Active_Not_Recruiting | 2022-03-13 | 2025-09-30 | ClinicalTrials.gov |
| NCT05232786 | Awareness, Care & Treatment In Obesity Management - An Observation in Switzerla… | — | Obesity | Completed | 2022-03-08 | 2022-04-08 | ClinicalTrials.gov |
| NCT05254158 | A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Norm… | Phase1 | Overweight and Obesity | Completed | 2022-03-03 | 2022-09-07 | ClinicalTrials.gov |
| NCT05262595 | A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Ty… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2022-03-03 | 2022-09-05 | ClinicalTrials.gov |
| NCT05236517 | A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and… | Phase1 | Obesity | Completed | 2022-02-08 | 2022-11-07 | ClinicalTrials.gov |
| NCT05227196 | A Research Study Looking at the Comparability of 2 Different Forms of Oral Sema… | Phase1 | Healthy Volunteers | Completed | 2022-02-04 | 2023-08-08 | ClinicalTrials.gov |
| NCT05230550 | Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use)… | — | Adult Growth Hormone Deficiency | Active_Not_Recruiting | 2022-02-03 | 2026-12-31 | ClinicalTrials.gov |
| NCT04938388 | Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Dia… | Phase4 | Diabetes Mellitus, Type 2 | Terminated | 2022-01-29 | 2023-02-16 | ClinicalTrials.gov |
| NCT05232708 | A Clinical Trial Looking at the Comparability of 2 Different Forms of Semagluti… | Phase1 | Healthy Volunteers (Diabetes Mellitus, Type 2) | Completed | 2022-01-19 | 2022-08-30 | ClinicalTrials.gov |
| NCT05243823 | Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatme… | — | Postmenopausal Vaginal Atrophy | Completed | 2022-01-15 | 2022-07-31 | ClinicalTrials.gov |
| NCT04873050 | Treatment to Regress to Normoglycemia in Women with a Recent History of GDM | Phase4 | Pre Diabetes | Recruiting | 2022-01-13 | 2026-03-01 | ClinicalTrials.gov |
| NCT04979130 | Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 D… | Phase4 | Type 2 Diabetes | Completed | 2022-01-01 | 2024-10-16 | ClinicalTrials.gov |
| NCT05241327 | Effects of Nitrate-rich Beetroot Juice in Pregnant Women With High Blood Pressu… | Na | Preeclampsia | Unknown | 2022-01-01 | 2023-05-30 | ClinicalTrials.gov |
| NCT05178550 | A Study in Healthy Participants Investigating Biomarkers After Exposure to Hepa… | Early_Phase1 | Healthy Volunteers | Completed | 2021-12-17 | 2022-01-17 | ClinicalTrials.gov |
| NCT05153564 | A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blo… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-12-13 | 2022-09-01 | ClinicalTrials.gov |
| NCT05091073 | A Research Study Looking at the Effect of Food Intake on How the Medicine NN038… | Phase1 | Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk | Completed | 2021-12-09 | 2022-05-31 | ClinicalTrials.gov |
| NCT05153590 | A Research Study About Weight Loss and Treatment Patterns With the Use of Saxen… | — | Obesity or Overweight | Completed | 2021-12-03 | 2022-04-15 | ClinicalTrials.gov |
| NCT03496883 | Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial | Phase3 | Intracerebral Hemorrhage | Active_Not_Recruiting | 2021-12-03 | 2028-01-01 | ClinicalTrials.gov |
| NCT05053139 | A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia … | Phase3 | Haemophilia A | Completed | 2021-12-02 | 2024-12-17 | ClinicalTrials.gov |
| NCT05134987 | A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Su… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2021-12-01 | 2022-05-06 | ClinicalTrials.gov |
| NCT05013229 | A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Co… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-11-30 | 2023-11-14 | ClinicalTrials.gov |
| NCT05144984 | A Research Study Looking at How Well a Combination of the Medicines Semaglutide… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2021-11-29 | 2023-03-23 | ClinicalTrials.gov |
| NCT05132088 | Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Wor… | Phase3 | Overweight and Obesity | Completed | 2021-11-16 | 2023-09-01 | ClinicalTrials.gov |
| NCT05094934 | A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body a… | Phase1 | Chronic Kidney Disease | Terminated | 2021-11-09 | 2022-08-24 | ClinicalTrials.gov |
| NCT05129891 | A Research Study Looking at New Protein-based Tablets in Healthy Male Participa… | Phase1 | Healthy Volunteers | Completed | 2021-11-03 | 2023-05-04 | ClinicalTrials.gov |
| NCT05069545 | A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresib… | — | Diabetes Mellitus, Type 1 | Completed | 2021-10-11 | 2024-09-10 | ClinicalTrials.gov |
| NCT05064735 | Research Study Looking at How Well Semaglutide Works in People Suffering From O… | Phase3 | Obesity | Completed | 2021-10-01 | 2023-09-08 | ClinicalTrials.gov |
| NCT05082116 | Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatm… | Phase3 | Haemophilia A | Completed | 2021-09-27 | 2022-12-28 | ClinicalTrials.gov |
| NCT05035095 | Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Wor… | Phase3 | Obesity | Completed | 2021-09-13 | 2023-05-12 | ClinicalTrials.gov |
| NCT04817644 | A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-09-10 | 2023-07-03 | ClinicalTrials.gov |
| NCT05040971 | Research Study Looking at How Well Semaglutide Works in People Living With Obes… | Phase3 | Obesity | Completed | 2021-09-06 | 2023-07-14 | ClinicalTrials.gov |
| NCT05046873 | A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-09-06 | 2022-01-05 | ClinicalTrials.gov |
| NCT05035082 | A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in P… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2021-09-01 | 2025-06-18 | ClinicalTrials.gov |
| NCT05016882 | Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semagl… | Phase2 | Non-alcoholic Steatohepatitis | Completed | 2021-08-31 | 2025-03-14 | ClinicalTrials.gov |
| NCT05021835 | ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo i… | Phase3 | Cardiovascular Risk | Completed | 2021-08-30 | 2026-06-09 | ClinicalTrials.gov |
| NCT05015894 | A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Part… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-08-30 | 2022-08-02 | ClinicalTrials.gov |
| NCT04624672 | Treatment of GLP-1 for Diabetic Bariatric Patients | Phase4 | Diabetes Mellitus, Type 2 | Terminated | 2021-08-25 | 2022-08-17 | ClinicalTrials.gov |
| NCT05013359 | Awareness, Care & Treatment In Obesity Management - An International Observatio… | — | Obesity | Completed | 2021-08-23 | 2021-12-13 | ClinicalTrials.gov |
| NCT05003440 | A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of … | Phase1 | Healthy Volunteers | Completed | 2021-08-19 | 2022-01-19 | ClinicalTrials.gov |
| NCT04981808 | Diabetes teleMonitoring of Patients in Insulin Therapy | Na | Type 2 Diabetes Treated With Insulin | Completed | 2021-08-18 | 2023-11-24 | ClinicalTrials.gov |
| NCT04916132 | Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors | — | Chronic Kidney Diseases | Recruiting | 2021-08-10 | 2043-12-31 | ClinicalTrials.gov |
| NCT04971785 | Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in A… | Phase2 | Nonalcoholic Steatohepatitis | Completed | 2021-08-09 | 2024-12-09 | ClinicalTrials.gov |
| NCT04992065 | A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Choles… | Phase2 | Atherosclerotic Cardiovascular Disease | Completed | 2021-08-03 | 2022-06-20 | ClinicalTrials.gov |
| NCT04982575 | Research Study to Look at How Well Cagrilintide Together With Semaglutide Works… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2021-08-02 | 2022-07-07 | ClinicalTrials.gov |
| NCT04970654 | A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treat… | Phase3 | Growth Hormone Deficiency in Children | Completed | 2021-07-22 | 2023-12-18 | ClinicalTrials.gov |
| NCT04969939 | A Research Study to Investigate How Well NNC0165-1875 in Combination With Semag… | Phase2 | Obesity | Completed | 2021-07-15 | 2023-01-30 | ClinicalTrials.gov |
| NCT05127473 | A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of… | Phase1 | Healthy Volunteers - Haemophilia A | Completed | 2021-07-14 | 2022-05-14 | ClinicalTrials.gov |
| NCT04940078 | A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After … | Phase1 | Obesity & Overweight | Completed | 2021-07-07 | 2022-02-16 | ClinicalTrials.gov |
| NCT04916470 | Research Study to Look at How Well Semaglutide Works in People Living With Hear… | Phase3 | Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2 | Completed | 2021-06-15 | 2023-10-11 | ClinicalTrials.gov |
| NCT04952779 | Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Deglu… | — | Diabetes Mellitus, Type 2 | Completed | 2021-06-02 | 2024-12-15 | ClinicalTrials.gov |
| NCT04892069 | Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in … | — | Diabetes Mellitus, Type 2 | Completed | 2021-05-27 | 2021-11-18 | ClinicalTrials.gov |
| NCT04777409 | A Research Study Investigating Semaglutide in People With Early Alzheimer's Dis… | Phase3 | Early Alzheimer´s Disease | Completed | 2021-05-18 | 2026-01-30 | ClinicalTrials.gov |
| NCT04777396 | A Research Study Investigating Semaglutide in People With Early Alzheimer's Dis… | Phase3 | Early Alzheimer's Disease | Completed | 2021-05-18 | 2026-01-30 | ClinicalTrials.gov |
| NCT04878406 | A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works … | Phase1 | Healthy Volunteers Type 2 Diabetes | Completed | 2021-05-18 | 2021-07-20 | ClinicalTrials.gov |
| NCT04880850 | A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-05-14 | 2022-06-16 | ClinicalTrials.gov |
| NCT04862923 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2021-05-12 | 2023-08-31 | ClinicalTrials.gov |
| NCT04878393 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2021-04-30 | 2023-02-09 | ClinicalTrials.gov |
| NCT04848480 | A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Availa… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2021-04-30 | 2022-12-02 | ClinicalTrials.gov |
| NCT04884204 | Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms… | Na | GVHD, Chronic | Completed | 2021-04-30 | 2023-07-01 | ClinicalTrials.gov |
| NCT04865770 | A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to P… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-04-28 | 2024-11-21 | ClinicalTrials.gov |
| NCT04857398 | A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Bod… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-04-28 | 2022-04-06 | ClinicalTrials.gov |
| NCT04656106 | A Study Investigating the Clinical Parameters Associated With the Use of Ryzode… | — | Diabetes Mellitus, Type 2 | Completed | 2021-04-27 | 2021-07-01 | ClinicalTrials.gov |
| NCT04838743 | GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With … | — | Diabetes Mellitus, Type 2 | Completed | 2021-04-23 | 2022-10-26 | ClinicalTrials.gov |
| NCT04698018 | A Research Study to Look at How Faster Aspart Works in Chinese People With Type… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2021-04-20 | 2022-07-22 | ClinicalTrials.gov |
| NCT04584892 | Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in R… | — | Haemophilia A | Completed | 2021-04-12 | 2023-03-27 | ClinicalTrials.gov |
| NCT04822181 | Research Study on Whether Semaglutide Works in People With Non-alcoholic Steato… | Phase3 | Non-alcoholic Steatohepatitis | Active_Not_Recruiting | 2021-04-01 | 2029-04-25 | ClinicalTrials.gov |
| NCT04334057 | Post-Marketing Surveillance (Use-results Surveillance) With Esperoct® | — | Haemophilia A | Completed | 2021-03-31 | 2024-01-10 | ClinicalTrials.gov |
| NCT04795531 | A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-03-24 | 2022-06-23 | ClinicalTrials.gov |
| NCT06046560 | Diabetes Remote Intervention to improVe Use of Evidence-based Medications | Phase4 | Cardiovascular Diseases | Completed | 2021-03-22 | 2023-07-25 | ClinicalTrials.gov |
| NCT04788511 | Research Study to Investigate How Well Semaglutide Works in People Living With … | Phase3 | Obesity | Completed | 2021-03-16 | 2023-04-18 | ClinicalTrials.gov |
| NCT04770532 | A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-03-05 | 2022-03-01 | ClinicalTrials.gov |
| NCT04775082 | SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering We… | Phase3 | Obesity | Active_Not_Recruiting | 2021-03-04 | 2027-02-08 | ClinicalTrials.gov |
| NCT04760626 | A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With Dose… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-03-01 | 2022-08-29 | ClinicalTrials.gov |
| NCT04945551 | Cellular Adaptations to Training in Patients With Type 2 Diabetes | Na | Diabetes Mellitus, Type 2 | Unknown | 2021-02-20 | 2023-10-01 | ClinicalTrials.gov |
| NCT04757545 | Symptom Identification and Management in Patients With Hematological Malignancy… | Na | Hematologic Malignancy | Completed | 2021-02-08 | 2023-02-01 | ClinicalTrials.gov |
| NCT04722653 | A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese a… | Phase1 | Non-alcoholic Steatohepatitis | Completed | 2021-02-02 | 2021-04-27 | ClinicalTrials.gov |
| NCT04669340 | E-learning in Patient Education to Patients With Rheumatoid Arthritis | Na | Rheumatoid Arthritis | Completed | 2021-02-01 | 2024-01-30 | ClinicalTrials.gov |
| NCT07560059 | Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-CO… | — | Diabetes Mellitus | Completed | 2021-01-28 | 2022-08-24 | ClinicalTrials.gov |
| NCT04572165 | Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With th… | — | Diabetes Mellitus, Type 2 | Completed | 2021-01-26 | 2025-11-25 | ClinicalTrials.gov |
| NCT03987802 | An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Saf… | — | Diabetes Mellitus, Type 1 | Completed | 2021-01-20 | 2022-06-28 | ClinicalTrials.gov |
| NCT04538352 | Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal I… | Phase4 | Type 2 Diabetes | Completed | 2021-01-18 | 2023-11-01 | ClinicalTrials.gov |
| NCT04707469 | Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily i… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2021-01-15 | 2023-03-08 | ClinicalTrials.gov |
| NCT04774211 | Prospective Prevalence and Validation Study of Pediatric Intensive Care Deliriu… | — | Pediatric Delirium | Completed | 2021-01-01 | 2022-06-30 | ClinicalTrials.gov |
| NCT04575766 | A Study of FT-7051 in Men With MCRPC | Phase1 | Metastatic Castration-resistant Prostate Cancer | Terminated | 2020-12-30 | 2022-11-15 | ClinicalTrials.gov |
| NCT03579615 | Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With … | Na | Diabetes Mellitus, Type 1 | Completed | 2020-12-23 | 2022-08-01 | ClinicalTrials.gov |
| NCT04597697 | A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Bod… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-12-22 | 2022-03-24 | ClinicalTrials.gov |
| NCT04682145 | Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol | — | Haemophilia A | Enrolling_By_Invitation | 2020-12-09 | 2026-02-01 | ClinicalTrials.gov |
| NCT04251156 | Research Study of How Well Semaglutide Works in People Living With Overweight o… | Phase3 | Overweight | Completed | 2020-12-08 | 2022-08-23 | ClinicalTrials.gov |
| NCT04460326 | Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type… | Phase3 | Type 2 Diabetes Treated With Insulin | Completed | 2020-12-07 | 2023-05-27 | ClinicalTrials.gov |
| NCT04676906 | A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radi… | Phase1 | Healthy Volunteers | Completed | 2020-11-26 | 2021-04-28 | ClinicalTrials.gov |
| NCT04460885 | A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2020-11-25 | 2022-12-01 | ClinicalTrials.gov |
| NCT04279613 | A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmaco… | Phase1 | Type I Diabetes | Completed | 2020-11-23 | 2024-04-24 | ClinicalTrials.gov |
| NCT05615909 | PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT | — | Prostate Cancer | Completed | 2020-11-19 | 2023-12-31 | ClinicalTrials.gov |
| NCT04601740 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2020-11-17 | 2022-12-19 | ClinicalTrials.gov |
| NCT04601753 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2020-11-12 | 2023-03-03 | ClinicalTrials.gov |
| NCT04655690 | A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2020-11-09 | 2021-11-26 | ClinicalTrials.gov |
| NCT04596631 | A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2020-11-02 | 2026-02-03 | ClinicalTrials.gov |
| NCT04057261 | Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes… | Phase3 | Type 2 Diabetes | Withdrawn | 2020-11-01 | 2022-11-01 | ClinicalTrials.gov |
| NCT04574076 | A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® | — | Haemophilia A | Enrolling_By_Invitation | 2020-10-23 | 2027-06-03 | ClinicalTrials.gov |
| NCT04626505 | Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic R… | Phase2 | Chronic Kidney Disease | Completed | 2020-10-22 | 2021-09-28 | ClinicalTrials.gov |
| NCT04666987 | A Research Study Looking at Long-term Blood Sugar Control in People With Type 2… | — | Diabetes Mellitus, Type 2 | Completed | 2020-10-21 | 2023-02-10 | ClinicalTrials.gov |
| NCT04575181 | A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC026… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-21 | 2021-12-24 | ClinicalTrials.gov |
| NCT04559815 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2020-10-21 | 2022-09-14 | ClinicalTrials.gov |
| NCT04582435 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Ins… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-16 | 2022-04-22 | ClinicalTrials.gov |
| NCT04588259 | Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Anothe… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2020-10-09 | 2022-08-05 | ClinicalTrials.gov |
| NCT04582448 | A Study Looking at How Insulin Icodec is Taken up in the Blood When Administere… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-01 | 2021-09-27 | ClinicalTrials.gov |
| NCT04560998 | A Research Study to Compare a Medicine Called Semaglutide Against Placebo in Pe… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2020-10-01 | 2024-07-12 | ClinicalTrials.gov |
| NCT04304963 | Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS | — | Diabetes Mellitus, Type 1 | Completed | 2020-10-01 | 2022-10-31 | ClinicalTrials.gov |
| NCT04398628 | ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | — | Hematologic Disorder | Recruiting | 2020-09-30 | 2035-12-01 | ClinicalTrials.gov |
| NCT04569994 | A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With… | Phase1 | Healthy Volunteers | Completed | 2020-09-30 | 2021-06-23 | ClinicalTrials.gov |
| NCT04524832 | Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy Pe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-09-29 | 2022-02-25 | ClinicalTrials.gov |
| NCT04079218 | Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial | Phase4 | HIV Infection | Completed | 2020-09-01 | 2023-08-09 | ClinicalTrials.gov |
| NCT04513704 | A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the M… | Phase1 | Healthy Volunteers Type 2 Diabetes | Completed | 2020-08-28 | 2021-05-26 | ClinicalTrials.gov |
| NCT04537637 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2020-08-28 | 2023-05-08 | ClinicalTrials.gov |
| NCT04537624 | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Di… | — | Diabetes Mellitus, Type 2 | Completed | 2020-08-24 | 2023-05-31 | ClinicalTrials.gov |
| NCT04469855 | Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use… | — | Diabetes Mellitus, Type 2 | Completed | 2020-07-27 | 2025-05-12 | ClinicalTrials.gov |
| NCT04482725 | Injection Site Pain Comparison of Excipient Solutions | Phase1 | Obesity | Completed | 2020-07-20 | 2020-09-25 | ClinicalTrials.gov |
| NCT04444856 | Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a … | — | Severe Postpartum Haemorrhage | Completed | 2020-06-29 | 2021-01-13 | ClinicalTrials.gov |
| NCT04657783 | French National Cohort of People With Type 1 Diabetes | — | Diabetes Mellitus, Type 1 | Recruiting | 2020-06-10 | 2035-06-10 | ClinicalTrials.gov |
| NCT03862690 | A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes … | — | Diabetes Mellitus, Type 2 | Withdrawn | 2020-05-28 | 2021-06-28 | ClinicalTrials.gov |
| NCT04723979 | NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL | — | Post Partum Hemorrhage | Completed | 2020-05-01 | 2021-01-31 | ClinicalTrials.gov |
| NCT04315688 | A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes … | — | Diabetes Mellitus, Type 2 | Completed | 2020-03-30 | 2021-08-02 | ClinicalTrials.gov |
| NCT04287179 | SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide T… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2020-03-09 | 2021-01-25 | ClinicalTrials.gov |
| NCT04262661 | A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People Wit… | Phase1 | Healthy Volunteers | Completed | 2020-03-02 | 2020-09-25 | ClinicalTrials.gov |
| NCT04259801 | First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide… | Phase1 | Healthy Volunteers | Completed | 2020-02-17 | 2022-03-16 | ClinicalTrials.gov |
| NCT04261933 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2020-02-13 | 2021-05-25 | ClinicalTrials.gov |
| NCT04238962 | A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in T… | Phase1 | Overweight | Completed | 2020-02-03 | 2020-10-20 | ClinicalTrials.gov |
| NCT04193566 | Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function i… | Phase4 | Nephropathy | Completed | 2020-02-01 | 2021-01-01 | ClinicalTrials.gov |
| NCT05503927 | A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy | — | Pregnancy | Enrolling_By_Invitation | 2020-02-01 | 2027-08-15 | ClinicalTrials.gov |
| NCT04228354 | A Research Study Looking at the Comparability (Bioequivalence) of Two Versions … | Phase1 | Healthy Volunteers | Completed | 2020-01-29 | 2020-06-01 | ClinicalTrials.gov |
| NCT04227431 | A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes … | — | Diabetes Mellitus, Type 2 | Completed | 2020-01-17 | 2021-07-17 | ClinicalTrials.gov |
| NCT04209049 | A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Norma… | Phase1 | Overweight | Completed | 2020-01-15 | 2021-01-05 | ClinicalTrials.gov |
| NCT04204408 | A Research Study Investigating Mim8 in People With Haemophilia A | Phase2 | Healthy Volunteers | Completed | 2020-01-10 | 2023-10-06 | ClinicalTrials.gov |
| NCT04232813 | Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vagi… | Phase3 | Vulvovaginal Atrophy | Completed | 2020-01-09 | 2020-11-30 | ClinicalTrials.gov |
| NCT03895515 | Effect of Fiasp® in Type 1 Diabetes Treatment | — | Diabetes Mellitus, Type 1 | Completed | 2020-01-03 | 2020-12-21 | ClinicalTrials.gov |
| NCT04187300 | A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of … | Phase1 | Overweight | Completed | 2019-12-16 | 2020-09-23 | ClinicalTrials.gov |
| NCT04189848 | Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc | Phase4 | Healthy Volunteers | Completed | 2019-12-03 | 2020-02-27 | ClinicalTrials.gov |
| NCT04152915 | A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions… | Phase1 | Healthy Volunteers | Completed | 2019-11-25 | 2020-05-25 | ClinicalTrials.gov |
| NCT04082429 | Research Study to Look at How Well the Drug Concizumab Works in Your Body if Yo… | Phase3 | Haemophilia A Without Inhibitors | Active_Not_Recruiting | 2019-11-13 | 2028-02-21 | ClinicalTrials.gov |
| NCT04061200 | Renal Effects of Treatment With Empagliflozin Alone or in Combination With Sema… | Phase4 | Type 2 Diabetes With Renal Manifestations | Unknown | 2019-11-01 | 2021-08-01 | ClinicalTrials.gov |
| NCT04136067 | A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-10-29 | 2020-08-23 | ClinicalTrials.gov |
| NCT03847909 | A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria … | Phase2 | Primary Hyperoxaluria Type 1 (PH1) | Completed | 2019-10-28 | 2021-06-29 | ClinicalTrials.gov |
| NCT04143945 | A Study Comparing the Injection Site Pain Experience After the Injection of Sem… | Phase2 | Healthy Volunteers Diabetes Mellitus, Type 2 | Completed | 2019-10-28 | 2020-01-04 | ClinicalTrials.gov |
| NCT04094415 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2019-10-28 | 2021-07-28 | ClinicalTrials.gov |
| NCT04083781 | Research Study to Look at How Well the Drug Concizumab Works in Your Body if Yo… | Phase3 | Haemophilia A With Inhibitors | Active_Not_Recruiting | 2019-10-21 | 2027-02-21 | ClinicalTrials.gov |
| NCT04016974 | A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are… | Phase1 | Healthy Volunteers | Completed | 2019-10-08 | 2021-02-26 | ClinicalTrials.gov |
| NCT04121780 | Growth Hormone Replacement Therapy for Retried Professional Football Players | Phase2 | TBI (Traumatic Brain Injury) | Recruiting | 2019-10-08 | 2026-09-01 | ClinicalTrials.gov |
| NCT04102189 | A Research Study on How Well Semaglutide Works in Adolescents With Overweight o… | Phase3 | Overweight | Completed | 2019-10-07 | 2022-03-28 | ClinicalTrials.gov |
| NCT04109508 | A Research Study Comparing Active Drug in the Blood in Healthy Participants Fol… | Phase1 | Healthy Volunteers | Completed | 2019-10-02 | 2021-01-27 | ClinicalTrials.gov |
| NCT04109547 | A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2019-10-01 | 2021-10-27 | ClinicalTrials.gov |
| NCT04097600 | A Research Study Comparing Active Drug in the Blood in Healthy Participants Fol… | Phase1 | Healthy Volunteers | Completed | 2019-09-30 | 2021-01-20 | ClinicalTrials.gov |
| NCT04083820 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2019-09-16 | 2021-09-27 | ClinicalTrials.gov |
| NCT04074174 | Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pil… | Phase1 | Overweight | Completed | 2019-09-12 | 2020-03-06 | ClinicalTrials.gov |
| NCT04074161 | Research Study to Investigate How Well Semaglutide Works Compared to Liraglutid… | Phase3 | Overweight | Completed | 2019-09-11 | 2021-05-11 | ClinicalTrials.gov |
| NCT03875547 | Post-marketing Surveillance (Use Result Surveillance) With Refixia® | — | Haemophilia B | Completed | 2019-08-23 | 2025-09-30 | ClinicalTrials.gov |
| NCT04058834 | A Research Study Investigating How NNC0385-0434 is Tolerated in People With or … | Phase1 | Healthy Volunteers | Completed | 2019-08-20 | 2020-04-23 | ClinicalTrials.gov |
| NCT04059367 | Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Bloo… | Phase1 | Healthy Volunteers | Completed | 2019-08-15 | 2020-01-02 | ClinicalTrials.gov |
| NCT04032197 | A Research Study of How Semaglutide Works in People With Disease Affecting the … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-08-12 | 2023-06-06 | ClinicalTrials.gov |
| NCT04067999 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2019-08-05 | 2021-07-19 | ClinicalTrials.gov |
| NCT05336487 | Physical Activity, Sports and Health in Adults With Intellectual Disabilities | Na | Intellectual Disability | Unknown | 2019-08-01 | 2022-12-31 | ClinicalTrials.gov |
| NCT04042441 | A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Wor… | — | Diabetes Mellitus, Type 2 | Completed | 2019-07-29 | 2020-12-11 | ClinicalTrials.gov |
| NCT04017832 | A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in Pe… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2019-07-29 | 2021-10-27 | ClinicalTrials.gov |
| NCT03987074 | Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in P… | Phase2 | Nonalcoholic Steatohepatitis | Completed | 2019-07-29 | 2020-07-13 | ClinicalTrials.gov |
| NCT04020913 | Skeletal Muscle Effects of GH in Boys | — | Growth Hormone Deficiency | Completed | 2019-07-22 | 2025-10-30 | ClinicalTrials.gov |
| NCT04012255 | A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injec… | Phase1 | Overweight | Terminated | 2019-07-15 | 2019-10-22 | ClinicalTrials.gov |
| NCT04010786 | A Research Study Investigating NNC0247-0829 for Weight Management in People Wit… | Phase1 | Overweight | Completed | 2019-07-11 | 2022-06-21 | ClinicalTrials.gov |
| NCT03878446 | A Research Study in Children Born Small and Who Stayed Small. Treatment is Soma… | Phase2 | Short Stature Children Born Small for Gestational Age (SGA) | Active_Not_Recruiting | 2019-07-04 | 2026-12-23 | ClinicalTrials.gov |
| NCT04007107 | A Study Comparing the Injection Site Pain Experience After the Injection of 2 D… | Phase2 | Healthy Volunteers Diabetes Mellitus, Type 2 | Completed | 2019-06-27 | 2019-09-04 | ClinicalTrials.gov |
| NCT03972345 | Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Nea… | — | Growth Hormone Deficiency in Children | Enrolling_By_Invitation | 2019-06-21 | 2031-06-30 | ClinicalTrials.gov |
| NCT03989232 | A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in Peopl… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2019-06-19 | 2020-11-09 | ClinicalTrials.gov |
| NCT03987451 | A Research Study on How Semaglutide Works in People With Fatty Liver Disease an… | Phase2 | Non-alcoholic Steatohepatitis | Completed | 2019-06-18 | 2021-06-10 | ClinicalTrials.gov |
| NCT03819153 | A Research Study to See How Semaglutide Works Compared to Placebo in People Wit… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2019-06-17 | 2024-01-09 | ClinicalTrials.gov |
| NCT03914326 | A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2019-06-17 | 2024-08-23 | ClinicalTrials.gov |
| NCT03965013 | A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With T… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2019-06-05 | 2019-12-14 | ClinicalTrials.gov |
| NCT03926117 | Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic R… | Phase2 | Chronic Kidney Diseases | Completed | 2019-06-03 | 2020-06-26 | ClinicalTrials.gov |
| NCT03929679 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2019-05-28 | 2020-11-24 | ClinicalTrials.gov |
| NCT03960814 | A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients U… | — | Diabetes Mellitus, Type 2 | Completed | 2019-05-21 | 2019-06-07 | ClinicalTrials.gov |
| NCT03811535 | A Research Study in Children With a Low Level of Hormone to Grow. Treatment is … | Phase3 | Growth Hormone Deficiency in Children | Completed | 2019-05-20 | 2025-09-30 | ClinicalTrials.gov |
| NCT03922750 | A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2019-05-09 | 2020-01-27 | ClinicalTrials.gov |
| NCT03951805 | A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glarg… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2019-05-09 | 2020-01-17 | ClinicalTrials.gov |
| NCT03811561 | A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabeti… | Phase3 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2019-05-08 | 2027-11-07 | ClinicalTrials.gov |
| NCT03945656 | A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-05-07 | 2021-09-27 | ClinicalTrials.gov |
| NCT04013828 | Treatment Decision-making in Patients With Recurrent High-grade Glioma | — | Malignant Glioma | Completed | 2019-05-06 | 2022-04-08 | ClinicalTrials.gov |
| NCT03876015 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2019-05-01 | 2020-08-12 | ClinicalTrials.gov |
| NCT04105803 | Cardiac Mitochondrial Function After Heart Transplantation | — | Cardiac Allograft Vasculopathy | Unknown | 2019-04-25 | 2024-03-01 | ClinicalTrials.gov |
| NCT03862716 | Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegL… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-04-23 | 2023-07-31 | ClinicalTrials.gov |
| NCT04011904 | The Role of Traditional or Western Diet in the TBC1D4 Gene on Glucose Homeostas… | Na | T2D | Completed | 2019-04-15 | 2020-11-23 | ClinicalTrials.gov |
| NCT03745924 | A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN | — | Haemophilia B | Enrolling_By_Invitation | 2019-04-01 | 2027-12-15 | ClinicalTrials.gov |
| NCT03905850 | A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan Af… | Phase1 | Healthy Volunteers | Completed | 2019-03-29 | 2019-07-15 | ClinicalTrials.gov |
| NCT03888157 | A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes i… | — | Diabetes Mellitus, Type 2 | Completed | 2019-03-10 | 2020-10-21 | ClinicalTrials.gov |
| NCT03856047 | Research Study Investigating How Well NNC0174-0833 Works in People Suffering Fr… | Phase2 | Overweight | Completed | 2019-03-01 | 2021-03-25 | ClinicalTrials.gov |
| NCT03816761 | Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump Syst… | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2019-02-25 | 2019-06-10 | ClinicalTrials.gov |
| NCT03842202 | A Research Study to Look at How Semaglutide Affects Gastric Emptying in People … | Phase1 | Overweight | Completed | 2019-02-15 | 2019-11-04 | ClinicalTrials.gov |
| NCT03823339 | A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes… | — | Diabetes Mellitus, Type 2 | Completed | 2019-01-29 | 2020-12-14 | ClinicalTrials.gov |
| NCT03811574 | STEP 6: Research Study Investigating How Well Semaglutide Works in People Livin… | Phase3 | Overweight | Completed | 2019-01-21 | 2020-11-20 | ClinicalTrials.gov |
| NCT03789578 | A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-01-17 | 2019-10-10 | ClinicalTrials.gov |
| NCT03797885 | A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart … | — | Diabetes Mellitus, Type 2 | Completed | 2019-01-15 | 2019-10-15 | ClinicalTrials.gov |
| NCT03737240 | IDegLira HIGH Trial | Phase3 | Diabetes Mellitus | Completed | 2019-01-15 | 2022-07-08 | ClinicalTrials.gov |
| NCT03795701 | To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Dete… | Na | Obesity | Completed | 2019-01-08 | 2022-05-01 | ClinicalTrials.gov |
| NCT03799198 | Real World Effectiveness of Combining an Employer-based Weight Management Progr… | Phase4 | Obesity | Completed | 2019-01-07 | 2020-05-22 | ClinicalTrials.gov |
| NCT03787225 | A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Voluntee… | Phase1 | Obesity | Completed | 2019-01-07 | 2019-06-04 | ClinicalTrials.gov |
| NCT03785522 | A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes … | — | Diabetes Mellitus, Type 2 | Completed | 2018-12-23 | 2020-11-30 | ClinicalTrials.gov |
| NCT03741881 | A Study Following People With Haemophilia A and B, With or Without Inhibitors, … | — | Haemophilia A | Completed | 2018-12-18 | 2021-10-25 | ClinicalTrials.gov |
| NCT03811288 | An International Survey of the Occurrence of Cardiovascular Disease Among Patie… | — | Diabetes Mellitus, Type 2 | Completed | 2018-12-10 | 2019-09-30 | ClinicalTrials.gov |
| NCT03766854 | A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Ins… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-12-07 | 2019-12-09 | ClinicalTrials.gov |
| NCT03786406 | An International Survey of the Occurrence of Diseases That Affects the Heart an… | — | Diabetes Mellitus, Type 2 | Completed | 2018-12-03 | 2019-05-31 | ClinicalTrials.gov |
| NCT03723772 | A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insul… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-11-29 | 2020-06-26 | ClinicalTrials.gov |
| NCT03751657 | A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Un… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2018-11-29 | 2020-01-17 | ClinicalTrials.gov |
| NCT03712098 | Daily Liraglutide for Nicotine Dependence | Phase2 | Smoking Cessation | Completed | 2018-11-29 | 2022-05-25 | ClinicalTrials.gov |
| NCT03745157 | RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type … | — | Diabetes Mellitus, Type 2 | Completed | 2018-11-21 | 2019-10-29 | ClinicalTrials.gov |
| NCT03668808 | Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type … | Phase4 | Diabetes Mellitus, Type 1 | Completed | 2018-11-16 | 2020-09-19 | ClinicalTrials.gov |
| NCT03723785 | A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in th… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-11-09 | 2019-09-06 | ClinicalTrials.gov |
| NCT03674866 | A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Swit… | — | Diabetes Mellitus, Type 1 | Completed | 2018-10-29 | 2019-04-26 | ClinicalTrials.gov |
| NCT03723759 | A Research Study Looking at How Faster Aspart Injected in Double Concentration … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-10-26 | 2019-03-27 | ClinicalTrials.gov |
| NCT03574597 | Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or … | Phase3 | Overweight | Completed | 2018-10-24 | 2023-06-29 | ClinicalTrials.gov |
| NCT03707990 | A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People W… | Phase1 | Obesity and Overweight | Completed | 2018-10-15 | 2019-08-13 | ClinicalTrials.gov |
| NCT03693430 | Two-year Research Study Investigating How Well Semaglutide Works in People Suff… | Phase3 | Overweight | Completed | 2018-10-05 | 2021-03-23 | ClinicalTrials.gov |
| NCT03687827 | A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2018-10-02 | 2019-12-27 | ClinicalTrials.gov |
| NCT03672617 | Validation of a Questionnaire That Identifies the Reasons for Non-adherence to … | — | Growth Hormone Deficiency in Children | Completed | 2018-10-02 | 2019-04-25 | ClinicalTrials.gov |
| NCT03689374 | A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2018-10-01 | 2021-02-22 | ClinicalTrials.gov |
| NCT03690336 | Adverse Event Data Collection From External Registries on Nonacog Beta Pegol | — | Haemophilia B | Enrolling_By_Invitation | 2018-10-01 | 2027-10-01 | ClinicalTrials.gov |
| NCT03660774 | A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thi… | — | Haemophilia A | Completed | 2018-09-27 | 2019-10-11 | ClinicalTrials.gov |
| NCT03480022 | Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic P… | Phase3 | Pre Diabetes | Completed | 2018-09-26 | 2021-05-19 | ClinicalTrials.gov |
| NCT03661879 | Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Ob… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2018-09-12 | 2019-10-09 | ClinicalTrials.gov |
| NCT03631186 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2018-09-12 | 2019-12-18 | ClinicalTrials.gov |
| NCT03572998 | Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment | Na | Secondary Lymphedema | Unknown | 2018-09-01 | 2019-08-01 | ClinicalTrials.gov |
| NCT03260881 | Liraglutide Effects on Epicardial Fat Inflammatory Genes | Phase4 | Type2 Diabetes | Completed | 2018-09-01 | 2024-09-05 | ClinicalTrials.gov |
| NCT03648281 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2018-08-24 | 2020-01-10 | ClinicalTrials.gov |
| NCT03638778 | Research Study Comparing Different Tablets With the Study Medicine Semaglutide … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-08-17 | 2018-12-05 | ClinicalTrials.gov |
| NCT03617081 | First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men. | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-08-09 | 2018-12-13 | ClinicalTrials.gov |
| NCT03611322 | A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutan… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-08-08 | 2019-01-07 | ClinicalTrials.gov |
| NCT03611582 | Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken… | Phase3 | Overweight | Completed | 2018-08-01 | 2020-04-28 | ClinicalTrials.gov |
| NCT03600480 | A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who… | Phase1 | Obesity | Completed | 2018-07-25 | 2020-06-12 | ClinicalTrials.gov |
| NCT03598621 | A Research Study to Look at Similarity Between Semaglutide Versions in Differen… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-07-23 | 2019-01-17 | ClinicalTrials.gov |
| NCT03596450 | Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard … | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2018-07-13 | 2023-06-09 | ClinicalTrials.gov |
| NCT03560336 | A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety an… | — | Obesity | Completed | 2018-07-05 | 2020-12-02 | ClinicalTrials.gov |
| NCT03179748 | Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophi… | — | Congenital Bleeding Disorder | Completed | 2018-06-20 | 2021-06-16 | ClinicalTrials.gov |
| NCT03574584 | A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight o… | Phase1 | Metabolism and Nutrition Disorders | Completed | 2018-06-18 | 2019-07-27 | ClinicalTrials.gov |
| NCT03588741 | Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoct… | Phase3 | Haemophilia A | Terminated | 2018-06-12 | 2019-06-19 | ClinicalTrials.gov |
| NCT03443258 | Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer R… | Na | Head and Neck Neoplasms | Completed | 2018-06-11 | 2019-11-30 | ClinicalTrials.gov |
| NCT03584191 | Awareness, Care & Treatment In Obesity Management - An International Observation | — | Obesity | Completed | 2018-06-04 | 2018-10-10 | ClinicalTrials.gov |
| NCT03552757 | Research Study Investigating How Well Semaglutide Works in People With Type 2 D… | Phase3 | Obesity | Completed | 2018-06-04 | 2020-05-01 | ClinicalTrials.gov |
| NCT03548987 | Research Study Investigating How Well Semaglutide Works in People Suffering Fro… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2018-06-04 | 2020-03-20 | ClinicalTrials.gov |
| NCT03548935 | STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffe… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2018-06-04 | 2021-03-05 | ClinicalTrials.gov |
| NCT03528551 | A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa P… | Phase3 | Congenital Bleeding Disorder | Completed | 2018-04-30 | 2020-12-03 | ClinicalTrials.gov |
| NCT03479762 | In Market Utilisation of Liraglutide Used for Weight Management in the UK: a St… | — | Obesity | Completed | 2018-04-20 | 2022-09-12 | ClinicalTrials.gov |
| NCT04409587 | Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump | Phase4 | Type1 Diabetes Mellitus | Completed | 2018-04-12 | 2020-11-01 | ClinicalTrials.gov |
| NCT03457012 | A Research Study Looking at How Semaglutide Works in People With Type 2 Diabete… | — | Diabetes Mellitus, Type 2 | Completed | 2018-03-29 | 2019-12-19 | ClinicalTrials.gov |
| NCT03450863 | Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients… | — | Diabetes | Completed | 2018-03-22 | 2019-09-04 | ClinicalTrials.gov |
| NCT03466567 | A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentra… | Phase1 | Diabetes | Completed | 2018-03-15 | 2018-07-10 | ClinicalTrials.gov |
| NCT03479892 | A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Cont… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2018-03-13 | 2019-06-04 | ClinicalTrials.gov |
| NCT03449342 | Research Study to Look at Side Effects During Regular Injection With Factor VII… | Phase4 | Congenital Bleeding Disorder | Completed | 2018-03-01 | 2019-04-22 | ClinicalTrials.gov |
| NCT03435627 | Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature D… | — | Genetic Disorder | Completed | 2018-02-26 | 2022-01-18 | ClinicalTrials.gov |
| NCT03444467 | First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Med… | Phase1 | Diabetes | Completed | 2018-02-05 | 2018-05-24 | ClinicalTrials.gov |
| NCT03416855 | A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (I… | — | Diabetes | Completed | 2018-01-31 | 2020-05-19 | ClinicalTrials.gov |
| NCT03407599 | A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart … | Phase1 | Diabetes | Completed | 2018-01-08 | 2018-07-05 | ClinicalTrials.gov |
| NCT03349840 | Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in… | Phase4 | Type2 Diabetes | Terminated | 2018-01-07 | 2018-12-31 | ClinicalTrials.gov |
| NCT03365180 | Starter Kit Study in Insulin naïve Patients | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2018-01-03 | 2020-01-15 | ClinicalTrials.gov |
| NCT03336528 | Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharge… | Phase4 | Type 2 Diabetes | Completed | 2018-01-02 | 2021-03-01 | ClinicalTrials.gov |
| NCT04216875 | Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland | — | Diabetes Mellitus, Type 2 | Completed | 2018-01-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT03430154 | Awareness, Care, and Treatment In Obesity Management of Patients With Hemophili… | — | Haemophilia A, Haemophilia B, Obesity | Completed | 2017-12-01 | 2018-04-29 | ClinicalTrials.gov |
| NCT04722289 | The Together on Diabetes Intervention - a Realist Evaluation | Na | Type 2 Diabetes Mellitus | Completed | 2017-12-01 | 2020-05-01 | ClinicalTrials.gov |
| NCT03523273 | Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Func… | Phase2 | Obesity | Completed | 2017-11-29 | 2021-08-31 | ClinicalTrials.gov |
| NCT03036800 | Saxenda in Obesity Services (STRIVE Study) | Phase4 | Obesity | Completed | 2017-11-28 | 2022-02-25 | ClinicalTrials.gov |
| NCT03357380 | A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver As… | Phase1 | Hepatobiliary Disorders | Completed | 2017-11-28 | 2020-03-20 | ClinicalTrials.gov |
| NCT03377699 | Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Ins… | Phase3 | Diabetes | Completed | 2017-11-22 | 2020-12-17 | ClinicalTrials.gov |
| NCT03374774 | A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a … | — | Diabetes | Completed | 2017-11-13 | 2018-07-04 | ClinicalTrials.gov |
| NCT03308721 | Research Study Investigating Study Medicine (NNC9204-1177) for Weight Managemen… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2017-10-16 | 2020-01-03 | ClinicalTrials.gov |
| NCT03308916 | Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers | Na | Liver Diseases, Alcoholic | Recruiting | 2017-10-06 | 2035-10-30 | ClinicalTrials.gov |
| NCT03292185 | A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Lir… | Phase1 | Diabetes | Completed | 2017-09-29 | 2018-01-02 | ClinicalTrials.gov |
| NCT03279731 | Binge Eating Liraglutide Intervention | Phase3 | Binge-Eating Disorder | Terminated | 2017-09-29 | 2019-10-01 | ClinicalTrials.gov |
| NCT03288740 | A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide … | Phase1 | Diabetes | Completed | 2017-09-21 | 2018-08-07 | ClinicalTrials.gov |
| NCT03268005 | Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another… | Phase3 | Diabetes | Completed | 2017-09-19 | 2019-01-29 | ClinicalTrials.gov |
| NCT03061214 | Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as… | Phase3 | Diabetes | Completed | 2017-08-28 | 2019-04-15 | ClinicalTrials.gov |
| NCT03212131 | Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of… | Phase1 | Growth Hormone Disorder | Completed | 2017-08-16 | 2018-03-08 | ClinicalTrials.gov |
| NCT03070704 | Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Deg… | — | Diabetes | Withdrawn | 2017-08-16 | 2019-08-16 | ClinicalTrials.gov |
| NCT03196297 | A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Conciz… | Phase2 | Haemostasis | Completed | 2017-08-16 | 2020-06-03 | ClinicalTrials.gov |
| NCT03196284 | A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Co… | Phase2 | Congenital Bleeding Disorder | Completed | 2017-08-10 | 2020-01-31 | ClinicalTrials.gov |
| NCT03235102 | Awareness, Care and Treatment in Obesity Management | — | Metabolism and Nutrition Disorder | Completed | 2017-08-03 | 2017-10-11 | ClinicalTrials.gov |
| NCT03225755 | Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Cha… | — | Growth Hormone Deficiency | Completed | 2017-08-01 | 2025-04-30 | ClinicalTrials.gov |
| NCT03222284 | The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powe… | Na | Diabetes Mellitus, Type 2 | Unknown | 2017-07-17 | 2017-11-30 | ClinicalTrials.gov |
| NCT03215498 | A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and O… | Phase1 | Diabetes | Completed | 2017-07-03 | 2017-11-20 | ClinicalTrials.gov |
| NCT03191396 | Research Study Comparing a New Medicine Semaglutide to Liraglutide in People Wi… | Phase3 | Diabetes | Completed | 2017-06-27 | 2018-08-13 | ClinicalTrials.gov |
| NCT03115424 | Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy | Phase3 | Obesity | Completed | 2017-06-22 | 2024-05-30 | ClinicalTrials.gov |
| NCT03186495 | Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of… | Phase1 | Growth Hormone Disorder | Completed | 2017-06-20 | 2018-05-17 | ClinicalTrials.gov |
| NCT03175120 | A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combinat… | Phase3 | Diabetes | Completed | 2017-05-26 | 2019-04-04 | ClinicalTrials.gov |
| NCT03172494 | A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liragluti… | Phase3 | Diabetes | Completed | 2017-05-26 | 2019-07-13 | ClinicalTrials.gov |
| NCT03048578 | Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain … | Phase4 | Obesity | Completed | 2017-05-22 | 2021-03-02 | ClinicalTrials.gov |
| NCT03093636 | Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes | Na | Type1 Diabetes Mellitus | Completed | 2017-04-17 | 2019-03-19 | ClinicalTrials.gov |
| NCT02953665 | Safety and Efficacy of Liraglutide in Parkinson's Disease | Phase2 | Parkinson Disease | Completed | 2017-04-03 | 2022-08-03 | ClinicalTrials.gov |
| NCT03244241 | Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Managemen… | Phase4 | Type 2 Diabetes Mellitus | Unknown | 2017-04-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT03095807 | Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being … | Phase1 | Metabolism and Nutrition Disorder | Completed | 2017-03-20 | 2017-08-31 | ClinicalTrials.gov |
| NCT03136484 | Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin … | Phase3 | Diabetes | Completed | 2017-03-15 | 2018-11-16 | ClinicalTrials.gov |
| NCT03086330 | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT… | Phase3 | Diabetes | Completed | 2017-03-15 | 2018-08-06 | ClinicalTrials.gov |
| NCT03078478 | A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glarg… | Phase3 | Diabetes | Completed | 2017-03-13 | 2019-03-04 | ClinicalTrials.gov |
| NCT03075670 | A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Hae… | Phase1 | Congenital Bleeding Disorder | Completed | 2017-03-07 | 2017-12-08 | ClinicalTrials.gov |
| NCT03075644 | A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-00… | Phase3 | Growth Hormone Disorder | Completed | 2017-03-03 | 2018-10-04 | ClinicalTrials.gov |
| NCT02964247 | LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors. | Phase3 | Diabetes | Completed | 2017-03-03 | 2018-05-08 | ClinicalTrials.gov |
| NCT02963935 | Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Th… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2017-02-06 | 2018-06-19 | ClinicalTrials.gov |
| NCT02963922 | Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity … | Phase3 | Metabolism and Nutrition Disorder | Completed | 2017-02-06 | 2018-09-25 | ClinicalTrials.gov |
| NCT03021187 | Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 … | Phase3 | Diabetes | Completed | 2017-02-02 | 2018-08-22 | ClinicalTrials.gov |
| NCT02994407 | Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injec… | Phase1 | Congenital Bleeding Disorder | Completed | 2017-01-30 | 2018-10-15 | ClinicalTrials.gov |
| NCT02692716 | A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects… | Phase3 | Diabetes | Completed | 2017-01-17 | 2018-09-25 | ClinicalTrials.gov |
| NCT03018028 | Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versu… | Phase3 | Diabetes | Completed | 2017-01-10 | 2018-08-15 | ClinicalTrials.gov |
| NCT03015220 | Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination … | Phase3 | Diabetes | Completed | 2017-01-10 | 2018-07-12 | ClinicalTrials.gov |
| NCT03015207 | First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics … | Phase1 | Metabolism and Nutrition Disorder | Completed | 2017-01-06 | 2017-10-26 | ClinicalTrials.gov |
| NCT03010475 | A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of… | Phase1 | Diabetes | Completed | 2017-01-05 | 2017-08-09 | ClinicalTrials.gov |
| NCT03038620 | Impact of Liraglutide 3.0 on Body Fat Distribution | Phase4 | Obesity, Visceral | Completed | 2017-01-01 | 2020-10-13 | ClinicalTrials.gov |
| NCT02967757 | In-market Utilisation of Liraglutide Used for Weight Management in Europe | — | Metabolism and Nutrition Disorder | Completed | 2016-12-22 | 2019-05-28 | ClinicalTrials.gov |
| NCT02938585 | Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleedin… | Phase3 | Congenital Bleeding Disorder | Completed | 2016-12-12 | 2018-12-12 | ClinicalTrials.gov |
| NCT02986984 | Transformative Research in Diabetic Nephropathy | — | Diabetic Nephropathies | Recruiting | 2016-12-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT02965144 | Long Term Survivors of High-grade Glioma and Their Caregivers | — | Quality of Life | Completed | 2016-12-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02970942 | Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semag… | Phase2 | Hepatobiliary Disorders | Completed | 2016-11-30 | 2020-03-19 | ClinicalTrials.gov |
| NCT02964104 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure … | Phase1 | Diabetes | Completed | 2016-11-15 | 2017-12-12 | ClinicalTrials.gov |
| NCT02958085 | Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-11-04 | 2018-01-24 | ClinicalTrials.gov |
| NCT03068078 | A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes | Na | Type2 Diabetes | Completed | 2016-11-01 | 2021-06-04 | ClinicalTrials.gov |
| NCT02905864 | Liraglutide 3 mg for Knee Osteoarthritis | Phase4 | Osteoarthritis | Completed | 2016-11-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT02962440 | A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan A… | Phase1 | Healthy | Completed | 2016-11-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02938572 | A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacok… | Phase1 | Diabetes | Completed | 2016-10-19 | 2017-07-04 | ClinicalTrials.gov |
| NCT02933853 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Fas… | Phase1 | Diabetes | Completed | 2016-10-14 | 2017-12-21 | ClinicalTrials.gov |
| NCT02920385 | A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics… | Phase1 | Diabetes | Completed | 2016-10-10 | 2017-06-16 | ClinicalTrials.gov |
| NCT02941354 | Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to … | Phase1 | Congenital Bleeding Disorder | Completed | 2016-10-10 | 2017-06-20 | ClinicalTrials.gov |
| NCT02941042 | A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetic… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-10-10 | 2017-09-30 | ClinicalTrials.gov |
| NCT02920398 | A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investig… | Phase1 | Congenital Bleeding Disorder | Completed | 2016-10-04 | 2017-04-07 | ClinicalTrials.gov |
| NCT02889510 | Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Me… | Phase3 | Type 2 Diabetes | Completed | 2016-10-04 | 2019-12-16 | ClinicalTrials.gov |
| NCT02918279 | Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects Wit… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2016-09-29 | 2019-08-08 | ClinicalTrials.gov |
| NCT02911870 | A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in… | Phase1 | Healthy | Completed | 2016-09-23 | 2017-05-11 | ClinicalTrials.gov |
| NCT02911948 | A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Li… | Phase3 | Diabetes | Completed | 2016-09-21 | 2017-11-22 | ClinicalTrials.gov |
| NCT02827708 | Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 … | Phase3 | Diabetes | Completed | 2016-09-20 | 2018-05-15 | ClinicalTrials.gov |
| NCT02906930 | Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 … | Phase3 | Diabetes | Completed | 2016-09-20 | 2017-12-08 | ClinicalTrials.gov |
| NCT02906917 | A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart … | Phase3 | Diabetes | Completed | 2016-09-20 | 2017-12-24 | ClinicalTrials.gov |
| NCT02849080 | Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based … | Phase3 | Diabetes | Completed | 2016-09-20 | 2019-03-27 | ClinicalTrials.gov |
| NCT02868229 | Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple … | Phase1 | Anemia | Completed | 2016-09-12 | 2018-12-11 | ClinicalTrials.gov |
| NCT02911818 | Lifestyle Modification and Liraglutide | Phase4 | Obesity | Completed | 2016-09-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02877355 | Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacoki… | Phase1 | Diabetes | Completed | 2016-08-22 | 2017-11-24 | ClinicalTrials.gov |
| NCT02870231 | Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-053… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-08-18 | 2017-09-03 | ClinicalTrials.gov |
| NCT02863419 | Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo i… | Phase3 | Diabetes | Completed | 2016-08-10 | 2018-03-30 | ClinicalTrials.gov |
| NCT02863328 | Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With T… | Phase3 | Diabetes | Completed | 2016-08-10 | 2018-03-08 | ClinicalTrials.gov |
| NCT02982408 | Impact of Overfeeding and Following Exercise Training in Individuals With and W… | Na | Type 2 Diabetes Mellitus | Completed | 2016-08-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT02835235 | A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-07-26 | 2017-07-07 | ClinicalTrials.gov |
| NCT02844790 | A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insuli… | Phase1 | Healthy | Completed | 2016-07-26 | 2016-09-27 | ClinicalTrials.gov |
| NCT02825251 | Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-actin… | Phase3 | Diabetes | Completed | 2016-07-06 | 2017-07-21 | ClinicalTrials.gov |
| NCT02845219 | A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of … | Phase1 | Diabetes | Completed | 2016-07-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02821052 | Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use… | — | Diabetes | Completed | 2016-07-01 | 2018-11-24 | ClinicalTrials.gov |
| NCT02779413 | A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excl… | — | Diabetes | Completed | 2016-06-02 | 2019-06-24 | ClinicalTrials.gov |
| NCT02773381 | A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on P… | Phase1 | Diabetes | Completed | 2016-06-02 | 2018-10-19 | ClinicalTrials.gov |
| NCT02773368 | A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Lir… | Phase3 | Diabetes | Completed | 2016-05-23 | 2017-10-23 | ClinicalTrials.gov |
| NCT02773355 | Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events f… | — | Obesity | Completed | 2016-05-16 | 2022-02-28 | ClinicalTrials.gov |
| NCT02670915 | Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both… | Phase3 | Diabetes | Completed | 2016-05-04 | 2018-03-03 | ClinicalTrials.gov |
| NCT02500706 | Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both… | Phase3 | Diabetes | Completed | 2016-05-04 | 2017-08-16 | ClinicalTrials.gov |
| NCT02762578 | Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 i… | Phase3 | Diabetes | Completed | 2016-05-03 | 2017-06-19 | ClinicalTrials.gov |
| NCT02617160 | Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously… | Na | Type 1 Diabetes | Terminated | 2016-05-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02754817 | A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an … | — | Diabetes | Completed | 2016-04-26 | 2016-10-20 | ClinicalTrials.gov |
| NCT02616562 | Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compare… | Phase2 | Growth Hormone Disorder | Completed | 2016-03-31 | 2024-09-26 | ClinicalTrials.gov |
| NCT02730377 | Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metf… | Phase4 | Diabetes | Completed | 2016-03-28 | 2019-08-12 | ClinicalTrials.gov |
| NCT02717858 | A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overwei… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-03-16 | 2017-02-27 | ClinicalTrials.gov |
| NCT02670213 | A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment … | — | Congenital Bleeding Disorder | Completed | 2016-03-16 | 2024-09-30 | ClinicalTrials.gov |
| NCT02696148 | A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics o… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2016-03-14 | 2017-04-13 | ClinicalTrials.gov |
| NCT02607865 | Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subject… | Phase3 | Diabetes | Completed | 2016-02-15 | 2018-03-28 | ClinicalTrials.gov |
| NCT02655770 | Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabete… | Phase4 | Diabetes Mellitus Type 2 | Completed | 2016-02-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT02501161 | A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degl… | Phase3 | Diabetes | Completed | 2016-01-31 | 2018-10-03 | ClinicalTrials.gov |
| NCT02648204 | Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in… | Phase3 | Diabetes | Completed | 2016-01-06 | 2017-05-19 | ClinicalTrials.gov |
| NCT02648217 | Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily an… | Phase3 | Diabetes | Completed | 2016-01-04 | 2016-09-05 | ClinicalTrials.gov |
| NCT02647944 | Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions i… | Phase2 | Obesity | Completed | 2015-12-18 | 2016-12-30 | ClinicalTrials.gov |
| NCT02662114 | Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching … | — | Diabetes | Completed | 2015-12-08 | 2016-08-12 | ClinicalTrials.gov |
| NCT02627287 | A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-i… | Phase1 | Diabetes | Completed | 2015-12-01 | 2016-02-25 | ClinicalTrials.gov |
| NCT02230618 | Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin A… | — | Diabetes | Completed | 2015-11-24 | 2017-06-01 | ClinicalTrials.gov |
| NCT02617693 | Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Pr… | Phase4 | Diabetes | Completed | 2015-11-23 | 2017-12-09 | ClinicalTrials.gov |
| NCT02607306 | A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insu… | Phase3 | Diabetes | Completed | 2015-11-18 | 2017-12-22 | ClinicalTrials.gov |
| NCT02443155 | A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type… | Phase2 | Diabetes | Completed | 2015-11-10 | 2019-02-27 | ClinicalTrials.gov |
| NCT02527200 | Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2015-11-09 | 2020-11-19 | ClinicalTrials.gov |
| NCT02612844 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Diabetes | Completed | 2015-11-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT03223493 | Awareness, Care & Treatment in Obesity Management (ACTION) Study | — | Metabolism and Nutrition Disorder | Completed | 2015-10-29 | 2015-11-12 | ClinicalTrials.gov |
| NCT02594033 | A Trial to Investigate Different Needle Features Assessed by Comparing Insulin … | Phase1 | Diabetes | Completed | 2015-10-27 | 2016-01-28 | ClinicalTrials.gov |
| NCT02582242 | Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (B… | Phase4 | Diabetes | Completed | 2015-10-19 | 2017-04-18 | ClinicalTrials.gov |
| NCT02568280 | Investigating the Postprandial Glucose Metabolism After Treatment With Faster-a… | Phase1 | Diabetes | Completed | 2015-10-06 | 2016-04-25 | ClinicalTrials.gov |
| NCT02415556 | Memory Aid by Intranasal Insulin in Diabetes (MemAID) | Phase2 | Type 2 Diabetes Mellitus | Completed | 2015-10-06 | 2020-05-31 | ClinicalTrials.gov |
| NCT02568306 | A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetic… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2015-10-05 | 2017-02-07 | ClinicalTrials.gov |
| NCT02580032 | Validation of Two Measures for Growth Hormone Deficiency in Children, the Treat… | — | Growth Disorder | Completed | 2015-10-05 | 2018-05-14 | ClinicalTrials.gov |
| NCT02453711 | Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subject… | Phase2 | Metabolism and Nutrition Disorder | Completed | 2015-10-01 | 2017-04-12 | ClinicalTrials.gov |
| NCT02573519 | Gastrointestinal Motility Among Diabetes Patients | Na | Diabetic Autonomic Neuropathy | Terminated | 2015-10-01 | 2019-02-11 | ClinicalTrials.gov |
| NCT02461589 | Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Place… | Phase2 | Diabetes | Completed | 2015-09-21 | 2016-10-13 | ClinicalTrials.gov |
| NCT02490787 | Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab… | Phase1 | Congenital Bleeding Disorder | Completed | 2015-09-10 | 2016-10-14 | ClinicalTrials.gov |
| NCT02557620 | Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Adm… | Phase1 | Diabetes | Completed | 2015-09-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02486237 | Complications in Central American Diabetic Patients: Historic Cohort | — | Diabetes Mellitus, Type 2 | Completed | 2015-09-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02568202 | Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-… | — | Haemostasis | Completed | 2015-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02536859 | Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec an… | Phase1 | Diabetes | Completed | 2015-08-31 | 2016-04-14 | ClinicalTrials.gov |
| NCT02453685 | A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and In… | Phase4 | Diabetes | Completed | 2015-08-31 | 2016-09-20 | ClinicalTrials.gov |
| NCT02473809 | The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function | Phase4 | Diabetes Complications | Completed | 2015-08-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02660047 | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 P… | Phase4 | Diabetes Mellitus Type 2 | Completed | 2015-08-01 | 2018-03-09 | ClinicalTrials.gov |
| NCT02420262 | A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide … | Phase3 | Diabetes | Completed | 2015-07-26 | 2016-10-05 | ClinicalTrials.gov |
| NCT02117622 | A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insu… | — | Diabetes | Completed | 2015-07-24 | 2017-04-05 | ClinicalTrials.gov |
| NCT02505334 | A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglut… | Phase3 | Diabetes | Completed | 2015-07-21 | 2017-11-09 | ClinicalTrials.gov |
| NCT02479022 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Diabetes | Completed | 2015-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02470039 | Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine… | Phase2 | Diabetes | Completed | 2015-06-01 | 2015-12-31 | ClinicalTrials.gov |
| NCT02522520 | Pedometer Intervention and Health Effects for Sedentary Colorectal Cancer Patie… | Na | Colorectal Cancer | Completed | 2015-06-01 | 2021-09-01 | ClinicalTrials.gov |
| NCT03264014 | Combining Registry Data in Haemophilia: TARGET H | — | Haemophilia | Completed | 2015-05-01 | 2015-09-30 | ClinicalTrials.gov |
| NCT02472717 | Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Eff… | Phase2 | Psoriatic Arthritis | Withdrawn | 2015-05-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02066766 | A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complication… | — | Diabetes | Completed | 2015-04-22 | 2015-08-31 | ClinicalTrials.gov |
| NCT02541942 | Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Expos… | Phase2 | Congenital Bleeding Disorder | Completed | 2015-04-03 | 2016-04-15 | ClinicalTrials.gov |
| NCT02545738 | Antiproteinuric Effects of Liraglutide Treatment | Phase4 | Diabetic Kidney Disease | Completed | 2015-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02255266 | Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Dail… | — | Diabetes | Completed | 2015-03-26 | 2015-11-16 | ClinicalTrials.gov |
| NCT02392117 | Investigating the Safety and Effectiveness of Insulin Degludec in a Real World … | — | Diabetes | Completed | 2015-03-16 | 2018-03-19 | ClinicalTrials.gov |
| NCT02382939 | A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily N… | Phase3 | Adult Growth Hormone Deficiency | Completed | 2015-02-12 | 2016-01-04 | ClinicalTrials.gov |
| NCT02371239 | SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabete… | Na | Type 2 Diabetes | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02486419 | Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study. | — | Nonshivering Thermogenisis | Completed | 2015-02-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02608853 | Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to b… | — | Diabetes | Completed | 2015-01-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02408705 | Investigating the Effect of Liraglutide on the Endogenous Glucose Production Du… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2015-01-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02321878 | Post-marketing Surveillance (Special Use-results Surveillance) on Use With Lira… | — | Diabetes | Completed | 2014-12-15 | 2017-06-16 | ClinicalTrials.gov |
| NCT02300844 | Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of N… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2014-12-01 | 2016-03-21 | ClinicalTrials.gov |
| NCT02531776 | Patient Experiences With Injection Needles | Na | Diabetes Mellitus, Type 2 | Completed | 2014-12-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02305381 | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basa… | Phase3 | Diabetes | Completed | 2014-12-01 | 2015-11-21 | ClinicalTrials.gov |
| NCT02284230 | The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure | Phase2 | Kidney Failure, Chronic | Withdrawn | 2014-12-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02304627 | Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formula… | Phase1 | Diabetes | Completed | 2014-11-24 | 2015-07-31 | ClinicalTrials.gov |
| NCT02298192 | A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide … | Phase3 | Diabetes | Completed | 2014-11-21 | 2015-12-23 | ClinicalTrials.gov |
| NCT02241694 | To Quantify the Range of Main Psychosocial Factors Affecting Patients and Careg… | — | Congenital Bleeding Disorder | Completed | 2014-11-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02229851 | Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Pla… | Phase3 | Growth Hormone Disorder | Completed | 2014-10-31 | 2018-05-07 | ClinicalTrials.gov |
| NCT02306681 | A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes | — | Diabetes | Completed | 2014-10-30 | 2015-05-14 | ClinicalTrials.gov |
| NCT01876745 | A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzman… | — | Congenital Bleeding Disorder | Completed | 2014-10-07 | 2017-06-01 | ClinicalTrials.gov |
| NCT02254291 | A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sit… | Phase3 | Diabetes | Completed | 2014-10-02 | 2015-11-11 | ClinicalTrials.gov |
| NCT02299388 | To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study | Phase4 | Diabetes Mellitus, Non-Insulin-Dependent | Completed | 2014-10-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02230631 | A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes | — | Diabetes | Completed | 2014-10-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01957592 | A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complication… | — | Diabetes | Withdrawn | 2014-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02249871 | Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semag… | Phase1 | Diabetes | Completed | 2014-09-24 | 2015-04-01 | ClinicalTrials.gov |
| NCT02249910 | Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformi… | Phase1 | Diabetes | Completed | 2014-09-18 | 2015-03-06 | ClinicalTrials.gov |
| NCT02243098 | Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Do… | Phase1 | Diabetes | Completed | 2014-09-16 | 2015-04-07 | ClinicalTrials.gov |
| NCT03679442 | Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Parace… | Phase1 | Drug-Induced Acute Liver Injury | Completed | 2014-09-08 | 2017-02-18 | ClinicalTrials.gov |
| NCT02235961 | Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC92… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2014-09-04 | 2016-07-06 | ClinicalTrials.gov |
| NCT02231684 | Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 m… | Phase1 | Diabetes | Completed | 2014-09-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02225483 | Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Plate… | — | Hemophilia A | Completed | 2014-09-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02097264 | A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) … | Phase2 | Inflammation | Withdrawn | 2014-09-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02220296 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Healthy | Completed | 2014-08-20 | 2015-03-31 | ClinicalTrials.gov |
| NCT02205528 | A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequ… | Phase2 | Diabetes | Completed | 2014-08-18 | 2015-09-15 | ClinicalTrials.gov |
| NCT02212067 | A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects… | Phase1 | Diabetes | Completed | 2014-08-11 | 2015-05-11 | ClinicalTrials.gov |
| NCT02210871 | Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subc… | Phase1 | Diabetes | Completed | 2014-08-07 | 2015-06-03 | ClinicalTrials.gov |
| NCT02128932 | Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Dai… | Phase3 | Diabetes | Completed | 2014-08-04 | 2015-09-03 | ClinicalTrials.gov |
| NCT02207374 | A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monothe… | Phase3 | Diabetes | Completed | 2014-08-04 | 2016-02-27 | ClinicalTrials.gov |
| NCT02207218 | To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Trea… | — | Congenital Bleeding Disorder | Completed | 2014-08-04 | 2020-11-10 | ClinicalTrials.gov |
| NCT02207348 | Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcu… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2014-08-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02141074 | Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patie… | Phase3 | Congenital Bleeding Disorder | Completed | 2014-07-02 | 2022-10-27 | ClinicalTrials.gov |
| NCT02137850 | Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Pa… | Phase3 | Congenital Bleeding Disorder | Completed | 2014-06-26 | 2023-06-07 | ClinicalTrials.gov |
| NCT02131272 | A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin… | Phase3 | Diabetes | Terminated | 2014-06-11 | 2016-06-14 | ClinicalTrials.gov |
| NCT02035384 | Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and… | — | Congenital Bleeding Disorder | Completed | 2014-06-05 | 2020-01-15 | ClinicalTrials.gov |
| NCT02172313 | Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects | Phase1 | Diabetes | Completed | 2014-06-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02161588 | A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerabili… | Phase1 | Diabetes | Completed | 2014-06-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02148861 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Diabetes | Completed | 2014-05-26 | 2015-06-01 | ClinicalTrials.gov |
| NCT02147431 | A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulat… | Phase1 | Diabetes | Completed | 2014-05-21 | 2015-05-20 | ClinicalTrials.gov |
| NCT02146079 | A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and To… | Phase1 | Diabetes | Completed | 2014-05-21 | 2014-10-20 | ClinicalTrials.gov |
| NCT02131246 | A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Proper… | Phase1 | Diabetes | Completed | 2014-05-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02098395 | The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 D… | Phase3 | Diabetes | Completed | 2014-05-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02133040 | Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue | — | Hyperthyroidism | Unknown | 2014-05-01 | 2020-05-10 | ClinicalTrials.gov |
| NCT02138045 | Treatment of Diabetic Neuropathy With Liraglutide | Na | Diabetes Mellitus, Type 1 | Completed | 2014-05-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT02100475 | A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Inc… | Phase3 | Diabetes | Completed | 2014-04-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02036619 | The Belgian Diabetes in Pregnancy Study: BEDIP-N Study | — | Gestational Diabetes | Completed | 2014-04-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT02089451 | A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspar… | Phase1 | Diabetes | Completed | 2014-03-17 | 2014-06-06 | ClinicalTrials.gov |
| NCT02079870 | Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensat… | Phase1 | Diabetes | Completed | 2014-03-06 | 2015-01-07 | ClinicalTrials.gov |
| NCT01959555 | Project to Update the Study of Congenital Haemophilia in Spain | — | Congenital Bleeding Disorder | Completed | 2014-03-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02094521 | Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Ad… | Phase1 | Diabetes | Completed | 2014-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02084810 | Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healt… | Phase1 | Congenital Bleeding Disorder | Withdrawn | 2014-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02076724 | Reinforcement of the Abdominal Wall After Breast Reconstruction With the Pedicl… | Na | Abdominal Donor-site | Completed | 2014-03-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT01919489 | Liraglutide Hospital Discharge Trial | Phase4 | Type 2 Diabetes | Completed | 2014-03-01 | 2020-08-30 | ClinicalTrials.gov |
| NCT02005198 | Assessing the Minimal Important Difference (MID) of the Treatment Related Impac… | — | Growth Hormone Disorder | Completed | 2014-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02070510 | A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics… | Phase1 | Diabetes | Completed | 2014-02-27 | 2014-08-20 | ClinicalTrials.gov |
| NCT02064348 | A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisatio… | Phase1 | Diabetes | Completed | 2014-02-26 | 2015-04-23 | ClinicalTrials.gov |
| NCT02077946 | A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabete… | — | Diabetes | Completed | 2014-02-10 | 2014-09-03 | ClinicalTrials.gov |
| NCT02060266 | Trial Investigating the Absorption, Metabolism and Excretion After a Single Sub… | Phase1 | Diabetes | Completed | 2014-02-04 | 2014-04-28 | ClinicalTrials.gov |
| NCT02054897 | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Sub… | Phase3 | Diabetes | Completed | 2014-02-03 | 2015-05-08 | ClinicalTrials.gov |
| NCT02035371 | A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adol… | Phase1 | Diabetes | Completed | 2014-01-13 | 2014-07-24 | ClinicalTrials.gov |
| NCT01917656 | Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination Wit… | Phase4 | Diabetes | Completed | 2014-01-09 | 2014-09-04 | ClinicalTrials.gov |
| NCT02030600 | A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glarg… | Phase3 | Diabetes | Completed | 2014-01-06 | 2015-12-04 | ClinicalTrials.gov |
| NCT02034513 | A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glarg… | Phase3 | Diabetes | Completed | 2014-01-05 | 2016-01-11 | ClinicalTrials.gov |
| NCT02033239 | A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Asp… | Phase1 | Diabetes | Completed | 2014-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT02022254 | Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin a… | Phase1 | Diabetes | Completed | 2013-12-17 | 2014-08-28 | ClinicalTrials.gov |
| NCT01973244 | A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynami… | Phase1 | Growth Hormone Disorder | Completed | 2013-12-16 | 2014-11-04 | ClinicalTrials.gov |
| NCT02043054 | Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA) | Phase3 | Type 2 Diabetes Mellitus | Completed | 2013-12-16 | 2017-09-29 | ClinicalTrials.gov |
| NCT02016911 | Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With … | Phase1 | Diabetes | Completed | 2013-12-12 | 2015-01-12 | ClinicalTrials.gov |
| NCT02014259 | Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With … | Phase1 | Diabetes | Completed | 2013-12-11 | 2014-10-24 | ClinicalTrials.gov |
| NCT01907854 | Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects Wi… | Phase4 | Diabetes | Completed | 2013-12-02 | 2015-06-15 | ClinicalTrials.gov |
| NCT01885208 | Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-… | Phase3 | Diabetes | Completed | 2013-12-02 | 2015-07-13 | ClinicalTrials.gov |
| NCT01923181 | Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semag… | Phase2 | Diabetes | Completed | 2013-12-02 | 2014-12-11 | ClinicalTrials.gov |
| NCT01930188 | Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as… | Phase3 | Diabetes | Completed | 2013-12-02 | 2015-10-12 | ClinicalTrials.gov |
| NCT02008682 | The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combina… | Phase4 | Diabetes | Completed | 2013-12-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02003677 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIA… | Phase1 | Diabetes | Completed | 2013-11-29 | 2014-08-14 | ClinicalTrials.gov |
| NCT01821846 | Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use … | — | Diabetes | Completed | 2013-11-20 | 2017-03-08 | ClinicalTrials.gov |
| NCT01999322 | A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an… | Phase3 | Diabetes | Completed | 2013-11-19 | 2014-05-14 | ClinicalTrials.gov |
| NCT01984372 | Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use… | — | Diabetes Mellitus, Type 1 | Completed | 2013-11-06 | 2019-04-30 | ClinicalTrials.gov |
| NCT01992588 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIA… | Phase1 | Diabetes | Completed | 2013-11-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01836523 | The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Tre… | Phase3 | Diabetes | Completed | 2013-11-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01761318 | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 P… | Phase4 | Diabetes Mellitus Type 2 | Completed | 2013-11-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01978613 | Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of… | Phase1 | Diabetes | Completed | 2013-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glar… | Phase3 | Diabetes | Completed | 2013-10-29 | 2016-10-16 | ClinicalTrials.gov |
| NCT01835431 | A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspar… | Phase3 | Diabetes | Completed | 2013-10-17 | 2014-11-07 | ClinicalTrials.gov |
| NCT01967589 | Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of… | Phase1 | Diabetes | Completed | 2013-10-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01988532 | Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemo… | — | Congenital Bleeding Disorder | Completed | 2013-10-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01973231 | Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin i… | Phase4 | Diabetes | Completed | 2013-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01892319 | An International Non-interventional Cohort Study to Evaluate the Safety of Trea… | — | Diabetes Mellitus | Completed | 2013-09-30 | 2019-09-30 | ClinicalTrials.gov |
| NCT01850615 | Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Ther… | Phase3 | Diabetes | Completed | 2013-09-23 | 2014-11-17 | ClinicalTrials.gov |
| NCT01952145 | A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versu… | Phase3 | Diabetes | Completed | 2013-09-20 | 2014-11-04 | ClinicalTrials.gov |
| NCT01819129 | Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Ins… | Phase3 | Diabetes | Completed | 2013-09-09 | 2015-01-22 | ClinicalTrials.gov |
| NCT01934673 | A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complication… | — | Diabetes | Completed | 2013-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01955603 | A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacod… | Phase1 | Inflammation | Completed | 2013-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01934686 | A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complication… | — | Diabetes | Completed | 2013-09-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01943084 | A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus G… | Phase1 | Growth Disorder | Completed | 2013-09-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01949792 | A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Pa… | Phase1 | Congenital Bleeding Disorder | Completed | 2013-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01934712 | A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subje… | Phase1 | Diabetes | Completed | 2013-08-30 | 2014-01-28 | ClinicalTrials.gov |
| NCT01831765 | Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination Wit… | Phase3 | Diabetes | Completed | 2013-08-26 | 2015-06-11 | ClinicalTrials.gov |
| NCT01927861 | Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatro… | Phase3 | Genetic Disorder | Completed | 2013-08-19 | 2018-07-12 | ClinicalTrials.gov |
| NCT01924637 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIA… | Phase1 | Diabetes | Completed | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01512095 | Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Ad… | Phase1 | Growth Disorder | Withdrawn | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT02458170 | Examination of Biopsies From Healthy Knee Joints | — | Abnormality in Synovial Tissue | Terminated | 2013-08-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01916174 | A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide … | Phase1 | Diabetes | Completed | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01931137 | A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000… | Phase1 | Diabetes | Completed | 2013-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01890993 | Retrospective Collection of Effectiveness and Safety Data From Patients Treated… | — | Diabetes | Completed | 2013-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01900834 | Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One … | — | Diabetes | Completed | 2013-07-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01849289 | A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine … | Phase3 | Diabetes | Completed | 2013-06-02 | 2014-05-15 | ClinicalTrials.gov |
| NCT01877200 | A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complication… | — | Diabetes | Completed | 2013-06-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01868542 | A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily Acc… | Phase4 | Diabetes | Completed | 2013-06-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01892020 | Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Ver… | Phase4 | Diabetes | Completed | 2013-06-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01880736 | A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and … | Phase3 | Diabetes | Completed | 2013-06-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01862367 | Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-… | — | Congenital Bleeding Disorder | Completed | 2013-05-17 | 2019-06-26 | ClinicalTrials.gov |
| NCT01846312 | An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in… | — | Diabetes | Completed | 2013-05-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01866748 | Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multip… | Phase1 | Diabetes | Completed | 2013-05-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT02615756 | Molecular and Functional Neurobiology of Physical Exercise | Na | Physical Exercise Behavior (Liking/Aversion) | Completed | 2013-04-01 | 2018-06-01 | ClinicalTrials.gov |
| NCT01787916 | 52 Week Trial of Liraglutide in Type 1 Diabetes | Phase4 | Type 1 Diabetes | Completed | 2013-04-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01809184 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Diabetes | Completed | 2013-03-04 | 2013-09-06 | ClinicalTrials.gov |
| NCT02403284 | The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans | Phase4 | Insulin Resistance | Completed | 2013-03-01 | 2023-11-01 | ClinicalTrials.gov |
| NCT02092896 | Liraglutide as add-on to Insulin in Type 1 Diabetes | Phase3 | Diabetes | Completed | 2013-03-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01626833 | Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeuti… | Phase2 | Anorexia Nervosa | Completed | 2013-03-01 | 2021-03-01 | ClinicalTrials.gov |
| NCT01814137 | A Randomised Trial Comparing Efficacy and Safety After Intensification With Eit… | Phase3 | Diabetes | Completed | 2013-03-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide … | Phase3 | Diabetes | Completed | 2013-02-21 | 2016-03-15 | ClinicalTrials.gov |
| NCT01796366 | A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics … | Phase1 | Diabetes | Completed | 2013-02-21 | 2013-08-19 | ClinicalTrials.gov |
| NCT01713530 | A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspar… | Phase3 | Diabetes | Completed | 2013-02-21 | 2014-01-09 | ClinicalTrials.gov |
| NCT01731600 | A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharm… | Phase3 | Congenital Bleeding Disorder | Completed | 2013-02-20 | 2018-09-28 | ClinicalTrials.gov |
| NCT01789086 | A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerabi… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2013-02-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01751152 | A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess … | Phase2 | Inflammation | Completed | 2013-02-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01778023 | Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in S… | Phase3 | Growth Disorder | Completed | 2013-01-17 | 2014-12-17 | ClinicalTrials.gov |
| NCT01789593 | A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function a… | Phase1 | Diabetes | Completed | 2013-01-14 | 2013-12-01 | ClinicalTrials.gov |
| NCT01755572 | Blood Pressure Outcomes With Liraglutide Therapy | Phase4 | Type 2 Diabetes | Completed | 2013-01-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT02113332 | Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple … | Phase2 | Type 2 Diabetes Mellitus | Completed | 2013-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01773798 | A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Ins… | Phase1 | Diabetes | Completed | 2013-01-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01780272 | A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjec… | Phase1 | Diabetes | Completed | 2013-01-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01692925 | Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemo… | Phase1 | Congenital Bleeding Disorder | Completed | 2012-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01664676 | Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients | Phase4 | Type 2 Diabetes Mellitus | Completed | 2012-12-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01795235 | Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones | Na | Healthy | Unknown | 2012-12-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01766245 | A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Heal… | Phase1 | Diabetes | Completed | 2012-12-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01435629 | A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treate… | — | Genetic Disorder | Completed | 2012-11-22 | 2015-12-04 | ClinicalTrials.gov |
| NCT01541215 | Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Me… | Phase3 | Diabetes | Completed | 2012-11-13 | 2020-05-20 | ClinicalTrials.gov |
| NCT01722266 | Liraglutide in the Treatment of Type 1 Diabetes Mellitus | Phase3 | Type 1 Diabetes | Completed | 2012-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01636843 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheuma… | Phase2 | Inflammation | Terminated | 2012-10-30 | 2014-11-10 | ClinicalTrials.gov |
| NCT01706783 | A Trial Investigating the Safety, Tolerability, Availability and Distribution i… | Phase1 | Growth Hormone Disorder | Completed | 2012-10-12 | 2013-11-18 | ClinicalTrials.gov |
| NCT01704417 | A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type… | Phase1 | Diabetes | Completed | 2012-10-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01666964 | Hormone Deficiency After Brain Injury During Combat | — | Traumatic Brain Injury | Unknown | 2012-10-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01730014 | A Trial Investigating the Safety, Tolerability, and Distribution and Activity i… | Phase1 | Diabetes | Completed | 2012-10-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01664247 | The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in… | Phase3 | Diabetes | Completed | 2012-10-01 | 2013-12-31 | ClinicalTrials.gov |
| NCT01706159 | A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Mo… | Phase2 | Inflammation | Terminated | 2012-10-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01686945 | Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of… | Phase1 | Diabetes | Completed | 2012-09-19 | 2013-04-08 | ClinicalTrials.gov |
| NCT01493778 | Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in… | Phase3 | Congenital Bleeding Disorder | Completed | 2012-09-17 | 2018-12-05 | ClinicalTrials.gov |
| NCT01690169 | Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of … | Phase1 | Diabetes | Completed | 2012-09-14 | 2012-12-11 | ClinicalTrials.gov |
| NCT01696266 | An International Survey on Hypoglycaemia Among Insulin-treated Patients With Di… | — | Diabetes | Completed | 2012-09-05 | 2013-12-30 | ClinicalTrials.gov |
| NCT01647451 | A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess … | Phase2 | Inflammation | Completed | 2012-09-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01682902 | A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations … | Phase1 | Diabetes | Completed | 2012-09-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01617434 | The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues … | Phase3 | Diabetes | Completed | 2012-09-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01689025 | An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Sy… | Phase1 | Inflammation | Terminated | 2012-09-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01680341 | Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens… | Phase3 | Diabetes | Completed | 2012-08-31 | 2013-08-22 | ClinicalTrials.gov |
| NCT01618162 | The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling G… | Phase3 | Diabetes | Completed | 2012-08-29 | 2013-10-23 | ClinicalTrials.gov |
| NCT01676116 | The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults… | Phase3 | Diabetes | Completed | 2012-08-29 | 2014-03-11 | ClinicalTrials.gov |
| NCT01489111 | Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedu… | Phase3 | Congenital Bleeding Disorder | Completed | 2012-08-03 | 2018-12-10 | ClinicalTrials.gov |
| NCT01680328 | Investigation of Pain During Subcutaneous Injections With Different Injection S… | Phase1 | Diabetes | Completed | 2012-08-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01610934 | The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) | Phase2 | Maturity-onset Diabetes of the Young | Completed | 2012-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01628445 | Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin | Phase3 | Type 2 Diabetes | Terminated | 2012-08-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01636817 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheuma… | Phase2 | Inflammation | Terminated | 2012-08-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01499108 | Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Typ… | Phase4 | Type 2 Diabetes | Completed | 2012-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01795248 | The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes … | Phase4 | Gestational Diabetes Mellitus | Completed | 2012-07-01 | 2020-09-01 | ClinicalTrials.gov |
| NCT01631942 | A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Phar… | Phase1 | Congenital Bleeding Disorder | Terminated | 2012-06-26 | 2012-09-04 | ClinicalTrials.gov |
| NCT01620489 | Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabete… | Phase3 | Diabetes | Completed | 2012-06-14 | 2013-08-20 | ClinicalTrials.gov |
| NCT01618188 | A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With… | Phase1 | Diabetes | Completed | 2012-06-11 | 2012-09-07 | ClinicalTrials.gov |
| NCT01386528 | Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subject… | Phase3 | Congenital Bleeding Disorder | Completed | 2012-06-07 | 2013-12-01 | ClinicalTrials.gov |
| NCT01557166 | Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sle… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2012-06-07 | 2013-06-17 | ClinicalTrials.gov |
| NCT01611688 | First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis | Phase1 | Inflammation | Completed | 2012-06-04 | 2013-06-17 | ClinicalTrials.gov |
| NCT01519674 | Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type… | Phase4 | Diabetes | Completed | 2012-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01618214 | Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Tw… | Phase4 | Diabetes | Completed | 2012-06-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01619345 | Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects | Phase1 | Diabetes | Completed | 2012-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01623375 | A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healt… | Phase1 | Diabetes | Completed | 2012-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01559103 | Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis… | Phase1 | Rheumatoid Arthritis | Terminated | 2012-05-31 | 2014-02-28 | ClinicalTrials.gov |
| NCT01589653 | Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Comb… | Phase4 | Diabetes | Completed | 2012-05-26 | 2015-07-09 | ClinicalTrials.gov |
| NCT01467427 | Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treat… | Phase3 | Congenital Bleeding Disorder | Completed | 2012-05-16 | 2023-11-17 | ClinicalTrials.gov |
| NCT01628341 | French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic… | — | Diabetes | Completed | 2012-05-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01550653 | Liraglutide Effects on Memory in Healthy Subjects | Phase1 | Healthy | Completed | 2012-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01893580 | Perioperative Rehabilitation in Operation for Lung Cancer | Na | Lung Cancer | Terminated | 2012-05-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01597713 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacody… | Phase1 | Diabetes | Completed | 2012-05-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01799447 | Early Intervention With the Marte Meo Method | Na | Health Behavior | Completed | 2012-05-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01395810 | Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients … | Phase3 | Congenital Bleeding Disorder | Completed | 2012-04-15 | 2014-03-30 | ClinicalTrials.gov |
| NCT01572753 | Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in … | Phase1 | Diabetes | Completed | 2012-04-12 | 2012-09-08 | ClinicalTrials.gov |
| NCT01572740 | Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared… | Phase3 | Diabetes | Completed | 2012-04-05 | 2013-03-27 | ClinicalTrials.gov |
| NCT01570751 | A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin… | Phase3 | Diabetes | Completed | 2012-04-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01569841 | A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Gly… | Phase3 | Diabetes | Completed | 2012-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01590836 | A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With… | Phase1 | Diabetes | Completed | 2012-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01206101 | Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing … | Phase2 | Diabetes | Terminated | 2012-03-21 | 2013-06-03 | ClinicalTrials.gov |
| NCT01555749 | Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Lev… | Phase1 | Congenital Bleeding Disorder | Completed | 2012-03-12 | 2012-05-08 | ClinicalTrials.gov |
| NCT01565408 | Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects W… | Phase1 | Inflammation | Completed | 2012-03-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01711892 | Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androge… | Na | Prostatic Neoplasms | Completed | 2012-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01493388 | To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptab… | — | Diabetes | Completed | 2012-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01507116 | Diabetes Attitudes Wishes and Needs | — | Diabetes | Completed | 2012-03-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01543893 | Effect of Personal Versus Video Instruction in Elastic Resistance Exercise on T… | Na | Musculoskeletal Disorders | Completed | 2012-03-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01536665 | The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycae… | Phase1 | Diabetes | Completed | 2012-02-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01542242 | Liraglutide Use in Prader-Willi Syndrome | Phase4 | Diabetes Mellitus Type 2 | Terminated | 2012-02-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01480180 | Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000… | Phase3 | Congenital Bleeding Disorder | Completed | 2012-01-30 | 2018-12-10 | ClinicalTrials.gov |
| NCT01514500 | First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects | Phase1 | Growth Hormone Disorder | Completed | 2012-01-16 | 2013-03-18 | ClinicalTrials.gov |
| NCT01513473 | A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children a… | Phase3 | Diabetes | Completed | 2012-01-16 | 2013-07-30 | ClinicalTrials.gov |
| NCT01513590 | A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BI… | Phase3 | Diabetes | Completed | 2012-01-16 | 2012-11-19 | ClinicalTrials.gov |
| NCT01512108 | Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With … | Phase3 | Diabetes | Completed | 2012-01-10 | 2013-04-26 | ClinicalTrials.gov |
| NCT01950637 | GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy f… | — | Diabetes | Completed | 2012-01-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01505673 | Adding Liraglutide to High Dose Insulin: Breaking the Cycle | Phase4 | Type 2 Diabetes Mellitus | Completed | 2012-01-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01503567 | Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing … | — | Congenital Bleeding Disorder | Completed | 2012-01-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01511393 | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | — | Diabetes | Enrolling_By_Invitation | 2012-01-01 | 2039-12-01 | ClinicalTrials.gov |
| NCT01232946 | Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake | Na | Type 2 Diabetes | Completed | 2012-01-01 | 2017-09-08 | ClinicalTrials.gov |
| NCT01392573 | A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and I… | Phase3 | Diabetes | Completed | 2011-11-28 | 2012-10-04 | ClinicalTrials.gov |
| NCT01484262 | Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Ty… | — | Diabetes | Completed | 2011-11-14 | 2014-10-31 | ClinicalTrials.gov |
| NCT01444443 | DiaCon Overnight Closed-Loop Glucose Control Study | Na | Type 1 Diabetes | Completed | 2011-11-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01454024 | Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Pra… | — | Diabetes | Completed | 2011-11-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01463449 | "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals… | — | Obesity | Completed | 2011-11-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01469143 | A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 … | Phase1 | Diabetes | Completed | 2011-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01472640 | The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure… | Na | Hyperglycemia | Completed | 2011-11-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01486966 | Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH In… | Phase4 | Diabetes | Terminated | 2011-11-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01440439 | Comparing Long-acting Insulins During Exercise in Type 1 Diabetes | Phase4 | Diabetes Mellitus, Type 1 | Unknown | 2011-11-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01473953 | Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subje… | Phase1 | Diabetes | Completed | 2011-10-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01467414 | A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Dia… | Phase1 | Diabetes | Terminated | 2011-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01455142 | A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With T… | Phase1 | Diabetes | Completed | 2011-10-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01437592 | Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subje… | Phase1 | Diabetes | Completed | 2011-09-06 | 2011-11-22 | ClinicalTrials.gov |
| NCT01388361 | Comparison of the Efficacy and Safety of Two Intensification Strategies in Subj… | Phase3 | Diabetes | Completed | 2011-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01394341 | Liraglutide Treatment to Patients With Severe Renal Insufficiency | Phase4 | Type 2 Diabetes Mellitus | Completed | 2011-09-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT02382757 | Changing Diabetes in Children | — | Diabetes | Terminated | 2011-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01427920 | Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject a… | Phase4 | Diabetes | Completed | 2011-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01435642 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2011-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01345734 | Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabe… | — | Diabetes | Completed | 2011-09-01 | 2013-07-26 | ClinicalTrials.gov |
| NCT01234649 | Combined Liraglutide and Metformin Therapy in Women With Previous Gestational D… | Phase3 | Gestational Diabetes Mellitus | Completed | 2011-08-11 | 2019-06-14 | ClinicalTrials.gov |
| NCT01405261 | Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects | Phase1 | Diabetes | Completed | 2011-08-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01355718 | Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Com… | — | Diabetes | Completed | 2011-08-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01403025 | Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 … | — | Diabetes | Completed | 2011-07-19 | 2015-12-28 | ClinicalTrials.gov |
| NCT01401244 | Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in … | Phase1 | Genetic Disorder | Completed | 2011-07-14 | 2011-09-27 | ClinicalTrials.gov |
| NCT01392547 | Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophil… | Phase3 | Congenital Bleeding Disorder | Completed | 2011-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01322620 | Survey Evaluating the Psychosocial Effects of Living With Haemophilia | — | Congenital Bleeding Disorder | Completed | 2011-06-03 | 2012-02-29 | ClinicalTrials.gov |
| NCT01404520 | Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) | Na | Acute Leukemia | Completed | 2011-06-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01272219 | Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweig… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2011-06-01 | 2015-03-02 | ClinicalTrials.gov |
| NCT01395719 | Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Imm… | Na | Kidney Transplantation | Unknown | 2011-06-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01365520 | A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A | Phase1 | Congenital Bleeding Disorder | Completed | 2011-06-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01272232 | Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type … | Phase3 | Metabolism and Nutrition Disorder | Completed | 2011-06-01 | 2013-01-25 | ClinicalTrials.gov |
| NCT01365507 | Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subject… | Phase3 | Diabetes | Completed | 2011-06-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01364428 | Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabete… | Phase3 | Diabetes | Completed | 2011-06-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01336023 | Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Com… | Phase3 | Diabetes | Completed | 2011-05-23 | 2012-11-22 | ClinicalTrials.gov |
| NCT01333163 | GLP-1: Acute Effects on Kidney Function in Healthy Men | Na | Kidney Functional | Completed | 2011-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01333111 | Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients | Phase3 | Congenital Bleeding Disorder | Completed | 2011-04-27 | 2013-03-31 | ClinicalTrials.gov |
| NCT01334034 | Safety of NNC 0123-0000-0338 in Healthy Subjects | Phase1 | Diabetes | Completed | 2011-04-11 | 2011-09-16 | ClinicalTrials.gov |
| NCT01239550 | Insulin Detemir in Obesity Management | Na | Diabetes | Active_Not_Recruiting | 2011-04-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT01327924 | Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Ch… | — | Growth Hormone Disorder | Completed | 2011-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01830712 | A Long-term Assessment of Physical Activity, Range of Motion, and Functional St… | — | Congenital Bleeding Disorder | Completed | 2011-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01351922 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2011-04-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01347801 | Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflamma… | Na | Hypoglycaemia | Completed | 2011-03-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01215435 | Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects Wit… | Phase4 | Diabetes | Completed | 2011-03-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01312636 | Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Conge… | — | Congenital Bleeding Disorder | Completed | 2011-03-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01319240 | Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects | Phase1 | Diabetes | Completed | 2011-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01324505 | Effect of Oral Contraceptives After Administration of Semaglutide in Subjects W… | Phase1 | Diabetes | Completed | 2011-03-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01326026 | Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Di… | Phase3 | Diabetes | Completed | 2011-03-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01296438 | A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With… | Phase1 | Diabetes | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01288326 | Observational Study on Effectiveness and Safety of Liraglutide in Subjects With… | — | Diabetes | Completed | 2011-02-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01282255 | Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis | Phase2 | Inflammation | Completed | 2011-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01242826 | Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 i… | Phase1 | Diabetes | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01310452 | Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2… | Na | Type 2 Diabetes Mellitus | Unknown | 2011-01-01 | — | ClinicalTrials.gov |
| NCT01223911 | A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthrit… | Phase2 | Inflammation | Completed | 2011-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01253811 | Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII… | Phase3 | Congenital Bleeding Disorder | Completed | 2011-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01269606 | Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1… | Phase1 | Diabetes | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01270789 | LIraglutide and Beta-cell RepAir (LIBRA) Study | Phase3 | Type 2 Diabetes | Completed | 2011-01-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01272193 | Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type … | Phase3 | Diabetes | Completed | 2011-01-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01272206 | Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC… | Phase1 | Congenital Bleeding Disorder | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01272973 | Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of… | Phase1 | Diabetes | Completed | 2011-01-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01278160 | Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial… | Phase4 | Diabetes | Completed | 2011-01-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01288391 | Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128… | Phase1 | Congenital Bleeding Disorder | Completed | 2011-01-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01285089 | Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleed… | — | Acquired Bleeding Disorder | Completed | 2010-12-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01238367 | A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With H… | Phase1 | Congenital Bleeding Disorder | Completed | 2010-11-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01230021 | Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With… | Phase3 | Congenital Bleeding Disorder | Completed | 2010-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01504802 | Pharmacodynamics of CNP During Growth Hormone Treatment | — | Pituitary Dwarfism | Completed | 2010-11-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01220141 | Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients… | — | Congenital Bleeding Disorder | Completed | 2010-11-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01212133 | A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type … | — | Diabetes | Completed | 2010-11-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01248351 | Reversibility of Dual Antiplatelet Therapy by Platelets | Phase2 | Bleeding | Completed | 2010-11-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01437072 | Changing Diabetes® World Tour | — | Diabetes | Completed | 2010-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01245374 | Norditropin NordiFlex® Device Compared to the Device Previously Used by Patient… | Phase4 | Growth Hormone Disorder | Completed | 2010-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01232491 | Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes | Phase4 | Diabetes | Completed | 2010-10-29 | 2011-11-14 | ClinicalTrials.gov |
| NCT01228669 | Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemoph… | Phase1 | Congenital Bleeding Disorder | Completed | 2010-10-25 | 2012-09-10 | ClinicalTrials.gov |
| NCT01165684 | Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insu… | Phase4 | Diabetes | Completed | 2010-10-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01180530 | Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Ch… | — | Diabetes | Completed | 2010-10-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01234545 | Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in… | — | Congenital Bleeding Disorder | Completed | 2010-10-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01090778 | Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I) | Phase2 | Growth Hormone Deficiency | Completed | 2010-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01223547 | Study of the Effects of Carbohydrate Counting | Na | Type 1 Diabetes | Completed | 2010-10-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01312090 | Chronic Intermittent Cold Exposure on Weight Loss | Na | Obesity | Completed | 2010-10-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01585506 | Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin… | — | Diabetes | Completed | 2010-09-20 | 2010-12-20 | ClinicalTrials.gov |
| NCT01205724 | Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A | Phase1 | Congenital Bleeding Disorder | Completed | 2010-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01208506 | First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumat… | Phase1 | Inflammation | Completed | 2010-09-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01226966 | Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type… | — | Diabetes | Completed | 2010-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT06167616 | Infections and Latent Autoimmune Diabetes in Adults | — | Latent Autoimmune Diabetes in Adults | Completed | 2010-09-01 | 2019-10-31 | ClinicalTrials.gov |
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome… | Phase3 | Diabetes | Completed | 2010-08-31 | 2015-12-17 | ClinicalTrials.gov |
| NCT01174303 | A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjec… | Phase1 | Diabetes | Completed | 2010-08-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01193387 | Comparison of Two Identical NN1250 Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2010-08-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01186003 | Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therap… | Na | Diabetes | Completed | 2010-08-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01237119 | Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis | Phase2 | Nonalcoholic Steatohepatitis | Completed | 2010-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01173926 | Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart… | Phase1 | Diabetes | Completed | 2010-07-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01101867 | Prandial Insulin Dosing in Hospitalized Patients | Phase4 | Diabetes | Completed | 2010-06-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01135927 | A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Dia… | Phase1 | Diabetes | Completed | 2010-06-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01135992 | Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Dia… | Phase3 | Diabetes | Completed | 2010-06-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01138488 | A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin As… | Phase1 | Diabetes | Completed | 2010-06-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01138501 | Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With… | Phase3 | Congenital Bleeding Disorder | Completed | 2010-06-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01151072 | A Trial Comparing the Effect of NN1250 After Different Routes of Injection in H… | Phase1 | Diabetes | Completed | 2010-06-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01153997 | Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers | Phase1 | Acquired Bleeding Disorder | Completed | 2010-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01154881 | A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With… | Phase1 | Diabetes | Completed | 2010-06-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01114542 | A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects … | Phase1 | Diabetes | Completed | 2010-05-03 | 2010-08-10 | ClinicalTrials.gov |
| NCT01134224 | A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2010-05-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01123980 | Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and… | Phase4 | Diabetes | Completed | 2010-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00271700 | Improving Glycemic Control on GMS: A Quality Improvement Study | Na | Diabetes Mellitus | Completed | 2010-05-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01557686 | Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study | Early_Phase1 | Acute Leukemia | Completed | 2010-05-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01076621 | Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal… | — | Menopause | Completed | 2010-05-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01125553 | A Comparison Between Two Formulations of NN5401 in Healthy Subjects | Phase1 | Diabetes | Completed | 2010-05-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01121276 | A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes | Phase1 | Diabetes | Completed | 2010-04-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01121289 | A Trial Investigating NN1218 in Subjects With Type 1 Diabetes | Phase1 | Diabetes | Completed | 2010-04-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01208012 | Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in T… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2010-04-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01087645 | A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects | Phase1 | Diabetes | Completed | 2010-03-12 | 2010-09-16 | ClinicalTrials.gov |
| NCT01076647 | Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2010-03-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01079234 | Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes | Phase3 | Diabetes | Completed | 2010-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01068665 | Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2010-03-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01068652 | Effect of Different Insulin Administrations, All in Combination With Metformin,… | Phase4 | Diabetes | Completed | 2010-03-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01082406 | Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two D… | Phase1 | Congenital Bleeding Disorder | Completed | 2010-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01085877 | Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopaus… | Phase1 | Menopause | Completed | 2010-03-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01950650 | GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy f… | — | Diabetes | Completed | 2010-03-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01077570 | An Observational Study Investigating the Safety and Effectiveness of Repaglinid… | — | Diabetes | Completed | 2010-03-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01117831 | An Analysis of Diabetes Control in Puerto Rico | — | Diabetes Mellitus | Completed | 2010-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01089075 | Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal I… | Phase4 | Partial Corticotrope Insufficiency | Terminated | 2010-02-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01038674 | Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis | Phase1 | Inflammation | Completed | 2010-02-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01059799 | Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2010-02-01 | 2010-12-16 | ClinicalTrials.gov |
| NCT01059812 | A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin … | Phase3 | Diabetes | Completed | 2010-02-01 | 2010-12-23 | ClinicalTrials.gov |
| NCT01068639 | An Observational Study on Treatment Compliance by Children Treated With Growth … | — | Growth Hormone Disorder | Withdrawn | 2010-02-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT01068678 | Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2010-02-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01074268 | Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspa… | Phase3 | Diabetes | Completed | 2010-02-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01076634 | Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes | Phase1 | Diabetes | Completed | 2010-02-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01044108 | A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male an… | Phase1 | Metabolism and Nutrition Disorder | Terminated | 2010-01-05 | 2011-09-20 | ClinicalTrials.gov |
| NCT01051102 | Effect of NN5401 in Japanese Subjects With Type 1 Diabetes | Phase1 | Diabetes | Completed | 2010-01-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT01046110 | Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Tr… | Phase3 | Diabetes | Completed | 2010-01-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01045707 | Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Trea… | Phase3 | Diabetes | Completed | 2010-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01045447 | Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antid… | Phase3 | Diabetes | Completed | 2010-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01828970 | Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients | Phase4 | Diabetes Mellitus | Completed | 2010-01-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01043510 | The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or … | Phase1 | Diabetes | Completed | 2010-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01037582 | A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects | Phase1 | Diabetes | Completed | 2009-12-17 | 2010-05-07 | ClinicalTrials.gov |
| NCT01030926 | A Trial Investigating the Concentration in the Blood of NN1250 in Children, Ado… | Phase1 | Diabetes | Completed | 2009-12-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01110928 | Observational Study of the Safety and Efficacy of Norditropin® in Patients With… | — | Foetal Growth Problem | Completed | 2009-11-26 | 2018-11-12 | ClinicalTrials.gov |
| NCT01009580 | Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase3 | Diabetes | Completed | 2009-11-05 | 2010-08-23 | ClinicalTrials.gov |
| NCT01006057 | A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Vari… | Phase1 | Diabetes | Completed | 2009-11-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01018238 | An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythema… | Phase1 | Inflammation | Withdrawn | 2009-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT01022762 | Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabet… | Phase4 | Diabetes | Completed | 2009-11-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01028404 | A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Typ… | Phase1 | Diabetes | Completed | 2009-11-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00943501 | Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2009-11-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01006291 | Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes | Phase3 | Diabetes | Completed | 2009-11-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00984126 | Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatme… | Phase3 | Congenital Bleeding Disorder | Completed | 2009-10-26 | 2016-06-29 | ClinicalTrials.gov |
| NCT01002768 | Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Typ… | Phase1 | Diabetes | Completed | 2009-10-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01223560 | Collection of Information-Rich Type 1 Diabetes Data | Na | Type 1 Diabetes | Completed | 2009-10-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00992537 | Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart… | Phase1 | Diabetes | Completed | 2009-10-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00993304 | A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels … | Phase1 | Diabetes | Completed | 2009-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01109017 | Observational Study of the Safety and Efficacy of Norditropin® in Adult Patient… | — | Growth Hormone Disorder | Completed | 2009-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00978380 | Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With … | Phase3 | Congenital Bleeding Disorder | Completed | 2009-09-21 | 2015-10-20 | ClinicalTrials.gov |
| NCT00978393 | A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obes… | Phase1 | Metabolism and Nutrition Disorder | Completed | 2009-09-16 | 2011-06-08 | ClinicalTrials.gov |
| NCT00951405 | Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophil… | Phase2 | Congenital Bleeding Disorder | Completed | 2009-09-01 | 2011-03-29 | ClinicalTrials.gov |
| NCT00993096 | Investigation of the Response Relationship of NN5401 in Type 1 Diabetics | Phase1 | Diabetes | Completed | 2009-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00972283 | Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Met… | Phase3 | Diabetes | Completed | 2009-09-01 | 2010-10-28 | ClinicalTrials.gov |
| NCT00982228 | Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Asp… | Phase3 | Diabetes | Completed | 2009-09-01 | 2010-11-08 | ClinicalTrials.gov |
| NCT00983021 | Safety and Tolerability of NN9068 in Healthy Male Volunteers | Phase1 | Diabetes | Completed | 2009-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00982644 | Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2009-09-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00916552 | Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in… | Phase2 | Mood Disorders | Completed | 2009-09-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00964964 | A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supple… | Phase1 | Diabetes | Completed | 2009-08-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00956345 | Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Hae… | Phase1 | Congenital Bleeding Disorder | Completed | 2009-08-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00959101 | Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide a… | Phase1 | Diabetes | Completed | 2009-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00964418 | A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With T… | Phase1 | Diabetes | Completed | 2009-08-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00966368 | Comparison of Two NN1250 Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2009-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00976326 | A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safe… | Phase1 | Diabetes | Completed | 2009-08-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00978627 | Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspa… | Phase3 | Diabetes | Completed | 2009-08-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00936403 | A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, … | Phase2 | Growth Hormone Disorder | Completed | 2009-08-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00961324 | A Trial Investigating the Within-subject Variability of NN1250 in Subjects With… | Phase1 | Diabetes | Completed | 2009-07-27 | 2009-10-26 | ClinicalTrials.gov |
| NCT00951873 | A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Do… | Phase1 | Congenital Bleeding Disorder | Completed | 2009-07-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00914589 | Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusi… | Phase2 | Acquired Bleeding Disorder | Completed | 2009-07-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00934063 | An Observational Study Validating a Score That Quantifies the Therapeutic Respo… | — | Growth Hormone Disorder | Completed | 2009-07-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00888732 | A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp7… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2009-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00922792 | Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Ac… | Phase1 | Congenital Bleeding Disorder | Completed | 2009-06-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00897169 | A Trial Investigating the Possible Difference in Development of Type 2 Diabetes… | Phase1 | Diabetes | Completed | 2009-06-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00918151 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2009-05-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00887874 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2009-05-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00906529 | Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Dia… | Phase4 | Type 2 Diabetes | Withdrawn | 2009-05-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00908973 | Gut Hormone Response, Appetite and Intestinal Transit Time in Good and Poor Wei… | — | Obesity | Completed | 2009-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00909480 | Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subj… | Phase4 | Diabetes | Completed | 2009-05-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00842894 | Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia | — | Diabetes | Completed | 2009-05-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00877526 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2009-05-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00874159 | A Survey to Evaluate Diabetes Management, Control, Complications and Psychosoci… | — | Diabetes | Completed | 2009-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00870220 | Initiating Transdermal Estradiol Therapy in Turner's Syndrome | Phase1 | Turner's Syndrome | Terminated | 2009-04-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00834262 | Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2… | — | Diabetes | Completed | 2009-04-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00795600 | Comparison of the Change in Fat Distribution in Overweight and Obese Subjects W… | Phase4 | Diabetes | Completed | 2009-04-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00882778 | PROPACT: Retrospective Prophylaxis Patient Case Collection | — | Congenital Bleeding Disorder | Completed | 2009-04-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00842192 | An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs a… | — | Diabetes | Completed | 2009-04-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00840086 | Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects | Phase3 | Congenital Bleeding Disorder | Completed | 2009-04-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00873639 | Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern… | — | Diabetes | Completed | 2009-04-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00821795 | Veterans Inpatient Insulin Study and Transition to Outpatient Therapy | Phase4 | Type 2 Diabetes Mellitus | Completed | 2009-03-11 | 2013-04-23 | ClinicalTrials.gov |
| NCT01282060 | Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Foll… | — | Type 2 Diabetes | Unknown | 2009-03-01 | 2021-09-01 | ClinicalTrials.gov |
| NCT00845247 | The Effect of Case Management in Complex Cancer Pathways | Na | Colonic Neoplasms | Completed | 2009-03-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00837356 | Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in H… | Phase1 | Congenital Bleeding Disorder | Completed | 2009-03-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00873223 | Examination of the Effects of Liraglutide on the Mode of Action of Insulin Dete… | Phase1 | Diabetes | Completed | 2009-03-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00839878 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2009-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00862875 | Levemir-Body Composition and Energy Metabolism | Phase4 | Type 2 Diabetes | Completed | 2009-03-01 | — | ClinicalTrials.gov |
| NCT00856986 | The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Com… | Phase3 | Diabetes | Completed | 2009-03-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00833716 | Effect of Renal Impairment on the Pharmacokinetics of NN9535 | Phase1 | Diabetes | Completed | 2009-02-02 | 2010-07-26 | ClinicalTrials.gov |
| NCT00849316 | Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes an… | — | Diabetes | Withdrawn | 2009-02-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00787878 | Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational A… | — | Foetal Growth Problem | Completed | 2009-02-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00865397 | Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy an… | — | Diabetes | Completed | 2009-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00819741 | Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformi… | Phase4 | Diabetes | Completed | 2009-02-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00851773 | Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in He… | Phase1 | Diabetes | Completed | 2009-02-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00806897 | Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatme… | — | Diabetes | Completed | 2009-01-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00842361 | Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen… | Phase2 | Diabetes | Completed | 2009-01-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00841087 | Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart … | Phase2 | Diabetes | Completed | 2009-01-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00836030 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2009-01-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00822185 | Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers | Phase1 | Congenital Bleeding Disorder | Completed | 2009-01-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00813020 | A Clinical Trial Investigating the Comparison of Three Different Concentrations… | Phase1 | Diabetes | Completed | 2009-01-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00849342 | Observational Study on Levemir® in Obese Diabetic Patients | — | Diabetes | Completed | 2008-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00818064 | Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With R… | Phase1 | Inflammation | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00805922 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2008-12-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00937703 | Multicentric Evaluation of Two Telematics Systems in Type 2 Diabetic Patients i… | Na | TYPE 2 DIABETES | Completed | 2008-12-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT00807092 | Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Hu… | Phase4 | Diabetes | Completed | 2008-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00806936 | Observational Study to Investigate the Efficacy and Safety of Human Insulin or … | — | Diabetes | Completed | 2008-12-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00869908 | Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone… | — | Diabetes | Completed | 2008-11-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00705172 | Retrospective Observational Study on Efficacy and Safety of Norditropin® in Chi… | — | Genetic Disorder | Completed | 2008-11-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00806858 | Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy … | — | Diabetes | Completed | 2008-11-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00793273 | Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Pa… | — | Diabetes | Completed | 2008-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00789711 | An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 a… | — | Diabetes | Completed | 2008-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00789191 | Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes | Phase3 | Diabetes | Completed | 2008-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00788853 | A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psych… | — | Diabetes | Completed | 2008-11-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00894270 | Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Wi… | Phase4 | Diabetes Mellitus | Completed | 2008-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00781937 | Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Su… | Phase3 | Metabolism and Nutrition Disorder | Completed | 2008-10-30 | 2010-09-01 | ClinicalTrials.gov |
| NCT00761540 | To Investigate the Blood Concentration of Liraglutide as Well as the Effects on… | Phase1 | Diabetes | Completed | 2008-10-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00793884 | Emory Latino Diabetes Education Program | — | Diabetes | Terminated | 2008-10-01 | 2019-11-01 | ClinicalTrials.gov |
| NCT00771680 | Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoM… | — | Diabetes | Completed | 2008-10-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00775736 | Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patien… | — | Diabetes | Completed | 2008-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00509704 | Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Rena… | — | Renal Cell Cancer | Completed | 2008-10-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00773279 | Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordis… | Phase3 | Diabetes | Completed | 2008-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00740519 | Observational Study on Safety of Self-titration of Once Daily Levemir® | — | Diabetes | Completed | 2008-09-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00755833 | Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Mon… | — | Diabetes | Completed | 2008-09-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT01529944 | Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Ext… | Phase3 | Genetic Disorder | Completed | 2008-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00639626 | Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-relat… | Phase2 | Cystic Fibrosis Related Diabetes | Terminated | 2008-08-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00713648 | Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients Wi… | Phase3 | Congenital Bleeding Disorder | Completed | 2008-08-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00697450 | Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type … | — | Diabetes | Completed | 2008-07-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00728455 | Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/… | Phase1 | Metabolism and Nutrition Disorder | Withdrawn | 2008-07-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00722540 | Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and… | Phase1 | Growth Hormone Disorder | Completed | 2008-07-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00717288 | Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir | Phase4 | Diabetes Mellitus | Completed | 2008-07-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00715689 | Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokin… | Phase2 | Growth Hormone Disorder | Completed | 2008-07-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00696657 | A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide… | Phase2 | Diabetes | Completed | 2008-06-03 | 2009-02-05 | ClinicalTrials.gov |
| NCT00697320 | Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life"… | — | Congenital Bleeding Disorder | Completed | 2008-06-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00700817 | The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Met… | Phase3 | Diabetes | Completed | 2008-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00715780 | Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type … | — | Diabetes | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00698802 | Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diab… | Phase2 | Diabetes | Completed | 2008-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT01464099 | Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes | Phase1 | Diabetes | Completed | 2008-06-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00710619 | Observational Patient Diary Study of Treatment Doses for Patients With Haemophi… | — | Congenital Bleeding Disorder | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT02151409 | Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects | Phase1 | Inflammation | Completed | 2008-06-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00699179 | Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type … | — | Diabetes | Completed | 2008-06-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00699426 | The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Ris… | Phase3 | Type 2 Diabetes | Completed | 2008-06-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00738153 | An Observational Study on Efficacy and Safety in Subjects Using Levemir® for th… | — | Diabetes | Completed | 2008-06-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00675493 | Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From… | — | Diabetes | Completed | 2008-05-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00704223 | Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type … | — | Diabetes | Completed | 2008-05-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00591227 | Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin … | Phase4 | Type 2 Diabetes Mellitus | Completed | 2008-05-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01868581 | Bioequivalence Between Two Explorative Insulin Degludec Formulations and Betwee… | Phase1 | Diabetes | Completed | 2008-05-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT01561950 | Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treate… | Phase1 | Haemostasis | Terminated | 2008-05-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00709683 | Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen® | — | Diabetes | Completed | 2008-05-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00709475 | Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the… | — | Diabetes | Completed | 2008-05-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00737776 | Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for th… | — | Diabetes | Completed | 2008-05-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00696163 | Observational Study to Assess the Quality of Life and Clinical Outcomes in Subj… | — | Diabetes | Completed | 2008-04-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT01076842 | Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Trea… | Phase4 | Diabetes Type 2 | Completed | 2008-04-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01261767 | First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerabil… | Phase1 | Inflammation | Terminated | 2008-04-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01532661 | National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology | — | Hemorrhage | Completed | 2008-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00687063 | Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes | — | Diabetes | Completed | 2008-04-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00657943 | The Copenhagen Insulin and Metformin Therapy Trial | Phase4 | Type 2 Diabetes | Completed | 2008-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01868568 | Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin D… | Phase1 | Diabetes | Completed | 2008-04-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00825643 | Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes | — | Diabetes | Completed | 2008-04-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00703911 | Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in P… | — | Congenital Bleeding Disorder | Completed | 2008-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00729898 | Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients … | — | Diabetes | Completed | 2008-03-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00735501 | Observational Study to Observe the Safety of Levemir® Treatment in Patients Wit… | — | Diabetes | Completed | 2008-03-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00774579 | The Effect of Growth Hormone Replacement on Liver Fat | — | Growth Hormone, Recombinant | Completed | 2008-03-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00657930 | Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatmen… | — | Diabetes | Completed | 2008-03-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00700648 | An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRa… | — | Diabetes | Completed | 2008-03-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00601861 | Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer | Phase2 | Cancer | Terminated | 2008-02-13 | 2008-06-25 | ClinicalTrials.gov |
| NCT00634842 | Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Pat… | Phase4 | Diabetes | Completed | 2008-02-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00627445 | Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With … | Phase3 | Diabetes | Completed | 2008-02-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00655200 | Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin De… | — | Diabetes | Completed | 2008-02-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00620282 | The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabe… | Phase3 | Diabetes | Completed | 2008-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00698269 | An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Pat… | — | Diabetes | Completed | 2008-02-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00687284 | Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antid… | — | Diabetes | Completed | 2008-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00660374 | Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Sub… | Phase2 | Diabetes | Completed | 2008-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00623194 | Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With … | Phase3 | Diabetes | Completed | 2008-02-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00676741 | Observational Study on Blood Glucose Control in Patients With Diabetes Using Mo… | — | Diabetes | Completed | 2008-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00700830 | Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 D… | — | Diabetes | Completed | 2008-01-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT01868529 | Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Di… | Phase1 | Diabetes | Completed | 2008-01-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00704574 | Observational Study to Observe the Safety of Levemir® Treatment in Children and… | — | Diabetes | Completed | 2008-01-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00670722 | Observational Study on Blood Glucose Control in Patients With Diabetes Using Mo… | — | Diabetes | Completed | 2008-01-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00853086 | Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia a… | — | Congenital Bleeding Disorder | Completed | 2008-01-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00625040 | Incretin Physiology and Beta-cell Function Before and After Weight-loss | — | Obesity | Terminated | 2008-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00614120 | Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Contro… | Phase3 | Diabetes | Completed | 2008-01-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00614055 | Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combinati… | Phase2 | Diabetes | Completed | 2008-01-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00613951 | Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in… | Phase2 | Diabetes | Completed | 2008-01-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00612040 | Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combinati… | Phase2 | Diabetes | Completed | 2008-01-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00611884 | Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combinati… | Phase2 | Diabetes | Completed | 2008-01-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00607737 | Applications Site Reactions After Injection of Insulin Detemir and Saline in Su… | Phase4 | Diabetes Mellitus | Completed | 2008-01-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00745433 | Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide | — | Diabetes | Completed | 2008-01-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00788840 | Detemir Energy Expenditure Study | Phase4 | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00700765 | Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes | — | Diabetes | Completed | 2008-01-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00915980 | Meal Stimulating After Roux-en Y Gastric Bypass | — | Gastric Bypass | Completed | 2008-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00671008 | Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of … | — | Diabetes | Completed | 2007-12-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT01603342 | A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Asso… | Phase1 | Haemostasis | Completed | 2007-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01868555 | Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) … | Phase1 | Diabetes | Completed | 2007-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00568568 | Metabolic Studies- Interactions Between GH and Insulin in GHDA | Na | Insulin Resistance | Completed | 2007-12-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00665665 | Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Ov… | Phase1 | Metabolism and Nutrition Disorder | Terminated | 2007-11-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00669864 | Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose C… | Phase4 | Diabetes | Completed | 2007-11-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00658099 | Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic A… | — | Diabetes | Completed | 2007-11-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00455858 | Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Curren… | Phase4 | Diabetes | Completed | 2007-11-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00523380 | Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer | Phase2 | Cancer | Completed | 2007-10-04 | 2009-01-07 | ClinicalTrials.gov |
| NCT00537277 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus W… | Phase4 | Diabetes | Completed | 2007-10-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00533221 | Pilot Study of Growth Hormon to Treat SMA Typ II and III | Phase2 | Muscular Atrophy, Spinal | Completed | 2007-10-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00569478 | The Effect of Rehabilitation for Patients Living With an Implantable Cardiovert… | Phase2 | Quality of Life | Completed | 2007-10-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00698126 | Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for T… | — | Diabetes | Completed | 2007-10-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00657319 | Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previou… | — | Diabetes | Completed | 2007-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01596010 | Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone … | Phase1 | Menopause | Completed | 2007-10-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00665808 | Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® Du… | — | Diabetes | Completed | 2007-10-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00537303 | Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatme… | Phase4 | Diabetes | Completed | 2007-10-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00712478 | Observational Study Describing Conditions for Intensification of Insulin Therap… | — | Diabetes | Completed | 2007-09-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00542620 | Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice… | Phase4 | Diabetes | Completed | 2007-09-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00706017 | Observational Study to Evaluate the Safety of Levemir® in Diabetes | — | Diabetes | Completed | 2007-09-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00523042 | Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma | Phase3 | Diabetes | Terminated | 2007-08-30 | 2008-02-28 | ClinicalTrials.gov |
| NCT01498939 | Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects | Phase1 | Diabetes | Completed | 2007-08-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00824668 | Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart … | Phase1 | Diabetes | Completed | 2007-08-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00518882 | Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Gluco… | Phase3 | Diabetes | Completed | 2007-08-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT01034202 | Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmaco… | Phase1 | Growth Hormone Disorder | Completed | 2007-08-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00617253 | Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal… | Phase2 | Cancer | Completed | 2007-07-12 | 2008-06-30 | ClinicalTrials.gov |
| NCT00509925 | Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes | Phase4 | Diabetes | Terminated | 2007-07-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00701155 | Observational Study to Evaluate the Safety While Using Levemir® | — | Diabetes | Completed | 2007-07-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00503698 | The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis | Phase3 | Chronic Kidney Disease | Terminated | 2007-07-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00497133 | Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes | — | Type 2 Diabetes Mellitus | Completed | 2007-07-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00670683 | Observational Study of Patients With Diabetes Using Levemir® FlexPen® | — | Diabetes | Completed | 2007-07-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00506662 | Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjec… | Phase4 | Diabetes | Terminated | 2007-07-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT03144271 | Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess S… | Phase1 | Diabetes | Completed | 2007-06-11 | 2007-10-08 | ClinicalTrials.gov |
| NCT00700908 | Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c… | Na | Type 2 Diabetes | Completed | 2007-06-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00486278 | Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds | Phase2 | Congenital Bleeding Disorder | Completed | 2007-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00700960 | Observational Study Describing Conditions for Administering Slow-acting Insulin… | — | Diabetes | Completed | 2007-06-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00998335 | Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secreti… | Phase4 | Type 2 Diabetes | Completed | 2007-06-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00675220 | Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™ | — | Diabetes | Completed | 2007-06-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00472953 | Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic … | Phase3 | Diabetes | Terminated | 2007-05-15 | 2008-03-05 | ClinicalTrials.gov |
| NCT00665093 | Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of … | — | Diabetes | Completed | 2007-05-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00474045 | Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) … | Phase3 | Diabetes | Completed | 2007-05-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00346996 | Insulin Analogues and Severe Hypoglycaemia | Phase4 | Type 1 Diabetes | Completed | 2007-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00655044 | Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes | — | Diabetes | Completed | 2007-05-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00715351 | Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin … | — | Diabetes | Completed | 2007-05-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00469092 | Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combin… | Phase4 | Diabetes | Completed | 2007-05-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00469586 | Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in… | Phase3 | Diabetes | Terminated | 2007-04-26 | 2008-04-24 | ClinicalTrials.gov |
| NCT00776607 | Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Dia… | Na | Latent Autoimmune Diabetes in Adults LADA | Unknown | 2007-04-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00476437 | Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabete… | Phase3 | Diabetes | Completed | 2007-04-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00449839 | Changes of the Infusion Rate in Insulin Pump Treatment | Phase4 | Diabetes | Completed | 2007-04-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01578135 | French National Registry of Children Born Small for Gestational Age Treated Wit… | — | Growth Disorder | Completed | 2007-03-18 | 2018-10-09 | ClinicalTrials.gov |
| NCT00709917 | Observational Study of the Switch of Metformin Alone to Metformin Combined With… | — | Diabetes | Completed | 2007-03-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00447382 | Safety of Insulin Detemir Produced by a New Process as Measured by Antibody For… | Phase3 | Diabetes | Completed | 2007-03-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00825253 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasi… | Phase1 | Diabetes | Completed | 2007-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00435019 | Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With … | Phase3 | Diabetes | Completed | 2007-02-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00715663 | Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoM… | — | Diabetes | Completed | 2007-02-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00428207 | Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Ther… | Na | Type 1 Diabetes Mellitus | Terminated | 2007-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT01513525 | Comparison of Liraglutide Injected at Three Different Injection Sites in Health… | Phase1 | Diabetes | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01053234 | Different Insulin Regimens and Postprandial Coagulation Activation | Na | Type 2 Diabetes | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00422058 | The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes | Phase2 | Metabolism and Nutrition Disorder | Completed | 2007-01-10 | 2009-04-30 | ClinicalTrials.gov |
| NCT00427154 | Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2… | Phase3 | Diabetes | Terminated | 2007-01-10 | 2008-03-11 | ClinicalTrials.gov |
| NCT01486979 | Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Wom… | Phase1 | Menopause | Completed | 2007-01-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01561937 | Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warf… | Phase1 | Haemostasis | Completed | 2007-01-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00431132 | Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrop… | Phase3 | Menopause | Completed | 2007-01-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT01565733 | Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised … | — | Diabetes | Completed | 2007-01-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT01515553 | Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2007-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00696995 | An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 T… | — | Diabetes | Completed | 2007-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT01500486 | Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ | — | Growth Hormone Disorder | Completed | 2007-01-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00463411 | Study of Male Osteoporosis and Aging | — | Osteoporosis | Unknown | 2006-12-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT00590226 | Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes | Phase4 | Type 2 Diabetes | Completed | 2006-12-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00521690 | The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients Wi… | Phase4 | Diabetes | Completed | 2006-12-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT01865331 | Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of… | Phase1 | Diabetes | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00411892 | Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabe… | Phase3 | Diabetes | Terminated | 2006-11-29 | 2008-03-18 | ClinicalTrials.gov |
| NCT00763412 | Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With … | Na | Cystic Fibrosis Related Diabetes | Completed | 2006-11-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01517568 | Metabolism and Excretion of Liraglutide in Healthy Male Volunteers | Phase1 | Diabetes | Completed | 2006-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00393718 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2006-11-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01508858 | Influence on the Effect of an Oral Contraceptive Drug After Administration of L… | Phase1 | Diabetes | Completed | 2006-11-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00399711 | Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Met… | Phase3 | Diabetes | Completed | 2006-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT01492166 | Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 No… | — | Diabetes | Completed | 2006-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00348712 | Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes | Phase3 | Diabetes | Terminated | 2006-10-30 | 2008-03-05 | ClinicalTrials.gov |
| NCT00343980 | Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes | Phase3 | Diabetes | Terminated | 2006-10-10 | 2008-03-10 | ClinicalTrials.gov |
| NCT01516242 | Evaluation of Safety and Parameters of Application Technique | — | Diabetes | Completed | 2006-10-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01542489 | Observational Study of the Predictability of Levemir® in Terms of Metabolic Con… | — | Diabetes | Completed | 2006-10-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01517555 | Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diab… | Phase1 | Diabetes | Completed | 2006-10-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00457093 | A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes | Na | Type 2 Diabetes | Completed | 2006-10-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00395746 | Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Co… | Phase3 | Diabetes | Completed | 2006-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00659282 | Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatmen… | — | Diabetes | Completed | 2006-09-11 | 2008-11-15 | ClinicalTrials.gov |
| NCT00564018 | Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins De… | Na | Type 1 Diabetes | Terminated | 2006-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00383877 | Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diab… | Phase3 | Diabetes | Completed | 2006-09-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT01865305 | Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co… | Phase1 | Diabetes | Completed | 2006-09-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT01865318 | Investigation of Pharmacodynamic Characteristics of Explorative Formulation of … | Phase1 | Diabetes | Completed | 2006-09-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00331604 | Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes | Phase3 | Diabetes | Terminated | 2006-08-31 | 2008-05-05 | ClinicalTrials.gov |
| NCT01865292 | Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation … | Phase1 | Diabetes | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01542476 | The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being a… | — | Diabetes | Completed | 2006-08-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT01490099 | Comparison of Insulin Detemir Produced by the Current Process and the NN729 Pro… | Phase1 | Diabetes | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00456105 | The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surg… | Na | Type 2 Diabetes | Terminated | 2006-07-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01516255 | Effect of Liraglutide on Heart Frequency in Healthy Volunteers | Phase1 | Diabetes | Completed | 2006-07-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01536626 | Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands | — | Diabetes | Completed | 2006-06-09 | 2007-04-10 | ClinicalTrials.gov |
| NCT01538511 | Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspar… | Phase1 | Diabetes | Completed | 2006-06-05 | 2007-03-13 | ClinicalTrials.gov |
| NCT01490658 | Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet i… | Phase1 | Diabetes | Completed | 2006-06-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00328133 | The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry | — | Traumatic Hemorrhage | Completed | 2006-06-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00343343 | Comparison of NovoFine® Needles (4 mm vs. 6 mm) | Phase2 | Diabetes | Completed | 2006-06-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00824603 | Impact of Continuing Medical Education (CME) Insulin Program | — | Diabetes | Completed | 2006-06-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT01489644 | Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet i… | Phase1 | Diabetes | Completed | 2006-06-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT01486901 | Bioequivalence of Two Insulatard® Formulations in Healthy Subjects | Phase1 | Diabetes | Completed | 2006-05-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT01486888 | Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects | Phase1 | Diabetes | Completed | 2006-05-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT01545791 | Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes | — | Diabetes | Completed | 2006-05-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00333151 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2006-05-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00318422 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2006-05-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00331851 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase3 | Diabetes | Completed | 2006-05-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00318461 | To Compare the Effect of Liraglutide When Given Together With Metformin With th… | Phase3 | Diabetes | Completed | 2006-05-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00322257 | Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes | Phase3 | Diabetes | Terminated | 2006-05-01 | 2008-04-02 | ClinicalTrials.gov |
| NCT01518166 | Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Poten… | Phase1 | Diabetes | Completed | 2006-05-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00323570 | Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to T… | Phase3 | Acquired Bleeding Disorder | Withdrawn | 2006-05-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT01515579 | Comparison of Two Liraglutide Formulations in Healthy Subjects | Phase1 | Diabetes | Completed | 2006-04-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00960128 | Observational Prospective Study on Patients Treated With Norditropin® | — | Growth Hormone Disorder | Completed | 2006-04-01 | 2016-12-31 | ClinicalTrials.gov |
| NCT01507454 | Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficien… | — | Menopause | Completed | 2006-04-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01536028 | Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Asp… | Phase1 | Diabetes | Completed | 2006-04-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT01561417 | Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temper… | Phase1 | Acquired Bleeding Disorder | Completed | 2006-04-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00313001 | Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patie… | Phase3 | Diabetes | Completed | 2006-04-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00313742 | The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes… | Phase4 | Diabetes | Completed | 2006-04-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00318786 | Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day B… | Phase3 | Diabetes | Completed | 2006-04-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT01530048 | Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) | Phase1 | Diabetes | Completed | 2006-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01542424 | An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment … | — | Diabetes | Completed | 2006-03-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01507389 | Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With No… | Phase1 | Diabetes | Completed | 2006-03-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00282451 | Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin A… | Phase4 | Diabetes | Completed | 2006-02-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT01548235 | Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting o… | — | Diabetes | Completed | 2006-02-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00294723 | To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglob… | Phase3 | Diabetes | Terminated | 2006-02-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00168545 | Immunology of Non-specific Effects of Vaccine | Phase4 | Measles | Completed | 2006-01-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT01548248 | Efficacy and Safety of Levemir® Used as Basal Insulin | — | Diabetes | Completed | 2006-01-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01486875 | Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes | — | Diabetes | Completed | 2006-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01536652 | Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Prem… | — | Diabetes | Completed | 2006-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00266006 | Factor VIIa in Acute Intracerebral Haemorrhage | Phase2 | Acquired Bleeding Disorder | Completed | 2006-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01515592 | Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers | Phase1 | Diabetes | Completed | 2006-01-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01536639 | Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes | — | Diabetes | Completed | 2006-01-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00283218 | A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphas… | Na | Type 1 Diabetes | Completed | 2006-01-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00267683 | Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes | Phase3 | Diabetes | Terminated | 2005-12-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01865279 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Form… | Phase1 | Diabetes | Completed | 2005-12-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01561924 | Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult C… | Phase1 | Congenital Bleeding Disorder | Completed | 2005-11-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01498926 | Comparison of Two Insulin Detemir Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2005-11-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01562457 | Intra-subject Variability Following Administrations of Activated Recombinant Hu… | Phase1 | Congenital Bleeding Disorder | Completed | 2005-11-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01511692 | Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type… | Phase1 | Diabetes | Completed | 2005-11-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00419718 | Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With … | Phase1 | Diabetes | Completed | 2005-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT01709929 | Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type… | Phase3 | Diabetes | Completed | 2005-10-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00184548 | Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding | Phase3 | Acquired Bleeding Disorder | Terminated | 2005-10-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT02239146 | Safety of rFXIII in Patients Following First Time Myocardial Revascularization … | Phase1 | Acquired Bleeding Disorder | Completed | 2005-10-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00264901 | Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects Wit… | Phase4 | Diabetes | Completed | 2005-10-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01779921 | Treatment of Congenital Factor VII Deficiency | — | Congenital Bleeding Disorder | Completed | 2005-10-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01486862 | Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing… | Phase4 | Diabetes | Completed | 2005-10-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00274274 | Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in T… | Phase4 | Diabetes | Completed | 2005-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00491725 | Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 … | Phase4 | Diabetes | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01492205 | NovoLet® Acceptance Study Within the Hospital Practise in Indonesia | — | Diabetes | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01497587 | Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan | Phase1 | Diabetes | Completed | 2005-08-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT01508806 | Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Functio… | Phase1 | Diabetes | Completed | 2005-08-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00127296 | Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and S… | Phase1 | Diabetes | Completed | 2005-07-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00121355 | Novofine Autocover Safety Needle Versus BD Safety Glide | Phase4 | Diabetes | Completed | 2005-07-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00519844 | Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment… | Phase4 | Foetal Growth Problem | Completed | 2005-07-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00184561 | Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type… | Phase4 | Diabetes | Completed | 2005-07-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00117780 | Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes | Phase4 | Diabetes | Completed | 2005-06-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01502137 | Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receivi… | Phase1 | Chronic Kidney Disease | Completed | 2005-06-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00115973 | A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump | Phase1 | Diabetes | Completed | 2005-06-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00134745 | Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome | Phase4 | Turner Syndrome | Completed | 2005-06-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT00187993 | Growth Hormone Treatment of Young Growth Hormone-Deficient Adults | — | Growth Hormone Deficiency | Unknown | 2005-05-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT01487811 | Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Form… | Phase1 | Diabetes | Completed | 2005-05-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00127283 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | Phase3 | Acquired Bleeding Disorder | Completed | 2005-05-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00184613 | Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in… | Phase1 | Diabetes | Completed | 2005-05-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT01497574 | Within-subject Variability of Insulin Detemir in Children and Adolescents With … | Phase1 | Diabetes | Completed | 2005-05-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT01604161 | Non-interventional Study of Patients Using Norditropin® for Growth Hormone Defi… | — | Growth Hormone Disorder | Completed | 2005-05-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00372125 | Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment … | Na | Prader-Willi Syndrome | Completed | 2005-04-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01487304 | Impact of Professional Societies' Recommendations on Practical Use of Hormone R… | — | Menopause | Completed | 2005-04-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00184574 | Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With … | Phase3 | Diabetes | Completed | 2005-04-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00569426 | Evaluating the Use of Two Different Needles in Subjects With Diabetes | Phase4 | Diabetes | Completed | 2005-04-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00504673 | Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight… | Phase3 | Diabetes | Completed | 2005-04-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01477632 | Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in P… | Phase1 | Menopause | Completed | 2005-03-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00388141 | Nursing and Nurturing Premature Infants | Early_Phase1 | Infant Growth | Completed | 2005-03-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00108849 | Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms | Phase3 | Menopause | Completed | 2005-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00106366 | Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes | Phase3 | Diabetes | Completed | 2005-03-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00104182 | Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin … | Phase3 | Diabetes | Completed | 2005-02-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01514487 | Comparison of Three Liraglutide Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2005-01-13 | 2005-03-30 | ClinicalTrials.gov |
| NCT00566124 | Basal Insulins - Pharmacodynamics | Phase4 | Diabetes | Completed | 2005-01-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00123591 | Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects… | Phase2 | Acquired Bleeding Disorder | Completed | 2005-01-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00920725 | Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydro… | Na | Diabetic Ketoacidosis | Completed | 2005-01-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00097877 | Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects… | Phase3 | Diabetes | Completed | 2005-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00154414 | Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2… | Phase2 | Diabetes | Completed | 2005-01-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01490112 | Surveillance Study of NovoRapid® for New Drug Re-examination | — | Diabetes | Completed | 2005-01-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00154401 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase2 | Diabetes | Completed | 2005-01-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00494988 | Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Dia… | Phase4 | Diabetes | Completed | 2004-12-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01024218 | Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle | Phase4 | Diabetes | Completed | 2004-12-01 | 2005-04-26 | ClinicalTrials.gov |
| NCT01620450 | Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process… | Phase1 | Diabetes | Completed | 2004-11-20 | 2005-02-26 | ClinicalTrials.gov |
| NCT00348231 | Jikei Optimal Insulin Therapy in Type 2 Diabetes | Na | Diabetes Mellitus, Type 2 | Unknown | 2004-11-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00184730 | Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) | Phase3 | Growth Hormone Disorder | Completed | 2004-11-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00184600 | Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 Wi… | Phase3 | Diabetes | Completed | 2004-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00124293 | Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identifica… | — | Acquired Bleeding Disorder | Completed | 2004-10-06 | 2005-11-23 | ClinicalTrials.gov |
| NCT00097071 | Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Ado… | Phase3 | Diabetes | Completed | 2004-10-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00101751 | INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study | Phase4 | Diabetes | Completed | 2004-10-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00184626 | Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic… | Phase4 | Diabetes | Completed | 2004-09-10 | 2005-10-24 | ClinicalTrials.gov |
| NCT01536600 | Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With … | — | Diabetes | Completed | 2004-09-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00336986 | Efficacy Study of IL-21 to Treat Metastatic Melanoma | Phase2 | Cancer | Completed | 2004-09-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT01542463 | Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Ty… | — | Diabetes | Completed | 2004-09-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00147836 | Evaluation of the Effects of Different Interventions on Glycemic Control in New… | Na | Type 2 Diabetes Mellitus | Completed | 2004-09-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00097084 | Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus… | Phase3 | Diabetes | Completed | 2004-09-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00095082 | Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glar… | Phase3 | Diabetes | Completed | 2004-09-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT01536613 | Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 | — | Diabetes | Completed | 2004-09-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00184717 | Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) | Phase3 | Foetal Growth Problem | Completed | 2004-08-18 | 2009-12-28 | ClinicalTrials.gov |
| NCT00184639 | Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes | Phase3 | Diabetes | Completed | 2004-08-16 | 2005-11-22 | ClinicalTrials.gov |
| NCT00154427 | Use of Activated Recombinant Human Factor VII in Cardiac Surgery | Phase2 | Acquired Bleeding Disorder | Terminated | 2004-08-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT01498900 | An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm®… | — | Diabetes | Completed | 2004-08-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00097279 | Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subject… | Phase3 | Diabetes | Completed | 2004-08-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00747409 | Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes | Phase4 | Type 2 Diabetes Mellitus | Unknown | 2004-07-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00102037 | Use of Activated Recombinant FVII in Spinal Surgery | Phase2 | Acquired Bleeding Disorder | Completed | 2004-07-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00095446 | NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes | Phase4 | Diabetes | Completed | 2004-07-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00282698 | Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients | Phase3 | Cardiac Surgical Procedures | Completed | 2004-07-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00593255 | Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes | Phase4 | Diabetes | Completed | 2004-07-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00564668 | Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current… | Phase3 | Diabetes | Completed | 2004-06-19 | 2005-04-12 | ClinicalTrials.gov |
| NCT00659295 | Observational Study to Evaluate the Safety of Levemir® in Diabetes | — | Diabetes | Completed | 2004-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00104455 | Dose Response to Recombinant Factor VIIa When Administered for Bleed | Phase1 | Congenital Bleeding Disorder | Completed | 2004-06-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00184665 | Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes | Phase3 | Diabetes | Completed | 2004-06-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01508897 | Comparison of Two Liraglutide Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2004-05-28 | 2004-06-30 | ClinicalTrials.gov |
| NCT00184795 | Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Co… | Phase3 | Menopause | Completed | 2004-05-28 | 2005-05-04 | ClinicalTrials.gov |
| NCT01497535 | Within-subject Variability of Insulin Detemir in Healthy Volunteers | Phase1 | Diabetes | Completed | 2004-05-27 | 2004-10-31 | ClinicalTrials.gov |
| NCT00605137 | Safety of Insulin Detemir in Children With Type 1 Diabetes | Phase3 | Diabetes | Completed | 2004-05-21 | 2005-04-23 | ClinicalTrials.gov |
| NCT00624364 | Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diab… | Phase4 | Diabetes | Completed | 2004-05-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01507337 | Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunte… | Phase1 | Diabetes | Completed | 2004-04-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00760448 | Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar … | Phase1 | Diabetes | Completed | 2004-04-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00500240 | Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acu… | Phase3 | Leukemia | Terminated | 2004-04-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00592527 | Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabe… | Phase3 | Diabetes | Completed | 2004-04-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00154492 | Use of NovoSeven® in Active Variceal Bleeding | Phase2 | Acquired Bleeding Disorder | Completed | 2004-04-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT01492959 | Observational Study With InnoLet® in Daily Clinical Practice | — | Diabetes | Completed | 2004-03-23 | 2005-03-23 | ClinicalTrials.gov |
| NCT01492218 | Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction | — | Diabetes | Completed | 2004-03-15 | 2004-08-30 | ClinicalTrials.gov |
| NCT00600366 | Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Sub… | Phase4 | Diabetes | Completed | 2004-03-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00108758 | Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia | Phase2 | Congenital Bleeding Disorder | Completed | 2004-03-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT01497600 | Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2004-02-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01542060 | Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 D… | — | Diabetes | Completed | 2004-01-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01476423 | Observational Registry of the Treatment of Glanzmann's Thrombasthenia | — | Congenital Bleeding Disorder | Completed | 2004-01-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00829569 | n-3 Fatty Acid Infusion and Type 2 Diabetes | Na | Type 2 Diabetes | Completed | 2004-01-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00600626 | Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart… | Phase3 | Diabetes | Completed | 2004-01-01 | 2004-07-01 | ClinicalTrials.gov |
| NCT00568074 | Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subject… | Phase4 | Diabetes | Completed | 2003-12-16 | 2004-09-02 | ClinicalTrials.gov |
| NCT00184743 | Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) | Phase3 | Growth Hormone Disorder | Completed | 2003-12-06 | 2005-12-28 | ClinicalTrials.gov |
| NCT00592969 | Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diab… | Phase4 | Diabetes | Completed | 2003-12-03 | 2004-11-02 | ClinicalTrials.gov |
| NCT00605020 | Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and B… | Phase3 | Diabetes | Completed | 2003-12-02 | 2005-03-03 | ClinicalTrials.gov |
| NCT00595374 | Efficacy and Safety of Insulin Detemir in Type 1 Diabetes | Phase3 | Diabetes | Completed | 2003-12-02 | 2004-10-07 | ClinicalTrials.gov |
| NCT01538576 | Paediatric Subjects - Special Survey | — | Diabetes | Completed | 2003-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01527656 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Sub… | Phase1 | Diabetes | Completed | 2003-12-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT01615978 | Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2003-12-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00619697 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin… | Phase4 | Diabetes | Completed | 2003-12-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00605111 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabe… | Phase4 | Diabetes | Completed | 2003-12-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00604253 | Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controll… | Phase3 | Diabetes | Completed | 2003-12-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01538589 | Special Survey for Patients With Type 1 or Type 2 Diabetes | — | Diabetes | Completed | 2003-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01620437 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Su… | Phase1 | Diabetes | Completed | 2003-11-29 | 2003-12-30 | ClinicalTrials.gov |
| NCT01527643 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Sub… | Phase1 | Diabetes | Completed | 2003-11-11 | 2003-12-17 | ClinicalTrials.gov |
| NCT00451620 | Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subj… | Phase2 | Type 2 Diabetes | Completed | 2003-11-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00280046 | Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With … | Phase3 | Diabetes | Completed | 2003-11-01 | 2004-07-01 | ClinicalTrials.gov |
| NCT00799448 | Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Vers… | Phase4 | Diabetes | Terminated | 2003-09-16 | 2004-09-20 | ClinicalTrials.gov |
| NCT00612599 | Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart … | Phase3 | Diabetes | Completed | 2003-09-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT01620476 | Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers | Phase1 | Diabetes | Completed | 2003-09-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00569998 | Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin | Phase3 | Diabetes | Completed | 2003-08-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT00571935 | Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years … | Phase4 | Diabetes | Completed | 2003-08-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00435006 | Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal … | — | Brain Injuries | Completed | 2003-08-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00306579 | Myocardial Damage In Patients With Cerebral Infarction | — | Ischemic Stroke | Completed | 2003-08-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00372086 | Rosiglitazone and Insulin in T1DM Adolescents | Phase4 | Type 1 Diabetes | Completed | 2003-08-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00557336 | Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestation… | Phase3 | Foetal Growth Problem | Completed | 2003-07-28 | 2005-06-29 | ClinicalTrials.gov |
| NCT01580605 | French National Registry of Adults With Growth Hormone Deficiency Treated With … | — | Growth Hormone Disorder | Completed | 2003-07-17 | 2011-11-28 | ClinicalTrials.gov |
| NCT00617565 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes | Phase3 | Diabetes | Completed | 2003-07-08 | 2003-11-26 | ClinicalTrials.gov |
| NCT00168558 | Early Two-dose Measles Vaccination Trial | Phase4 | Measles | Completed | 2003-07-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01543880 | Safety and Efficacy of Long-term Somatropin Treatment in Adults | — | Growth Hormone Disorder | Completed | 2003-07-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00282594 | The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit | Na | Sepsis | Completed | 2003-07-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT01487421 | An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (Fl… | — | Diabetes | Completed | 2003-07-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00791895 | Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs | Phase4 | Diabetes | Completed | 2003-06-26 | 2004-11-29 | ClinicalTrials.gov |
| NCT00519558 | Growth Hormone Deficiency in Adults (GHDA) | Phase3 | Growth Hormone Disorder | Completed | 2003-05-31 | 2005-01-24 | ClinicalTrials.gov |
| NCT00604656 | Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Proc… | Phase3 | Diabetes | Completed | 2003-05-05 | 2004-01-29 | ClinicalTrials.gov |
| NCT01848002 | Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Health… | Phase1 | Congenital Bleeding Disorder | Completed | 2003-05-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00569400 | Comparison of Human Insulin Produced by the Current Process and the NN729 Proce… | Phase3 | Diabetes | Completed | 2003-05-01 | 2004-01-19 | ClinicalTrials.gov |
| NCT00102817 | Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children | Phase3 | Growth Hormone Disorder | Completed | 2003-05-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00604344 | Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring D… | Phase3 | Diabetes | Completed | 2003-04-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00135473 | Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Tri… | Phase3 | Severe Sepsis | Completed | 2003-04-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00184652 | Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease | Phase2 | Chronic Kidney Disease | Completed | 2003-04-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00560924 | Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urin… | Phase3 | Menopause | Terminated | 2003-03-21 | 2004-03-17 | ClinicalTrials.gov |
| NCT00567385 | Liquid Somatropin Formulation in Children With Growth Hormone Deficiency | Phase4 | Growth Hormone Disorder | Completed | 2003-03-10 | 2004-03-22 | ClinicalTrials.gov |
| NCT00056589 | Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congeni… | Phase1 | Congenital Bleeding Disorder | Completed | 2003-03-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT01497561 | Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type … | Phase1 | Diabetes | Completed | 2003-03-01 | 2003-06-01 | ClinicalTrials.gov |
| NCT00283751 | Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabeti… | Phase3 | Diabetes | Completed | 2003-03-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00604396 | Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabet… | Phase3 | Diabetes | Completed | 2003-03-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT01492153 | NovoLet® Surveillance Study on Using Human Insulin System in Indonesia | — | Diabetes | Completed | 2003-02-11 | 2006-09-05 | ClinicalTrials.gov |
| NCT00572806 | Initiation of Insulin Aspart in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2003-02-05 | 2004-02-02 | ClinicalTrials.gov |
| NCT01527565 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Mal… | Phase1 | Diabetes | Completed | 2003-01-20 | 2003-02-26 | ClinicalTrials.gov |
| NCT01486914 | Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process | Phase1 | Diabetes | Completed | 2003-01-19 | 2003-02-24 | ClinicalTrials.gov |
| NCT01847989 | Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers | Phase1 | Congenital Bleeding Disorder | Completed | 2003-01-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT00822471 | Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program … | Na | Diabetes | Completed | 2003-01-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT01620463 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in H… | Phase1 | Diabetes | Completed | 2002-12-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT00572052 | Comparison of Glycemic Control Achieved With 2 Different Needles | Phase4 | Diabetes | Completed | 2002-12-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00568984 | Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-11-21 | 2003-11-10 | ClinicalTrials.gov |
| NCT01527630 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Jap… | Phase1 | Diabetes | Completed | 2002-11-16 | 2003-01-08 | ClinicalTrials.gov |
| NCT01527552 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Mal… | Phase1 | Diabetes | Completed | 2002-11-05 | 2002-12-18 | ClinicalTrials.gov |
| NCT00184756 | Efficacy on Height in SGA Children Treated With Growth Hormone | Phase3 | Foetal Growth Problem | Completed | 2002-11-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00571584 | High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moder… | Phase4 | Congenital Bleeding Disorder | Completed | 2002-11-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00598793 | Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy | Phase3 | Diabetes | Completed | 2002-11-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00567775 | Comparison of Human Insulin to Insulin Inhalation Solution in Children With Typ… | Phase2 | Diabetes | Completed | 2002-10-21 | 2002-11-20 | ClinicalTrials.gov |
| NCT01448070 | Comparison of Human Insulin Produced by the Current Process and the NN729 Proce… | Phase1 | Diabetes | Completed | 2002-10-15 | 2002-12-20 | ClinicalTrials.gov |
| NCT00597233 | Human Insulin NPH and Insulin Aspart in Type 1 Diabetes | Phase4 | Diabetes | Completed | 2002-10-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01720303 | Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-09-19 | 2003-04-10 | ClinicalTrials.gov |
| NCT00725036 | Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Hu… | Phase3 | Diabetes | Completed | 2002-09-02 | 2004-12-14 | ClinicalTrials.gov |
| NCT01698697 | Comparison of Two Insulin Aspart Formulations in Healthy Volunteers | Phase1 | Diabetes | Completed | 2002-09-02 | 2002-10-18 | ClinicalTrials.gov |
| NCT01601457 | Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruc… | Phase2 | Acquired Bleeding Disorder | Completed | 2002-09-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00365170 | Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Wom… | Phase4 | Diabetes | Completed | 2002-09-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01562587 | Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Pat… | Phase1 | Congenital Bleeding Disorder | Completed | 2002-09-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT01467401 | Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-08-19 | 2003-05-15 | ClinicalTrials.gov |
| NCT01511172 | Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or … | Phase2 | Diabetes | Completed | 2002-08-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00312156 | Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Childre… | Phase3 | Diabetes | Completed | 2002-08-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT01542450 | Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes | Phase1 | Diabetes | Completed | 2002-08-01 | 2003-02-01 | ClinicalTrials.gov |
| NCT00426803 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | Phase2 | Acquired Bleeding Disorder | Completed | 2002-08-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT01720290 | Comparison of Repaglinide and Metformin Administered Alone or in Combination in… | Phase4 | Diabetes | Completed | 2002-07-25 | 2003-02-25 | ClinicalTrials.gov |
| NCT01697631 | Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-07-22 | 2003-04-24 | ClinicalTrials.gov |
| NCT01564563 | Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of B… | Phase2 | Acquired Bleeding Disorder | Terminated | 2002-06-28 | 2003-10-27 | ClinicalTrials.gov |
| NCT01009905 | An Observational Study (Registry) Assessing Treatment Outcomes and Safety for C… | — | Growth Hormone Disorder | Completed | 2002-06-24 | 2016-09-30 | ClinicalTrials.gov |
| NCT01467141 | Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes | Phase4 | Diabetes | Completed | 2002-06-19 | 2003-10-15 | ClinicalTrials.gov |
| NCT00071448 | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population | Phase3 | Diabetes | Completed | 2002-06-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT01487798 | Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin A… | Phase4 | Diabetes | Completed | 2002-06-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01526980 | Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 … | Phase2 | Diabetes | Completed | 2002-05-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01698931 | Efficacy of Repaglinide in Subjects With Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-04-26 | 2003-03-06 | ClinicalTrials.gov |
| NCT00312104 | Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Pa… | Phase3 | Diabetes | Completed | 2002-04-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT00513643 | Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses | Phase1 | Diabetes Mellitus | Completed | 2002-04-01 | 2002-06-01 | ClinicalTrials.gov |
| NCT01487369 | Special Survey of Production of Insulin Aspart Specific Antibody | — | Diabetes | Completed | 2002-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01487382 | Special Survey for Paediatric Subjects | — | Diabetes | Completed | 2002-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01487408 | Special Survey for Type 1 or Type 2 Diabetic Patients | — | Diabetes | Completed | 2002-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01486381 | Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes | Phase3 | Diabetes | Completed | 2002-03-20 | 2003-05-30 | ClinicalTrials.gov |
| NCT01465152 | Comparison of Metformin, Repaglinide or the Combination of Both in Subjects Wit… | Phase4 | Diabetes | Completed | 2002-03-06 | 2004-10-21 | ClinicalTrials.gov |
| NCT01563523 | Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injur… | Phase2 | Acquired Bleeding Disorder | Completed | 2002-03-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT01649570 | Safety and Efficacy of Insulin Aspart in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2002-03-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00168571 | Long-term Follow-up of Measles Antibodies | Phase4 | Measles | Completed | 2002-03-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT01486940 | Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human S… | Phase3 | Diabetes | Completed | 2002-03-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00115479 | KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients | Phase2 | Critical Illness | Completed | 2002-03-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00184678 | Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hoo… | Phase3 | Growth Hormone Disorder | Completed | 2002-02-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00676819 | Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and H… | Phase4 | Diabetes | Completed | 2002-01-10 | 2002-07-19 | ClinicalTrials.gov |
| NCT01562574 | Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Pae… | Phase3 | Acquired Bleeding Disorder | Completed | 2002-01-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01527539 | Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Ty… | Phase3 | Diabetes | Completed | 2001-11-23 | 2004-10-12 | ClinicalTrials.gov |
| NCT01605773 | Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes | Phase4 | Diabetes | Completed | 2001-11-08 | 2003-03-13 | ClinicalTrials.gov |
| NCT01563445 | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for P… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-11-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01563471 | Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Fac… | Phase1 | Congenital Bleeding Disorder | Completed | 2001-10-01 | 2002-07-01 | ClinicalTrials.gov |
| NCT01511159 | Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Inject… | Phase1 | Diabetes | Completed | 2001-10-01 | 2001-12-01 | ClinicalTrials.gov |
| NCT00662714 | Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis | Phase3 | Cystic Fibrosis | Completed | 2001-09-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01697657 | Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in We… | Phase3 | Diabetes | Completed | 2001-09-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT00108797 | Trial of NovoSeven® in Haemophilia - Joint Bleeds | Phase4 | Congenital Bleeding Disorder | Completed | 2001-09-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01561352 | Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Hae… | Phase2 | Other Haemostasis Disorder | Completed | 2001-09-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01498913 | Observational Study of NovoNorm® in Subjects With Diabetes | — | Diabetes | Completed | 2001-08-30 | 2005-03-25 | ClinicalTrials.gov |
| NCT01705249 | Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in P… | Phase4 | Menopause | Completed | 2001-08-14 | 2003-06-06 | ClinicalTrials.gov |
| NCT01566786 | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Ac… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-08-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00254514 | Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Grow… | Phase2 | Bone Fracture | Completed | 2001-08-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT01563458 | Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Under… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-08-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT01562821 | Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Pati… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-07-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00421850 | Using Networks, Informatics, Technology, and Education in Care for People With … | Na | Diabetes Mellitus | Completed | 2001-07-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT01601613 | Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fev… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-07-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01508949 | Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diab… | Phase2 | Diabetes | Completed | 2001-06-01 | 2002-03-01 | ClinicalTrials.gov |
| NCT00072904 | Diabetes Therapy to Improve BMI and Lung Function in CF | Phase3 | Cystic Fibrosis | Completed | 2001-06-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01562561 | Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With T… | Phase3 | Diabetes | Completed | 2001-06-01 | 2002-12-20 | ClinicalTrials.gov |
| NCT01698944 | Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone … | Phase4 | Growth Hormone Disorder | Terminated | 2001-05-16 | 2002-11-18 | ClinicalTrials.gov |
| NCT01502124 | Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency | Phase3 | Growth Hormone Disorder | Completed | 2001-05-08 | 2003-03-05 | ClinicalTrials.gov |
| NCT01508923 | Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With… | Phase2 | Diabetes | Completed | 2001-05-01 | 2002-02-01 | ClinicalTrials.gov |
| NCT01526941 | Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin… | Phase1 | Diabetes | Completed | 2001-05-01 | 2001-07-01 | ClinicalTrials.gov |
| NCT01704378 | Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Typ… | Phase4 | Diabetes | Completed | 2001-04-18 | 2003-03-14 | ClinicalTrials.gov |
| NCT01562158 | Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of B… | Phase2 | Acquired Bleeding Disorder | Completed | 2001-04-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT01509742 | Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2001-04-01 | 2001-11-01 | ClinicalTrials.gov |
| NCT01511198 | Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 … | Phase2 | Diabetes | Completed | 2001-02-01 | 2001-10-01 | ClinicalTrials.gov |
| NCT03220425 | Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of … | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2001-02-01 | 2001-11-12 | ClinicalTrials.gov |
| NCT01511185 | Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 D… | Phase1 | Diabetes | Completed | 2001-02-01 | 2001-10-01 | ClinicalTrials.gov |
| NCT01620424 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in S… | Phase1 | Diabetes | Completed | 2001-02-01 | 2001-04-01 | ClinicalTrials.gov |
| NCT00400283 | A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes | Phase1 | Diabetes | Completed | 2001-01-19 | 2001-05-03 | ClinicalTrials.gov |
| NCT01467375 | Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase3 | Diabetes | Completed | 2001-01-08 | 2004-10-22 | ClinicalTrials.gov |
| NCT01543867 | Safety and Efficacy of Long-term Somatropin Treatment in Children | — | Growth Hormone Disorder | Completed | 2001-01-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01524809 | Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 D… | Phase1 | Diabetes | Completed | 2001-01-01 | 2001-06-01 | ClinicalTrials.gov |
| NCT01650129 | Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabe… | Phase3 | Diabetes | Completed | 2000-12-13 | 2001-10-18 | ClinicalTrials.gov |
| NCT01563926 | Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Gro… | Phase3 | Growth Hormone Disorder | Completed | 2000-10-23 | 2002-10-10 | ClinicalTrials.gov |
| NCT01509755 | Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects Wi… | Phase2 | Diabetes | Completed | 2000-10-01 | 2001-10-01 | ClinicalTrials.gov |
| NCT00516113 | A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in … | Phase4 | Premenstrual Dysphoric Disorder | Completed | 2000-10-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT00262249 | Effect of Growth Hormone in Children With Growth Hormone Deficiency | Phase3 | Growth Hormone Disorder | Completed | 2000-08-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT01734447 | Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation | Phase4 | Foetal Growth Problem | Completed | 2000-04-30 | 2003-04-30 | ClinicalTrials.gov |
| NCT00931476 | A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating t… | Phase1 | Growth Hormone Disorder | Completed | 2000-04-06 | 2000-06-08 | ClinicalTrials.gov |
| NCT00065130 | Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational … | Phase3 | Diabetes | Completed | 2000-04-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01520818 | Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subject… | Phase3 | Diabetes | Completed | 2000-03-01 | 2001-04-01 | ClinicalTrials.gov |
| NCT00654121 | Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relat… | Phase2 | Diabetes, Type I | Completed | 2000-02-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT01620333 | Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volun… | Phase1 | Diabetes | Completed | 2000-02-01 | 2000-04-01 | ClinicalTrials.gov |
| NCT00832182 | Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Tre… | Phase3 | Diabetes | Completed | 1999-12-22 | 2002-11-25 | ClinicalTrials.gov |
| NCT01523041 | Comparison of Two Formulations of Biphasic Insulin Aspart 70 | Phase1 | Diabetes | Completed | 1999-11-03 | 1999-11-30 | ClinicalTrials.gov |
| NCT02162407 | A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial… | Phase1 | Diabetes | Completed | 1999-10-01 | 1999-12-01 | ClinicalTrials.gov |
| NCT01507311 | Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Di… | Phase1 | Diabetes | Completed | 1999-09-01 | 1999-12-01 | ClinicalTrials.gov |
| NCT01507285 | Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With … | Phase1 | Diabetes | Completed | 1999-08-01 | 1999-11-01 | ClinicalTrials.gov |
| NCT01520831 | Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Hea… | Phase1 | Diabetes | Completed | 1999-04-01 | 2000-05-01 | ClinicalTrials.gov |
| NCT00184691 | Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at … | Phase3 | Foetal Growth Problem | Completed | 1999-04-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT01579968 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and … | — | Congenital Bleeding Disorder | Completed | 1999-03-10 | 2010-03-09 | ClinicalTrials.gov |
| NCT01579955 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and … | — | Congenital Bleeding Disorder | Completed | 1999-03-10 | 2010-03-09 | ClinicalTrials.gov |
| NCT01586936 | Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in… | — | Congenital Bleeding Disorder | Completed | 1999-03-10 | 2010-03-09 | ClinicalTrials.gov |
| NCT01507272 | Safety and Tolerability of Liraglutide in Healthy Male Volunteers | Phase1 | Diabetes | Completed | 1999-03-01 | 1999-12-01 | ClinicalTrials.gov |
| NCT01520753 | Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Di… | Phase3 | Diabetes | Completed | 1999-03-01 | 1999-06-01 | ClinicalTrials.gov |
| NCT01562834 | Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult… | Phase4 | Growth Hormone Disorder | Completed | 1998-10-21 | 2002-12-01 | ClinicalTrials.gov |
| NCT01710696 | Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome | Phase3 | Genetic Disorder | Completed | 1998-07-23 | 2004-07-26 | ClinicalTrials.gov |
| NCT01467323 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes | Phase3 | Diabetes | Completed | 1998-04-01 | 1998-09-01 | ClinicalTrials.gov |
| NCT01561391 | Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Pa… | Phase4 | Congenital Bleeding Disorder | Completed | 1998-04-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00184769 | Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insuff… | Phase4 | Chronic Kidney Disease | Completed | 1998-01-29 | 2005-12-21 | ClinicalTrials.gov |
| NCT00872560 | Comparison of 2 NovoFine® Needles on the Reflux of Insulin | Phase3 | Diabetes | Completed | 1998-01-20 | 1998-07-27 | ClinicalTrials.gov |
| NCT00375388 | The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Rand… | Phase3 | Type 2 Diabetes Mellitus | Completed | 1998-01-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT01707134 | Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes | Phase3 | Diabetes | Completed | 1997-09-01 | 2000-05-01 | ClinicalTrials.gov |
| NCT01516229 | Special Survey for Long Term Application | — | Genetic Disorder | Completed | 1997-05-01 | 2007-03-31 | ClinicalTrials.gov |
| NCT00871416 | Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics… | Phase3 | Diabetes | Completed | 1997-04-09 | 1997-07-18 | ClinicalTrials.gov |
| NCT01697618 | Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in … | Phase2 | Diabetes | Completed | 1997-04-01 | 1998-11-01 | ClinicalTrials.gov |
| NCT01734486 | Growth Response in Girls With Turner Syndrome | Phase4 | Genetic Disorder | Completed | 1996-09-23 | 2003-05-21 | ClinicalTrials.gov |
| NCT01707160 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy … | Phase1 | Diabetes | Completed | 1995-11-01 | 1995-12-01 | ClinicalTrials.gov |
| NCT00570102 | Nutritional Prevention Pilot Trial for Type 1 Diabetes | Phase2 | Type 1 Diabetes Mellitus | Completed | 1995-02-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00464971 | Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic… | Phase3 | Menopause | Completed | 1995-01-31 | 1996-11-30 | ClinicalTrials.gov |
| NCT00465192 | Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis | Phase3 | Menopause | Completed | 1994-08-31 | 1995-11-30 | ClinicalTrials.gov |
| NCT01697644 | Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardati… | Phase4 | Foetal Growth Problem | Completed | 1990-10-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00252408 | Danish Osteoporosis Prevention Study | Phase4 | Osteoporosis | Completed | 1990-10-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01529840 | Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syn… | Phase3 | Genetic Disorder | Completed | 1990-06-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00410033 | Comparison of Antibody Levels in Children and Adolescents After Initiation of I… | Na | Diabetes | Completed | 1989-12-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01518062 | Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls … | Phase4 | Genetic Disorder | Completed | 1989-11-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT01518036 | Use of Somatropin in Turner Syndrome | Phase3 | Genetic Disorder | Completed | 1987-09-14 | 2004-04-11 | ClinicalTrials.gov |
Total clinical trials: 1672
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| placebo (semaglutide) | Other | Phase PHASE3 | Overweight and Obesity | COMPLETED | NCT05132088 |
| semaglutide 50 mg | Other | Phase PHASE3 | Overweight and Obesity | COMPLETED | NCT05132088 |
| Oral Semaglutide | Other | Preclinical | Type 2 Diabetes | COMPLETED | NCT06269120 |
| Etavopivat C | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Etavopivat B | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Etavopivat A | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Placebo | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06612268 |
| Etavopivat | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06612268 |
| Placebo (NNC0487-0111 oral) | Other | Phase PHASE2 | Type 2 Diabetes (T2D) | COMPLETED | NCT06542874 |
| NNC0487-0111 oral | Other | Phase PHASE2 | Type 2 Diabetes (T2D) | COMPLETED | NCT06542874 |
| Placebo (NNC0487-0111 subcutanous) | Other | Phase PHASE2 | Type 2 Diabetes (T2D) | COMPLETED | NCT06542874 |
| NNC0487-0111 subcutanous | Other | Phase PHASE2 | Type 2 Diabetes (T2D) | COMPLETED | NCT06542874 |
| Norditropin® | Other | Phase PHASE2 | Short Stature Children Born Small for Gestational Age (SGA) | ACTIVE_NOT_RECRUITING | NCT03878446 |
| Somapacitan | Other | Phase PHASE2 | Short Stature Children Born Small for Gestational Age (SGA) | ACTIVE_NOT_RECRUITING | NCT03878446 |
| Concizumab | Other | Phase PHASE3 | Haemophilia A Without Inhibitors | ACTIVE_NOT_RECRUITING | NCT04082429 |
| Eptacog alfa (NovoSeven) | Other | Phase PHASE4 | Severe Postpartum Haemorrhage | RECRUITING | NCT07157423 |
| Somapacitan | Other | Phase PHASE3 | SGA | ACTIVE_NOT_RECRUITING | NCT05723835 |
| Semaglutide | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07087795 |
| Placebo | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07087795 |
| NNC0194-0499 | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07087795 |
| Concizumab | Other | Phase PHASE3 | Haemophilia A and B With and Without Inhibitors | ACTIVE_NOT_RECRUITING | NCT05135559 |
| Oral semaglutide | Other | Phase PHASE3 | Type 2 Diabetes | COMPLETED | NCT07271251 |
| Trizepatide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06326047 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06326047 |
| NNC0519-0130 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06326047 |
| Placebo | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05636176 |
| Ziltivekimab | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05636176 |
| Etavopivat | Other | Phase PHASE2 | Sickle Cell Disease | RECRUITING | NCT06198712 |
| Insulin glargine | Other | Phase PHASE3 | Diabetes, Type 2 | COMPLETED | NCT06340854 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes, Type 2 | COMPLETED | NCT06340854 |
| Insulin Glargine 300U/mL | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin Degludec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin Glargine 100U/mL | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Basal insulin analogues | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07112339 |
| Insulin icodec | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07112339 |
| LED | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07757087 |
| Placebo | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07757087 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07757087 |
| oral glucose-lowering medications (commercially available) | Drug | Phase PHASE4 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05035082 |
| semaglutide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05035082 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07668388 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07668388 |
| UBT251 Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07668388 |
| UBT251 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07668388 |
| NNC0442-0344 A | Other | Phase PHASE1 | Haemophilia A | RECRUITING | NCT07220564 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05726227 |
| Semaglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05726227 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07220642 |
| Cagrilintide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07220642 |
| Placebo | Other | Phase PHASE2 | Heart Failure | RECRUITING | NCT06979362 |
| CDR132L | Other | Phase PHASE2 | Heart Failure | RECRUITING | NCT06979362 |
| Placebo | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07566390 |
| NNC0113-5840 | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07566390 |
| No treatment given | Drug | Preclinical | Medullary Thyroid Carcinoma | ENROLLING_BY_INVITATION | NCT07713901 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| Placebo | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Semaglutide | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Placebo semaglutide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07745504 |
| Placebo cagrilintide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07745504 |
| Cagrilintide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07745504 |
| Placebo (semaglutide) | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT03811561 |
| Semaglutide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT03811561 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE2 | Diabetes type1 | RECRUITING | NCT06411210 |
| Semaglutide Pen Injector | Other | Phase PHASE2 | Diabetes type1 | RECRUITING | NCT06411210 |
| Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY] | Other | Phase PHASE4 | Obesity | COMPLETED | NCT05548647 |
| Placebo | Other | Phase PHASE4 | Obesity | COMPLETED | NCT05548647 |
| Behavioral Treatment | Drug | Phase PHASE4 | Obesity | COMPLETED | NCT05548647 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE3 | Overweight | ACTIVE_NOT_RECRUITING | NCT07220759 |
| Cagrilintide | Other | Phase PHASE3 | Overweight | ACTIVE_NOT_RECRUITING | NCT07220759 |
| Placebo | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT06200207 |
| Ziltivekimab | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT06200207 |
| No treatment is given | Drug | Preclinical | MASLD/MASH | ACTIVE_NOT_RECRUITING | NCT07739901 |
| Semaglutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Cagrisema | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Placebo (NNC6989-0001) | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07437079 |
| NNC6989-0001 | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07437079 |
| Placebo (Ziltivekimab C) | Other | Phase PHASE3 | Cardiovascular Risk | COMPLETED | NCT05021835 |
| Placebo (Ziltivekimab B) | Other | Phase PHASE3 | Cardiovascular Risk | COMPLETED | NCT05021835 |
| Ziltivekimab C | Other | Phase PHASE3 | Cardiovascular Risk | COMPLETED | NCT05021835 |
| Ziltivekimab B | Other | Phase PHASE3 | Cardiovascular Risk | COMPLETED | NCT05021835 |
| No treatment given | Drug | Preclinical | Diabetes Mellitus, Type 2 | RECRUITING | NCT07532863 |
| Placebo (administered by PDS290 pen-injector) | Other | Phase PHASE2 | Lower Back Pain | NOT_YET_RECRUITING | NCT07731256 |
| Semaglutide (administered by PDS290 pen-injector) | Other | Phase PHASE2 | Lower Back Pain | NOT_YET_RECRUITING | NCT07731256 |
| Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07011667 |
| CagriSema (Cagrilintide B and Semaglutide I) | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07011667 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07720271 |
| zenagamtide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07720271 |
| Placebo | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| HU - Hydroxyurea | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| NDec - oral decitabine-tetrahydrouridine | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| Placebo ( matched to Zenagamtide) | Other | Phase PHASE3 | Obesity | NOT_YET_RECRUITING | NCT07668401 |
| Zenagamtide | Other | Phase PHASE3 | Obesity | NOT_YET_RECRUITING | NCT07668401 |
| No Intervention | Other | Preclinical | Pregnancy | ENROLLING_BY_INVITATION | NCT05503927 |
| Semaglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Oral Semaglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Liraglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteer | RECRUITING | NCT07270731 |
| NNC9733-0001 | Other | Phase PHASE1 | Healthy Volunteer | RECRUITING | NCT07270731 |
| No treatment given | Drug | Preclinical | Medullary Thyroid Carcinoma | ENROLLING_BY_INVITATION | NCT07713901 |
| Tirzepatide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06534411 |
| Semaglutide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06534411 |
| Cagrilintide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06534411 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo semaglutide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07253285 |
| Placebo cagrilintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07253285 |
| Semaglutide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07253285 |
| Cagrilintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07253285 |
| Placebo semaglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05567796 |
| Placebo cagrilintide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05567796 |
| Semaglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05567796 |
| Cagrilintide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05567796 |
| Cocktail (Warfarin/Caffeine/Midazolam) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07710768 |
| UBT251 | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07710768 |
| Acetaminophen | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07710729 |
| Oral contraceptive | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07710729 |
| UBT251 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07710729 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07567001 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07567001 |
| Semaglutide placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07639021 |
| NNC0662-0419 Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07639021 |
| Semaglutide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07639021 |
| NNC0662-0419 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07639021 |
| Placebo | Other | Phase PHASE2 | Heart Failure | RECRUITING | NCT06979362 |
| CDR132L | Other | Phase PHASE2 | Heart Failure | RECRUITING | NCT06979362 |
| Placebo CagriSema | Other | Phase PHASE3 | Overweight | WITHDRAWN | NCT07357766 |
| Cagrisema | Other | Phase PHASE3 | Overweight | WITHDRAWN | NCT07357766 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | ACTIVE_NOT_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | ACTIVE_NOT_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Somapacitan | Other | Phase PHASE3 | SGA | ACTIVE_NOT_RECRUITING | NCT05723835 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Placebo CagriSema | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | WITHDRAWN | NCT07357740 |
| CagriSema | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | WITHDRAWN | NCT07357740 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Placebo | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07693868 |
| NNC6022-0004 | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07693868 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Placebo semaglutide | Other | Phase PHASE3 | Type 2 Diabetes Mellitus | COMPLETED | NCT06065540 |
| Placebo cagrilintide | Other | Phase PHASE3 | Type 2 Diabetes Mellitus | COMPLETED | NCT06065540 |
| Semaglutide | Other | Phase PHASE3 | Type 2 Diabetes Mellitus | COMPLETED | NCT06065540 |
| Cagrilintide | Other | Phase PHASE3 | Type 2 Diabetes Mellitus | COMPLETED | NCT06065540 |
| Semaglutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Cagrisema | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Placebo | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05636176 |
| Ziltivekimab | Other | Phase PHASE3 | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05636176 |
| Placebo (semaglutide) | Other | Phase PHASE3 | Early Alzheimer's Disease | COMPLETED | NCT04777396 |
| Semagludtide | Other | Phase PHASE3 | Early Alzheimer's Disease | COMPLETED | NCT04777396 |
| Insulin glargine | Other | Phase PHASE3 | Diabetes, Type 2 | COMPLETED | NCT06340854 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes, Type 2 | COMPLETED | NCT06340854 |
| No treatment is given | Drug | Preclinical | Liver Disease | RECRUITING | NCT07682363 |
| Placebo (NNC6022-0001) | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT06336005 |
| NNC6022-0001 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT06336005 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07220642 |
| Cagrilintide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT07220642 |
| CDR132L (s.c.) | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07656454 |
| CDR132L (i.v.) | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07656454 |
| Mim8 | Other | Phase PHASE3 | Haemophilia A | RECRUITING | NCT05685238 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07567001 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07567001 |
| Insulin Icodec | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT06807190 |
| Insulin aspart | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Insulin glargine | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Placebo | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Semaglutide | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Insulin icodec | Other | Preclinical | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07160816 |
| No treatment given | Drug | Preclinical | Diabetes Mellitus, Type 2 | ENROLLING_BY_INVITATION | NCT07673822 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Placebo (semaglutide) | Other | Phase PHASE3 | Early Alzheimer´s Disease | COMPLETED | NCT04777409 |
| Semaglutide | Other | Phase PHASE3 | Early Alzheimer´s Disease | COMPLETED | NCT04777409 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07597018 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07607587 |
| Placebo (matched to zenagamtide) | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07668414 |
| Placebo (matched to semaglutide) | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07668414 |
| Semaglutide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07668414 |
| Zenagamtide | Other | Phase PHASE3 | Overweight | NOT_YET_RECRUITING | NCT07668414 |
| Placebo ( matched to Zenagamtide) | Other | Phase PHASE3 | Obesity | NOT_YET_RECRUITING | NCT07668401 |
| Zenagamtide | Other | Phase PHASE3 | Obesity | NOT_YET_RECRUITING | NCT07668401 |
| Semaglutide Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07668388 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07668388 |
| UBT251 Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07668388 |
| UBT251 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07668388 |
| Placebo oral tablet | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05441267 |
| Semaglutide Oral Tablet | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05441267 |
| Functional rice variaties | Other | Approved | Prediabetes / Type 2 Diabetes | NOT_YET_RECRUITING | NCT07663123 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT06625307 |
| NNC0537-1482 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT06625307 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Insulin icodec | Other | Preclinical | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07658417 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Concizumab | Other | Phase PHASE3 | Haemophilia A and B With and Without Inhibitors | ACTIVE_NOT_RECRUITING | NCT05135559 |
| Placebo | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| HU - Hydroxyurea | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| NDec - oral decitabine-tetrahydrouridine | Other | Phase PHASE2 | Sickle Cell Disease | COMPLETED | NCT05405114 |
| No treatment given | Drug | Preclinical | Diabetes Mellitus, Type 2 | RECRUITING | NCT07532863 |
| Etavopivat | Other | Phase PHASE1 | Liver Diseases | COMPLETED | NCT06336018 |
| CDR132L (s.c.) | Other | Phase PHASE1 | Healthy Volunteers | NOT_YET_RECRUITING | NCT07656454 |
| CDR132L (i.v.) | Other | Phase PHASE1 | Healthy Volunteers | NOT_YET_RECRUITING | NCT07656454 |
| Placebo | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06612268 |
| Etavopivat | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06612268 |
| NNC0442-0344 A | Other | Phase PHASE1 | Haemophilia A | COMPLETED | NCT07238816 |
| No treatment given | Drug | Preclinical | Haemophilia A | NOT_YET_RECRUITING | NCT07653139 |
| Turoctocog alfa | Other | Preclinical | Congenital Bleeding Disorder | COMPLETED | NCT06574984 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| Placebo | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Semaglutide | Other | Phase PHASE3 | Non-alcoholic Steatohepatitis | ACTIVE_NOT_RECRUITING | NCT04822181 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05726227 |
| Semaglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT05726227 |
| Insulin Glargine 300U/mL | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin Degludec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin Glargine 100U/mL | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04760626 |
| Semaglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Oral Semaglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Liraglutide | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07225816 |
| Semaglutide | Other | Phase PHASE4 | Obesity, Childhood | NOT_YET_RECRUITING | NCT06977438 |
| Turoctocog alfa pegol | Other | Preclinical | Haemophilia A | COMPLETED | NCT04334057 |
| Concizumab | Other | Preclinical | Haemophilia A, Haemophilia B | ENROLLING_BY_INVITATION | NCT06831734 |
| Concizumab | Other | Preclinical | Congenital Haemophilia | AVAILABLE | NCT04921956 |
| Concizumab | Other | Preclinical | Haemophilia A | ENROLLING_BY_INVITATION | NCT06285071 |
| Eptacog alfa (NovoSeven) | Other | Phase PHASE4 | Severe Postpartum Haemorrhage | RECRUITING | NCT07157423 |
| Concizumab | Other | Phase PHASE3 | Haemophilia A With Inhibitors | ACTIVE_NOT_RECRUITING | NCT04083781 |
| Somapacitan | Other | Preclinical | Adult Growth Hormone Deficiency | ENROLLING_BY_INVITATION | NCT05718570 |
| Placebo insulin degludec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04795531 |
| Insulin degludec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04795531 |
| Placebo insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04795531 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04795531 |
| Semaglutide 1 mg | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05259033 |
| IcoSema | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05259033 |
| Norditropin® | Other | Phase PHASE3 | SGA, Turner Syndrome, Noonan Syndrome, ISS | ACTIVE_NOT_RECRUITING | NCT05330325 |
| Somapacitan | Other | Phase PHASE3 | SGA, Turner Syndrome, Noonan Syndrome, ISS | ACTIVE_NOT_RECRUITING | NCT05330325 |
| Mim8 | Other | Phase PHASE3 | Haemophilia A | ACTIVE_NOT_RECRUITING | NCT05685238 |
| Concizumab | Other | Phase PHASE3 | Haemophilia A Without Inhibitors | ACTIVE_NOT_RECRUITING | NCT04082429 |
| Nonacog beta pegol | Other | Preclinical | Haemophilia B | ENROLLING_BY_INVITATION | NCT03745924 |
| Rybelsus® | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04572165 |
| Active Comparator | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04572165 |
| Ozempic® | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04572165 |
| Etavopivat C | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Etavopivat B | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Etavopivat A | Other | Phase PHASE3 | Sickle Cell Disease | RECRUITING | NCT06609226 |
| Semaglutide placebo | Other | Phase PHASE2 | Obesity | NOT_YET_RECRUITING | NCT07639021 |
| NNC0662-0419 Placebo | Other | Phase PHASE2 | Obesity | NOT_YET_RECRUITING | NCT07639021 |
| Semaglutide | Other | Phase PHASE2 | Obesity | NOT_YET_RECRUITING | NCT07639021 |
| NNC0662-0419 | Other | Phase PHASE2 | Obesity | NOT_YET_RECRUITING | NCT07639021 |
| Norditropin® | Other | Phase PHASE2 | Short Stature Children Born Small for Gestational Age (SGA) | ACTIVE_NOT_RECRUITING | NCT03878446 |
| Somapacitan | Other | Phase PHASE2 | Short Stature Children Born Small for Gestational Age (SGA) | ACTIVE_NOT_RECRUITING | NCT03878446 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Tirzepatide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT06534411 |
| Semaglutide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT06534411 |
| Cagrilintide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT06534411 |
| No Intervention | Other | Preclinical | Pregnancy | ENROLLING_BY_INVITATION | NCT05503927 |
| Insulin degludec | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06288412 |
| Insulin icodec | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | COMPLETED | NCT06288412 |
| Insulin icodec | Other | Preclinical | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07632404 |
| Insulin Icodec | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT06807190 |
| Basal insulin analogues | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07112339 |
| Insulin icodec | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07112339 |
| NNC0363-1063 | Other | Phase PHASE1 | Diabetes Mellitus, Type 1 | COMPLETED | NCT07305805 |
| Insulin aspart | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Insulin glargine | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Insulin icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07076199 |
| Placebo (semaglutide) | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04560998 |
| Semaglutide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT04560998 |
| Insulin icodec | Other | Preclinical | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07160816 |
| Insulin glargine | Other | Phase PHASE3 | Type 2 Diabetes | COMPLETED | NCT06269107 |
| IcoSema | Other | Phase PHASE3 | Type 2 Diabetes | COMPLETED | NCT06269107 |
| Placebo | Other | Phase PHASE1 | Type 1 Diabetes (T1D) | RECRUITING | NCT07578584 |
| NNC0497-0040 | Other | Phase PHASE1 | Type 1 Diabetes (T1D) | RECRUITING | NCT07578584 |
| Placebo | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07566390 |
| NNC0113-5840 | Other | Phase PHASE1 | Obesity | RECRUITING | NCT07566390 |
| Semaglutide | Other | Preclinical | Overweight | RECRUITING | NCT07627074 |
| Placebo | Other | Phase PHASE2 | NAFLD | RECRUITING | NCT05424003 |
| Semaglutide Pen Injector | Other | Phase PHASE2 | NAFLD | RECRUITING | NCT05424003 |
| Semaglutide | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05813912 |
| Insulin Icodec | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | COMPLETED | NCT05813912 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Phase PHASE4 | Obesity | ACTIVE_NOT_RECRUITING | NCT06571383 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Semaglutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Cagrisema | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07564414 |
| Insulin glargine | Other | Phase PHASE3 | Type 2 Diabetes | COMPLETED | NCT06269107 |
| IcoSema | Other | Phase PHASE3 | Type 2 Diabetes | COMPLETED | NCT06269107 |
| Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07282613 |
| CagriSema (Cagrilintide B and Semaglutide I) | Other | Phase PHASE3 | Diabetes Mellitus, Type 2 | NOT_YET_RECRUITING | NCT07282613 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (NNC6019-0001) | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| NNC6019-0001 | Other | Phase PHASE3 | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | RECRUITING | NCT07207811 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo (matched to Cagrilintide) | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07607587 |
| No treatment given | Drug | Preclinical | X-linked Hypophosphatemia (XLH) | NOT_YET_RECRUITING | NCT07607600 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Norditropin® | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Somapacitan | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Norditropin® | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Somapacitan | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Norditropin® | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Somapacitan | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Norditropin® | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Somapacitan | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Placebo | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Liraglutide | Other | Phase PHASE3 | Obesity | ACTIVE_NOT_RECRUITING | NCT04775082 |
| Cagrilintide D | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Cagrilintide B | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07605052 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571005 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07571109 |
| Norditropin® | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Somapacitan | Other | Phase PHASE3 | Growth Hormone Deficiency in Children | COMPLETED | NCT03811535 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Control group | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 2: Mobilization the first 4 postoperative weeks | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Intervention 1: Mobilization during hospitalization | Other | Approved | Postoperative Pain, Acute | RECRUITING | NCT06222151 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Cagrilintide B and placebo semaglutide I | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Cagrilintide D | Other | Phase PHASE1 | Obesity | NOT_YET_RECRUITING | NCT07597018 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| NNC1679-0001 | Other | Phase PHASE1 | Healthy Volunteers | RECRUITING | NCT07570992 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| NNC0487-0111 | Other | Phase PHASE3 | Diabetes Mellitus | RECRUITING | NCT07533175 |
| Placebo | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Semaglutide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Cagrilintide | Other | Phase PHASE3 | Cardiovascular Disease | ACTIVE_NOT_RECRUITING | NCT05669755 |
| Placebo | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Semaglutide | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| NNC0662-0419 | Other | Phase PHASE2 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07415954 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07503210 |
| semaglutide | Other | Preclinical | Diabetes Mellitus, Type 2 | COMPLETED | NCT04469855 |
| Warfarin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Atorvastatin | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Semaglutide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Cagrilintide | Other | Phase PHASE1 | Obesity | COMPLETED | NCT06289504 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Semaglutide | Other | Phase PHASE3 | Overweight | COMPLETED | NCT06041217 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Cagrilintide | Other | Phase PHASE1 | Overweight | RECRUITING | NCT07557953 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07509307 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
| NNC0487-0111 | Other | Phase PHASE1 | Overweight | NOT_YET_RECRUITING | NCT07587710 |
| Placebo (matched to NNC0487-0111 ) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07481630 |
| Semaglutide | Other | Preclinical | Obesity | ENROLLING_BY_INVITATION | NCT07055607 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
| Placebo (matched to NNC0487-0111) | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| NNC0487-0111 | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07339423 |
| SEMAFOLLOW questionnaire | Other | Preclinical | Obesity & Overweight | NOT_YET_RECRUITING | NCT07423481 |
Total products: 875